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Anterior  cruciate  ligament  reconstruction  utilizing  a  hamstring  autograft  is  a  surgical  
technique  that  has  gained  popularity  among  orthopedic  surgeons  caring  for  adolescent  
patients.    While  utilization  of  a  hamstring  autograft  is  a  revered  technique,  harvest  of  the  
hamstring  yields  significant  pain.    Sciatic  peripheral  nerve  blockade  has  proven  to  
reliably  provide  analgesia  at  the  hamstring  donor  site.    Single-­injection  sciatic  peripheral  
nerve  blockade  is  considered  a  basic  and  effective  technique,  making  its  use  following  
anterior  cruciate  ligament  reconstruction  standard  practice  in  many  institutions.    The  
duration  of  action  of  a  single-­injection  sciatic  peripheral  nerve  blockade  may  fail  to  
   
outlast  the  pain  arising  from  the  hamstring  donor  site,  prompting  some  clinicians  to  
employ  continuous  sciatic  peripheral  nerve  blockade  via  an  indwelling  catheter.    A  lack  
of  comparative  effectiveness  studies  exists  in  the  literature  regarding  the  duration  of  
action  of  peripheral  nerve  blockade  necessary  to  adequately  provide  pain  control  
following  hamstring  autograft  harvest,  resulting  in  disagreement  among  clinicians  as  to  
best  pain  control  practices.    Proponents  of  continuous  sciatic  peripheral  nerve  blockade  
assert  that  while  more  costly,  the  extended  duration  of  analgesia  afforded  by  this  
technique  improves  pain  control  postoperatively  and  decreases  the  use  of  other  pain  
medications.    Advocates  of  single-­injection  sciatic  peripheral  nerve  blockade  cite  
concerns  associated  with  continuous  sciatic  peripheral  nerve  blockade  known  to  be  
detrimental  to  rehabilitation,  such  as  decreased  active  knee  flexion  and  increased  risk  of  
falls.    The  purpose  of  this  research  is  to  compare  the  effect  of  single-­injection  sciatic  
PNB  to  continuous  sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  self-­
reported  pain  scores,  pain  medication  use,  and  unplanned  hospital  admission  due  to  
poor  pain  control,  2)  active  knee  flexion,  and  3)  patient  satisfaction  with  pain  control  
following  ACL  reconstruction  with  a  hamstring  autograft.    The  findings  of  this  study  have  
the  potential  to  guide  informed  clinical  reasoning  and  decision  making  regarding  sciatic  
peripheral  nerve  blockade  techniques  following  hamstring  autograft  harvest  in  
adolescents  undergoing  anterior  cruciate  ligament  reconstruction.    
     




Chapter  One:  Introduction  
 
In  1980,  Rosenblatt  first  reported  the  use  of  a  continuous  femoral  nerve  catheter  
as  the  sole  means  of  providing  postoperative  analgesia  following  knee  surgery  for  
patella  alta,  or  high  riding  patella,  in  an  adolescent  (Rosenblatt,  1980).    With  the  patient  
under  general  anesthesia,  a  small  incision  was  made  below  the  inguinal  ligament,  just  
lateral  to  the  femoral  artery.    An  18-­gauge  Teflon-­coated  intravenous  (IV)  catheter  was  
then  threaded  over  a  22-­gauge  spinal  needle  through  the  incision  at  a  30-­degree  angle  
to  the  skin,  leaving  the  tip  of  the  catheter  adjacent  to  the  femoral  nerve  in  the  
neurovascular  sheath.    The  spinal  needle  was  then  withdrawn  and  the  IV  catheter  was  
connected  to  extension  tubing  and  sutured  in  place.    Bupivacaine,  a  local  anesthetic,  
was  infused  through  the  catheter  for  the  next  24  hours.    At  the  time,  the  duration  for  
infusion  of  the  local  anesthetic  was  chosen  arbitrarily  as  the  uptake  and  distribution  of  
drugs  from  the  femoral  space  was  unknown.  
While  likely  unaware  of  the  impact  of  this  procedure  on  the  future  of  clinical  
practice,  Rosenblatt  provided  the  foundation  for  what  would  soon  become  the  gold  
standard  in  providing  postoperative  analgesia  following  knee  surgery:  continuous  
peripheral  nerve  blockade.    Much  has  changed  since  Rosenblatt  first  introduced  the  use  
of  a  continuous  femoral  nerve  catheter  for  postoperative  analgesia.    Local  anesthetics  
utilized  today  offer  a  safer  side-­effect  profile  compared  to  their  predecessors.    
Additionally,  modern  purpose-­specific  equipment,  such  as  continuous  perineural  
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infusion  (CPI)  catheters,  allows  clinicians  to  provide  effective  site-­specific  analgesia  
over  an  extended  period  in  a  more  reliable  fashion.    
Background  
Anterior  cruciate  ligament  (ACL)  injury  is  the  most  prevalent  injury  treated  in  
orthopedic  sports  medicine.    The  incidence  of  ACL  injuries  continues  to  increase  with  
approximately  250,000  now  occurring  annually  in  the  United  States  (Gagnier,  
Morgenstern,  &  Chess,  2012).    As  such,  ACL  reconstruction  has  become  a  common  
surgical  procedure  and  is  frequently  performed  on  an  outpatient  basis.    ACL  
reconstruction  has  historically  been  avoided  in  skeletally  immature  patients  due  to  
concerns  of  injuring  the  immature  physes,  resulting  in  growth  deformities.    Advances  in  
surgical  techniques,  however,  now  allow  ACL  reconstruction  to  be  performed  safely  and  
effectively  in  skeletally  immature  patients.    Given  the  decreasing  age  of  patients  now  
undergoing  this  surgical  procedure,  orthopedic  surgeons  are  charged  with  ensuring  
optimal  ACL  longevity  following  reconstruction.    Subsequently,  there  has  been  a  marked  
increased  in  the  use  of  hamstring  autografts  for  reconstruction  of  the  injured  ACL  in  
adolescents  due  to  the  favorable  long-­term  outcome  profile  of  this  surgical  technique  
when  compared  to  other  available  graft  reconstruction  options.    The  harvesting  of  a  
hamstring  autograft,  however,  yields  significant  postoperative  pain  for  which  no  
consensus  exists  among  clinicians  as  to  how  to  best  treat.    
Statement  of  the  Problem    
Several  options  exist  for  replacement  of  the  damaged  ligament  during  ACL  
reconstruction  in  adolescents,  yet  the  use  of  a  hamstring  autograft  has  emerged  as  the  
technique  of  choice  due  to  the  overall  decreased  morbidity  and  proven  long-­term  
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stability  when  compared  to  other  ligament  reconstruction  options  (Mehta,  Mandala,  
Foster,  &  Petsche,  2010;;  Pallis,  Svoboda,  Cameron,  &  Owens  2012).    The  growing  
trend  to  use  a  hamstring  autograft  for  ligament  reconstruction  is  a  departure  from  the  
technique  typically  employed  in  the  adult  population,  where  use  of  an  allograft  tendon,  
or  transplant  tendon  from  another  individual,  has  been  the  predominant  technique  
employed.    The  use  of  hamstring  autograft  creates  new  concerns  for  surgeons  and  
anesthetists  alike.      
A  hamstring  autograft  is  commonly  comprised  of  both  semitendinosus  and  
gracilis  muscles  harvested  via  an  anterior  approach  from  the  ipsilateral  leg  during  ACL  
reconstruction  (Figure  1).    Once  harvested,  the  two  harvested  muscles  are  sutured  into  
a  unified  graft  in  an  effort  to  replicate  the  size  and  strength  of  the  native  ACL.    Despite  
the  benefits  of  using  a  hamstring  autograft,  it  is  not  without  its  drawbacks.    One  of  the  
biggest  disadvantages  related  to  the  use  of  hamstring  autograft  is  significant  pain  at  the  
hamstring  donor  site  during  the  postoperative  period.    Accordingly,  pain  control  
accounting  for  pain  arising  from  the  donor  site  is  of  the  utmost  importance  when  
developing  an  analgesic  plan  (Bushnell,  Sakryd,  &  Noonan,  2010).      
Pain  control  can  be  operationalized  a  multitudes  of  ways.    For  the  purposes  of  
this  study,  pain  control  will  be  measured  via  self-­reported  pain  scores,  the  frequency  of  
oral  pain  medicine  use  following  discharge  from  the  hospital  after  surgery,  and  the  
incidence  of  unplanned  hospital  admission  due  to  poor  pain  control.    While  it  is  
acknowledged  that  hamstring  harvest  leads  to  considerable  pain  during  the  immediate  
postoperative  period,  the  significance  of  this  pain  beyond  the  initial  24  hours  
postoperatively  remains  undetermined  as  it  has  yet  to  be  fully  investigated  (Bushnell,  
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Figure  1.  Hamstring  Autograft  Harvest  Via  an  Anterior  Approach.  (Parikh,  2011)  
  
  
Sakryd,  &  Noonan,  2010).    Given  the  ever-­increasing  number  of  adolescents  
undergoing  ACL  reconstruction  with  a  hamstring  autograft,  discerning  best  pain  control  
practices  following  hamstring  autograft  harvest  is  a  concern  demanding  more  empirical  
attention.      
Femoral  peripheral  nerve  blockade  (PNB)  is  the  gold  standard  for  providing  
analgesia  following  ACL  reconstruction,  however,  femoral  PNB  alone  does  not  provide  
adequate  pain  control  following  ACL  reconstruction  with  a  hamstring  autograft  (Williams,  
Kentor,  Vogt,  Williams,  Chelly,  Valalik,  Harner,  &  Fu,  2003).    Various  modalities  are  
available  to  provide  analgesia  at  the  hamstring  donor  site  (Table  1),  yet  not  all  are  
available  in  the  outpatient  setting.    Only  intravenous  opioids,  local  infiltration,  intra-­
articular  injection,  or  sciatic  PNB  are  able  to  provide  analgesia  beyond  discharge  from  
the  hospital.    Of  these  modalities,  most  either  inadequately  control  pain  following  ACL  
reconstruction  with  a  hamstring  autograft  or  are  fraught  with  adverse  side  effects,  such  
as  nausea  and  vomiting,  lethargy,  hypopnea,  constipation,  and  pruritus.    Sciatic  PNB,  
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Table  1    
  
Options  for  Blocking  Pain  at  Hamstring  Donor  Site  
however,  provides  adequate  pain  control  while  avoiding  undesirable  opioid-­related  side  
effects  and  has  proven  to  abate  hamstring  donor  site  pain  in  a  reliable  fashion  
(Bushnell,  Sakryd,  &  Noonan,  2010).    The  efficacy  of  sciatic  PNB  can  be  attributed  to  
the  origin  of  pain  following  hamstring  autograft  harvest,  graft  fixation,  or  both,  which  lies  
in  the  sciatic  nerve  distribution  (Frost,  Grossfeld,  Kirkley,  Litchfield,  Fowler,  &  
Amendola,  2000).      
Controversy  remains  as  to  whether  single-­injection  or  continuous  sciatic  PNB  is  
most  appropriate  following  ACL  reconstruction  with  a  hamstring  autograft.    Single-­
injection  sciatic  PNB  is  a  regional  anesthetic  technique  employed  to  anesthetize  the  
sciatic  nerve  with  a  single  dose  of  local  anesthetic.    This  technique  offers  pain  control  
Treatment  Modality   Advantages   Disadvantages  
Intravenous  opioids   Gold  standard  in  pain  control,  cost-­effective  
Undesirable  side  effects:  N/V,  
pruritus,  somnolence,  urinary  
retention,  hypoventilation  
Epidural/spinal   Excellent  postoperative  pain  control   Limited  to  in-­hospital  use  
Local  infiltration/intra-­articular  
injection  
Not  technically  challenging  to  
perform,  practical,  cost-­
effective  
Fails  to  consistently  control  
donor  site  pain  
Single-­injection  sciatic  PNB  
Minimizes  opioid  requirement,  
provides  site-­specific  
analgesia,  improved  early  
mobilization  of  major  joints  
Time  consuming,  limited  
duration  of  action  
Continuous  sciatic  PNB  
Minimizes  opioid  requirement,  
provides  site-­specific  
analgesia,  improved  early  
mobilization  of  major  joints  
Time  consuming,  costly,  
increased  potential  for  toxicity  
and/or  infection  
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for  a  limited  amount  of  time  based  on  the  volume  and  concentration  of  local  anesthetic  
used.    Continuous  sciatic  PNB  entails  placing  a  CPI  catheter  so  that  local  anesthetic  
may  be  released  slowly  but  continuously  adjacent  to  the  sciatic  nerve  (perineural)  for  
several  days  postoperatively.    While  both  techniques  of  sciatic  PNB  alleviate  pain  in  the  
immediate  postoperative  period,  only  continuous  PNB  has  the  ability  to  reliably  provide  
analgesia  on  subsequent  postoperative  days.    No  consensus  exists  regarding  the  
duration  of  action  necessary  to  adequately  provide  pain  control  following  ACL  
reconstruction  with  a  hamstring  autograft.    The  disagreement  among  clinicians  as  to  
best  practices  of  pain  control  following  ACL  reconstruction  with  a  hamstring  autograft  is  
largely  due  to  the  lack  of  evidence  comparing  single-­injection  and  continuous  sciatic  
PNB  following  hamstring  autograft  harvest.      
To  date,  there  has  only  been  one  study  reported  in  the  literature  comparing  
single-­injection  and  continuous  sciatic  PNB.    Continuous  sciatic  PNB  was  reported  to  
offer  significant  advantages  in  pain  control  for  adults  only  during  the  initial  24  hours  
following  knee  surgery  (Wegener,  van  Ooij,  van  Dijk,  Hollmann,  Preckel,  &  Stevens,  
2011).    It  should  be  noted,  however,  this  study  does  not  refer  to  ACL  reconstruction,  
rather  the  study  population  is  comprised  of  patients  undergoing  total  knee  replacement  
making  it  challenging  to  appropriately  translate  and  apply  the  clinical  knowledge  gained  
from  that  study  to  other  clinical  scenarios.      
Advantage/disadvantage  of  single-­injection  sciatic  PNB.    The  two  most  
significant  advantages  attributed  to  single-­injection  PNB  techniques  are  ease  and  cost-­
effectiveness.    Single-­injection  sciatic  PNB  requires  little  additional  equipment  or  time  to  
perform  when  compared  to  continuous  sciatic  PNB.    This  is  a  basic  technique  that  
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requires  no  additional  training  beyond  that  received  during  anesthesia  residency  or  
nurse  anesthetist  training.    In  its  simplest  form,  the  only  required  equipment  is  
antibacterial  skin  preparation,  sterile  gloves,  a  PNB  injection  needle,  local  anesthetic,  
and  a  nerve  stimulator.    In  the  hands  of  a  skilled  clinician,  it  takes  no  more  than  two  
minutes  to  perform  a  single-­injection  sciatic  PNB.    Depending  on  the  volume  and  
concentration  of  local  anesthetic  used,  single-­injection  sciatic  PNB  has  been  reported  to  
effectively  provide  analgesia  up  to  24  hours.    There  have  been  occasional  reports  of  the  
duration  of  action  lasting  up  to  36  hours  when  the  maximum  recommended  dose  of  
local  anesthetic  has  been  administered  in  adults,  further  bolstering  the  argument  for  the  
use  of  this  technique.    The  main  disadvantage  of  single-­injection  sciatic  PNB  is  that  it  
may  fail  to  outlast  the  pain  arising  from  the  hamstring  donor  site  (Ganesh  &  Cucchiaro,  
2007).    A  duration  of  action  greater  than  24  hours  in  younger,  smaller  patients  is  
challenging  to  achieve  due  to  the  weight-­based  dosing  restrictions  that  limit  the  total  
dose  that  can  safely  be  administered.    The  total  dose  of  local  anesthetic  is  the  product  
of  the  volume  and  concentration  of  the  local  anesthetic.    Furthermore,  when  multiple  
PNBs  are  administered  concurrently,  the  total  dose  of  local  anesthetic  must  be  divided  
between  each  PNB  as  to  not  exceed  safe  dosing  recommendations.    Therefore,  while  
the  initial  costs  attributed  to  a  single-­injection  sciatic  PNB  are  minimal,  the  use  of  this  
technique  may  lead  to  more  costs,  as  increased  dosing  of  pain  medication  is  required  to  
compensate  for  the  limited  duration  of  analgesia.    
Advantage/disadvantage  of  continuous  sciatic  PNB.    The  primary  advantage  
of  continuous  sciatic  PNB  when  compared  to  single-­injection  PNB  is  the  ability  to  extend  
the  duration  of  analgesia  postoperatively.    Proponents  of  continuous  PNB  demonstrated  
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that  the  extended  duration  of  analgesia  afforded  by  a  CPI  catheter  following  orthopedic-­
related  surgeries  improves  overall  pain  control  postoperatively  and  decreases  the  need  
for  supplemental  pain  medications  during  the  postoperative  period  (Ganesh  &  
Cucchiaro,  2007).    The  additional  costs  attributed  to  continuous  sciatic  PNB  may  lead  
some  clinicians  to  deem  the  modality  prohibitive,  as  additional  equipment  is  required,  
including  catheters,  needles,  an  infusion  pump,  dressing  supplies  and  additional  local  
anesthetic.    It  has  been  argued  that  the  additional  costs  are  justified,  however,  as  the  
ability  to  provide  extended  analgesia  postoperatively  decreases  the  average  length  of  
hospitalization.    Thus,  improving  postoperative  pain  control  ultimately  leads  to  efficient  
use  of  health  resources  and  decreases  overall  costs  for  patients  (Strassels,  Chen,  &  
Carr,  2002).    
Several  potential  disadvantages  exist  related  to  the  use  of  continuous  sciatic  
PNB.    Concerns  of  increased  falls,  decreased  knee  flexion,  and  masking  of  
compartment  syndrome  following  the  placement  of  a  sciatic  CPI  catheter  as  reasons  to  
preclude  their  routine  use  following  ACL  reconstruction  with  a  hamstring  autograft  (Liu  &  
Wu,  2007).    The  sciatic  nerve  innervates  the  hamstrings,  which  are  responsible  for  knee  
flexion  (Distad  &  Weiss,  2013).    The  extended  duration  of  anesthesia  provided  
continuous  sciatic  PNB  may  prolong  motor  blockade,  thereby  limiting  active  knee  
flexion.    Hindering  active  knee  flexion  postoperatively  may  impede  rehabilitation.    In  
addition,  should  a  femoral  PNB  and  sciatic  PNB  be  administered  on  the  same  leg  
concurrently,  the  patient  will  lose  sensation  and  motor  function  of  the  leg  from  the  thigh  
to  the  toes.    They  will  not  have  the  strength  to  safely  bear  weight  with  the  anesthetized  
extremity  until  the  PNB  has  resolved.      
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Although  infrequently  reported,  a  major  risk  factor  of  continuous  PNB  is  CPI  
catheter  infection  (Lai,  Jaeger,  Jones,  Kaderbek,  &  Malchow,  2011).    While  minimal,  the  
rate  of  infection  continues  to  rise  as  the  duration  the  catheter  is  left  in  place  increases.    
Local  anesthetic  toxicity  is  a  potential  hazard  for  both  single-­injection  and  continuous  
sciatic  PNB.    This  concern  is  heightened  for  continuous  sciatic  PNB  due  to  the  
continuous  infusion  of  local  anesthetic  via  the  CPI  catheter.    To  avoid  reaching  toxic  
level,  the  total  dose  of  local  anesthetic  infused  is  based  on  patient  weight.    
Significance  of  the  Problem  
Currently  the  mean  age  of  ACL  reconstruction  is  18  years,  indicating  half  of  the  
number  of  patients  undergoing  ACL  reconstruction  are  adolescents  (Silvers  &  
Mandelbaum,  2007).    Historically,  adolescents  with  ACL  injuries  have  been  treated  
conservatively,  with  many  orthopedic  surgeons  relying  on  non-­surgical  techniques,  such  
as  bracing  and  activity  restrictions,  for  treatment.    Due  to  the  increased  safety  profile  of  
ACL  reconstruction  in  skeletally  immature  patients  over  time  and  the  long-­term  
detriment  to  the  meniscus  should  ACL  reconstruction  be  delayed,  the  incidence  of  ACL  
reconstruction  in  the  adolescent  population  has  increased  by  over  400  percent  in  the  
last  decade.    Despite  this  exponential  growth,  there  is  no  professional  standard  of  care  
addressing  postoperative  pain  control  for  this  patient  population.      
Mismanagement  of  pain  can  be  detrimental,  resulting  in  negative  physiological,  
psychological,  and  economic  consequences  (Agin  &  Glass,  2005).    Failure  to  address  
pain  may  lead  to  future  impairment  in  functioning  as  well  as  heighten  anxiety  and  fear,  
which  in  turn  may  further  increase  the  perception  of  pain  (Matthews,  2011).    Continued  
mismanagement  of  pain  results  in  increased  suffering  and  misery  that  can  ultimately  
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impact  one’s  lifestyle  and  personality  (Beales,  Holt,  Keen  &  Mellor,  1983).    In  addition,  
unaddressed  pain  can  cause  great  disruption  to  families  caring  for  patients.    From  an  
economic  perspective,  the  mismanagement  of  pain  can  lead  to  slower  rates  of  recovery,  
resulting  in  increased  healthcare-­related  costs  and  time  away  from  school  and  work  
(Twycross,  2002).  
Pain  is  an  individual  experience.    While  every  patient  has  a  different  perception  
of  pain,  it  is  a  reasonable  expectation  that  evidence-­based  protocols  exist  to  guide  pain  
control  following  ACL  reconstruction  for  the  adolescent  population  given  the  frequency  
with  which  this  surgery  is  performed.    The  goal  of  pain  control  is  to  decrease  the  
intensity  and  duration  of  pain  to  the  level  that  is  tolerable  for  the  patient  without  
impeding  recovery.    Although  acute  pain  is  often  managed  successfully,  further  
research  is  necessary  to  determine  how  to  best  provide  pain  control  several  days  
postoperatively  following  ACL  reconstruction  with  a  hamstring  autograft  such  that  
negative  physiological,  psychological,  and  economic  consequences  are  avoided.      
Research  Question  
   This  study  aims  to  answer  the  following  research  question:  Does  single-­injection  
sciatic  PNB  or  continuous  sciatic  PNB  provide  more  effective  postoperative  pain  control  
following  ACL  reconstruction  with  a  hamstring  autograft  in  the  adolescent  population?    
Purpose  of  the  Study  
The  purpose  of  this  research  is  to  compare  the  effect  of  single-­injection  sciatic  
PNB  to  continuous  sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  self-­
reported  pain  scores,  pain  medication  use,  and  unplanned  hospital  admission  due  to  
poor  pain  control,  2)  active  knee  flexion,  and  3)  patient  satisfaction  with  pain  control  
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following  ACL  reconstruction  with  a  hamstring  autograft.    The  results  of  this  research  
have  the  potential  to  positively  impact  pain  control  for  the  adolescent  population  
undergoing  this  surgical  procedure  and  foster  responsible  utilization  of  limited  
resources.      
Chapter  Summary  
 ACL  reconstruction  with  a  hamstring  autograft  is  a  surgical  technique  that  has  
gained  popularity  among  orthopedic  surgeons  caring  for  adolescent  patients  with  ACL  
injuries  due  to  the  long-­lasting  nature  of  the  graft.    While  the  use  of  a  hamstring  
autograft  is  a  revered  surgical  technique,  postoperative  pain  at  the  graft  donor  site  can  
be  significant.    Sciatic  PNB,  in  general,  has  proven  to  reliably  provide  analgesia  at  the  
hamstring  donor  site.    Single-­injection  sciatic  PNB  is  considered  to  be  a  basic  and  
effective  technique,  making  its  use  following  ACL  reconstruction  routine  practice  in  
many  institutions.    The  duration  of  action  of  a  single-­injection  sciatic  PNB,  however,  may  
fail  to  outlast  the  pain  arising  from  the  hamstring  donor  site,  prompting  some  clinicians  
to  employ  a  sciatic  CPI  catheter  for  continued  infusion  of  local  anesthetic  medications.    
Use  of  a  sciatic  CPI  catheter,  however,  adds  additional  cost,  may  lead  to  falls  or  hinder  
rehabilitation,  increases  the  risk  of  local  anesthetic  toxicity,  and  is  a  potential  vector  for  
infection.    No  definitive  evidence  exists  in  the  literature  guiding  practitioners  in  the  
decision  to  use  either  single-­injection  sciatic  PNB  or  continuous  sciatic  PNB  for  pain  
control  following  ACL  reconstruction  with  a  hamstring  autograft.    This  research  has  the  
potential  to  contribute  to  improving  pain  control  strategies  for  adolescents  undergoing  
ACL  reconstruction  with  a  hamstring  autograft.    
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Chapter  Two:  Literature  Review  
  
Chapter  Introduction    
Quite  often,  the  choice  of  anesthesia  and  pain  control  is  at  the  discretion  of  the  
anesthesia  team  and  is  based  on  the  patient’s  medical  history,  presence  of  comorbid  
medical  conditions,  and  surgical  goals.    In  many  instances,  protocols  are  developed  for  
frequently  performed  procedures  and  are  refined  over  time  to  guide  anesthetists  toward  
delivering  a  safe  and  effective  anesthetic.    When  caring  for  a  patient  undergoing  an  
uncommon  surgical  procedure,  however,  anesthetists  are  charged  with  relying  on  their  
cadre  of  skills  and  experiences  to  quickly  develop  and  implement  an  anesthetic  plan  to  
best  serve  the  patient.    Evidence  uncovered  in  the  current  literature  enables  
anesthetists  to  better  understand  aspects  of  care  given  an  unfamiliar  situation.    While  
ACL  reconstruction  utilizing  a  hamstring  autograft  in  adolescents  is  becoming  more  
frequent,  many  anesthetists  remain  unfamiliar  with  caring  for  this  patient  population.    In  
this  chapter,  the  form  and  function  of  the  ACL  will  be  described,  as  well  as  the  current  
surgical  options  for  repairing  an  injured  ACL.    In  addition,  the  definitions  and  
components  of  pain  will  be  summarized  and  the  most  current  understanding  of  pain  
control  for  patients  undergoing  ACL  reconstruction  utilizing  a  hamstring  autograft  will  be  
outlined.      
The  anterior  cruciate  ligament.    The  ACL  is  a  band-­like  structure  comprised  of  
dense  connective  tissues  that  course  from  the  femur  to  the  tibia  (Duthon,  Barea,  
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Abrassart,  Fasel,  Fritschy,  &  Menetrey,  2006).    It  is  a  key  structure  in  the  knee  joint,  as  
it  functions  as  the  primary  restraint  to  anterior  tibial  translation.    Without  an  intact  ACL,  
anterior  translocation  of  the  tibia  occurs  during  normal  knee  movement  activity  leading  
to  pain  and  instability  (Hudgens  &  Dahm,  2012).                                                                                                                                                  
It  is  widely  accepted  that  the  ACL,  which  lies  intraarticular  yet  extrasynovial,  is  
comprised  of  the  anteromedial  (AMB)  and  posterolateral  bundles  (PLB)  (Bicer,  Lustig,  
Servien,  Selmi,  &  Neyret,  2010)  (Figure  2).    Debate  exists,  however,  as  to  whether  or  
not  these  bundles  occur  as  separate,  distinct  bundles  or  as  one  unified  bundle.    The  
origin  of  each  of  these  bundles  is  well  documented  (Bicer,  Lustig,  Servien,  Selmi,  &  
Neyret,  2010).    Enveloped  in  synovium,  the  AMB  originates  at  the  most  anterior  and  
proximal  aspects  of  the  femoral  insertion  site  with  the  PLB  originating  at  the  posterior  
and  inferior  aspect  of  the  femoral  attachment  (Bicer,  Lustig,  Servien,  Selmi,  &  Neyret,  
2010).    Distally,  the  ACL  passes  beneath  the  transverse  meniscal  ligament  and  inserts  
into  the  anterior  intercondylar  fossa,  anterolateral  to  the  medial  tibial  spine  (Bicer,  
Lustig,  Servien,  Selmi,  &  Neyret,  2010).    The  AMB  and  PLB  collectively  function  to  
maintain  anterior  and  rotational  stability  utilizing  varying  tensioning  patterns  throughout  
the  full  range  of  motion  of  the  knee  (Bicer,  Lustig,  Servien,  Selmi,  &  Neyret,  2010).  
ACL  durability:  venerable  or  vulnerable?    The  knee  is  the  most  common  site  
of  injury  requiring  surgical  repair  (Kartus,  Movin,  &  Karlsson,  2001).    ACL  injuries  
represent  the  largest  single  injury  in  orthopedic  sports  medicine  and  the  incidence  
continues  to  increase,  with  approximately  250,000  ACL  injuries  occurring  annually  in  the  
United  States  (Gagnier,  Morgenstern,  &  Chess,  2012).    Therefore,  every  year  1  out  of  
every  3,000  Americans  will  sustain  an  ACL  injury  (Macaulay,  Perfetti,  &  Levine,  2012).      
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Figure  2.  Schematic  Drawings  of  the  Sagittal  View  of  the  AMB  (orange)  and  the  PLB    




A  multitude  of  hormonal,  anatomic,  environmental,  and  neuromuscular  factors  
can  lead  to  ACL  injury  (Boden,  Griffen,  &  Garrett,  2000).    The  degree  to  which  specific  
etiologic  factors  contribute  to  ACL  laxity,  tensile  failure,  or  increased  flexibility,  however,  
remains  unknown  (Boden,  Griffen,  &  Garrett,  2000).    Regardless  of  cause,  the  resultant  
ACL  deficiency  greatly  increases  the  likelihood  of  ACL  sprain  or  rupture,  as  the  ACL  is  
not  able  to  function  normally  and  properly  restrict  anterior  neutral  position  shift.      As  a  
result,  the  anterior  translation  of  the  tibia  relative  to  the  femur  is  four  times  greater  than  
that  of  normal  knees  in  the  presence  of  ACL  deficiency  (Beynnon,  Flemming,  Labovitch,  
&  Parsons,  2002).    
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ACL  injury  in  adolescents.    Among  adolescent  athletes,  the  knee  is  the  most  
frequent  site  of  muscloskeletal  injury  (Micheli  &  Foster,  1993).    While  ACL  injury  can  be  
due  to  trauma  or  genetic  defect,  the  most  frequent  cause  of  ACL  injury  in  adolescents  is  
participation  in  competitive  sports  (McConkey,  Bonasia,  &  Amendola,  2011).    The  
competitive  nature  of  youth  sports  today  is  largely  to  blame  for  the  increase  in  knee  
injuries  among  children  and  adolescents  (Mohtadi  &Grant,  2006).    In  adolescents,  the  
mechanism  of  injury  most  often  is  a  non-­contact  pivoting  motion  on  a  fixed  foot,  
however,  the  ACL  can  also  be  injured  secondary  to  hyperextension  (Boden,  Dean,  
Feagin,  &  Garret,  2000).    Sports  that  force  a  pivoting  motion  are  more  likely  to  be  
associated  with  ACL  injury,  with  the  greatest  incidence  of  ACL  tears  found  among  
basketball  and  soccer  players  (Piasecki,  Spindler,  Warren,  Andrish,  &  Parker,  2003).    In  
fact,  over  a  5-­year  period  Shea,  Pfeiffer,  Jo,  Curtin,  and  Apel  (2004)  noted  that  in  soccer  
players  aged  5  to  18  years,  knee  injuries  accounted  for  22%  of  all  injuries,  with  ACL  
injuries  accounting  for  31%  of  those  claims.    
During  non-­contact  activity,  ACL  injury  can  occur  in  the  adolescent  population  
during  deceleration  or  movement  that  involves  a  change  of  directional  forces,  such  as  
when  playing  basketball,  football  or  soccer  (Adirim  &  Cheng,  2003).    While  injuries  to  
the  ACL  are  more  frequent  among  certain  cutting  and  pivoting  sports,  mechanisms  of  
sustaining  an  ACL  injury  in  various  sports  remains  largely  unknown  (Granan,  Inacio,  
Maletis,  Funahashi,  &  Engebretsen,  2013).      Non-­contact,  sudden  deceleration,  with  the  
knee  positioned  near  full  extension,  is  considered  the  primary  cause  of  the  majority  of  
ACL  injuries,  with  valgus  loading  considered  to  be  an  important  mechanism  of  injury  
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(Podraza  &  White,  2010).    ACL  injuries  may  also  be  attributed  to  the  inability  to  disperse  
energy  by  the  ankle  when  impacting  the  ground  (Podraza  &  White,  2010).      
Historically,  ACL  tears  were  thought  to  only  occur  following  the  closure  of  the  
epiphyseal  plate,  which  is  a  hyaline  cartilage  near  the  end  of  the  long  bones  in  children  
and  adolescents  (Rang,  1983).    The  incidence  of  skeletally  immature  patients  requiring  
ACL  reconstruction,  however,  continues  to  grow  rapidly  (Schachter  &  Rokito,  2007).    
Skeletal  maturity  refers  to  the  acceleration  in  bone  growth  and  subsequent  obliteration  
of  the  cartilaginous  zones,  or  growth  plates,  which  occurs  during  puberty  secondary  to  
alterations  in  endogenous  sex  hormones  (Wall,  Meyer,  &  May,  2011).    The  risk  for  
complete  ACL  tears  continues  to  rise  as  children  mature  due  to  the  increase  in  skeletal  
rigidity  associated  with  maturation  and  closure  of  the  cartilaginous  growth  plates  in  the  
knee  (Prince,  Laor,  &  Bean,  2005).    ACL  injuries  typically  occur  in  adolescents  within  6-­
12  months  of  skeletal  maturity  (Woods  &  O’Connor,  2004).    Multiple  factors  can  be  
credited  with  the  dramatic  rise  in  ACL  reconstruction  in  the  adolescent  population  over  
the  last  decade,  namely  increased  participation  in  sports  at  early  ages,  increased  
awareness  of  the  potential  for  injury  and  improved  diagnostic  imaging  techniques  of  
such  injuries  (Hui  &  Chowdhary,  2011).    
While  Piasecki  et  al.  (2003)  found  no  significant  differences  relating  to  gender  
and  mechanism  of  injury  in  adolescent  ACL  injuries,  female  athletes  in  general  have  an  
increased  tendency  towards  knee  injuries,  being  two  to  six  times  more  likely  to  suffer  an  
ACL  tear.    Likewise,  year-­round  female  soccer  and  basketball  athletes  have  an  ACL  
tear  rate  of  approximately  5%  per  year,  which  is  approximately  three  times  that  of  their  
male  counterparts  (Prodromos,  Han,  Rogowski,  Joyce,  &  Shi,  2007).      Following  
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skeletal  maturation,  females  continue  to  have  a  higher  risk  of  ACL  rupture,  with  the  
incidence  2  to  8  times  higher  than  that  of  males  of  equal  age  (Prince,  Laor,  &  Bean,  
2005).    Prior  to  skeletal  maturity,  however,  males  have  a  higher  incidence  of  ACL  
rupture  (Hudgens  &  Dahm,  2012).      
ACL  reconstruction.    ACL  reconstruction  is  accomplished  using  a  graft  to  
replace  the  damaged  ACL.    Once  it  has  been  determined  that  ACL  reconstruction  is  
necessary,  the  surgeon  is  charged  with  deciding  which  graft  type  best  suites  the  
individual  patient’s  needs.    A  graft  is  tissue  from  one’s  own  body  (autograft)  ,  tissue  from  
another  person  (allograft),  or  artificial  tissue  that  is  surgically  implanted  without  a  native  
blood  supply  (synthetic  graft).    Factors  considered  by  the  surgeon  in  making  this  
determination  are  many,  but  often  include  donor  site  morbidity,  graft  failure  rate,  
surgeon  familiarity  with  the  graft  type,  graft  availability,  surgical  time,  associated  
complications,  ability  to  restore  the  patient’s  activity  to  pre-­injury  level  and  cost-­
effectiveness  of  the  chosen  technique  (Dheerendra,  Khan,  Singhal,  Shivarathre,  
Pydisetty,  &  Johnstone,  2012).      
In  the  adult  population,  a  variety  of  techniques  have  been  successfully  employed,  
namely  the  use  of  synthetic  grafts,  allografts,  and  autografts.    The  two  most  common  
autografts  are  the  bone-­patellar  tendon-­bone  and  hamstrings  tendon  grafts  (Dheerendra  
et  al.,  2012).    Multiple  types  of  grafts  have  been  employed  to  reconstruct  the  damaged  
ACL  in  adolescents,  with  the  use  of  semitendinosus  and  gracilis  tendon  autografts  being  
the  preferred  technique  in  this  patient  population.    Once  harvested,  the  semitendinosus  
and  gracilis  tendon  are  sutured  together  to  form  a  single  graft  approximately  the  size  of  
the  native  ACL  or  larger.    Once  sutured  together,  the  graft  is  commonly  referred  to  as  a  
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hamstring  autograft.    The  use  of  a  hamstring  autograft  is  associated  with  decreased  
morbidity  and  proven  long-­term  stability  when  compared  to  the  other  ACL  replacement  
options,  however,  choosing  to  use  a  hamstring  autograft  leads  to  a  second  site  of  pain  
that  must  be  accounted  for  in  the  postoperative  period  (Mehta,  Mandala,  Foster,  &  
Petsche,  2010;;  Pallis,  Svoboda,  Cameron,  &  Owens,  2012).  
Anesthetic  challenges  with  ACL  reconstruction.    ACL  reconstruction  is  
recognized  as  a  painful  surgical  procedure.    Advances  in  surgical  technique,  the  
understanding  of  pain,  and  advances  in  pain  management  protocols,  however,  have  
improved  clinicians’  abilities  to  successfully  manage  the  patient’s  pain  on  an  outpatient  
basis  in  both  the  adult  and  adolescent  population.    Still,  several  challenges  remain  to  
providing  adequate  analgesia  following  ACL  reconstruction  with  a  hamstring  autograft  
given  there  are  two  sources  of  tissue  damage,  the  ACL  and  the  hamstring  donor  site.    
Multiple  prospective,  randomized  studies  have  examined  how  to  best  address  pain  at  
the  reconstruction  site  following  ACL  repair  in  general.    To  date,  however,  little  is  known  
about  the  most  effective  techniques  to  abate  donor  site  pain  following  hamstring  
autograft  harvest.      
The  femoral  nerve  provides  sensory  and  motor  innervation  to  the  anterior  thigh,  
anterior  knee,  and  the  medial  aspect  of  the  leg  below  the  knee  (Mall  &  Wright,  2010).    
Femoral  PNB  involves  injecting  local  anesthetic  into  the  space  surrounding  the  femoral  
nerve,  thereby  modulating  sensory  and  motor  signals  traveling  along  the  distribution  of  
the  femoral  nerve.    While  femoral  PNB  is  widely  utilized  for  postoperative  pain  control  
following  ACL  reconstruction,  this  intervention  fails  to  account  for  pain  at  the  native  
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donor  site  of  the  hamstring  autograft  (Kristensen,  Pfeiffer-­Jensen,  Storm,  &  Thillemann,  
2012).      
Definitions  of  Pain    
The  International  Association  for  the  Study  of  Pain  (IASP)  describes  pain  as  “an  
unpleasant  sensory  and  emotional  experience  associated  with  actual  or  potential  tissue  
damage,  or  described  in  terms  of  such  damage”  (Mersky  &  Bogduk,  1994).    A  single  
definition  of  pain  is  challenging  to  capture,  however,  as  there  are  many  factors  to  
consider  and  it  is  a  subjective  experience.    In  general,  the  definition  of  pain  largely  
relates  to  a  given  circumstance.    There  is  no  objective  measurement  of  pain  (Farrar,  
Berlin,  &  Strom,  2003).    Rather,  the  measurement  thereof  relies  on  report  from  the  
individual  patient  (Farrar,  Portenoy,  Berlin,  Kinman,  &  Strom,  2000).  
In  2008,  the  IASP  greatly  expanded  the  definition  of  pain,  which  reflects  an  
improved  understanding  of  the  phenomenon  of  pain  (Loeser  &  Treede,  2008).    As  the  
understanding  of  pain  and  pain  pathways  continues  to  expand,  definitions  of  pain  are  
likely  to  evolve  accordingly.    For  the  purpose  of  this  study,  acute  postoperative  pain  will  
be  the  primary  focus  of  interest,  as  this  remains  clinically  challenging  to  manage  in  
adolescents  undergoing  outpatient  ACL  reconstruction  with  a  hamstring  autograft  
(Brennan,  2011).  
The  Physiology  of  Pain  
   Pain  has  been  described  as  the  perception  of  an  adverse  stimulus  (Almeida,  
Roizenblatt,  &  Tufik,  2004).    This  stimulus  may  be  chemical,  mechanical,  or  thermal  in  
origin  (Caterina  &  Julius,  2001).    The  phenomenon  of  pain  occurs  along  a  three-­neuron  
pathway  responsible  for  transmitting  noxious  stimuli  from  the  periphery  of  the  body  to  
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the  cerebral  cortex  in  the  central  nervous  system,  where  the  perception  of  pain  or  
discomfort  is  realized  (Morgan,  Mikhail,  &  Murray,  2006).    
Pain  begins  with  the  activation  of  nociceptors:  sensory  neurons  that  respond  to  
potentially  damaging  stimuli  by  sending  signals  to  the  spinal  cord  and  brain.    
Nociceptors  are  found  widely  in  skin,  mucosa,  membranes,  deep  fascias,  connective  
tissues  of  visceral  organs,  ligaments  and  articular  capsules,  periosteum,  muscles,  
tendons,  and  arterial  vessels  (Almeida,  Roizenblatt,  &  Tufik,  2004).    Nociceptors  
represent  the  most  distal  aspect  of  first-­order  afferent  neurons  in  the  periphery  and  
consist  of  A-­delta,  C,  or  A-­beta  fibers.    First-­order  afferent  neurons  have  a  single  
bifurcating  axon  located  in  the  dorsal  root  ganglia  of  the  vertebral  foramina,  which  sends  
one  end  to  the  peripheral  tissue  and  the  other  to  the  dorsal  horn  of  the  spinal  cord  
(Morgan,  Mikhail,  &  Murray,  2006).    
Nociception,  the  encoding  and  processing  of  harmful  stimuli,  is  a  peripheral  
phenomenon  that  ultimately  concludes  in  the  dorsal  horn  of  the  spinal  cord  (Loeser,  
2000).    Nociceptive  input  is  conveyed  from  a  peripheral  end  organ,  such  as  the  skin,  to  
the  central  nervous  system  predominantly  by  two  classes  of  first-­order  afferent  fibers,  A-­
delta  fibers  and  C  fibers  (Katz  &  Rothenberg,  2005).    A-­delta  fibers,  which  are  
myelinated,  are  classified  into  two  groups,  those  with  high-­threshold  mechanoreceptors  
that  primarily  respond  to  mechanical  stimuli  of  high  intensity,  such  as  hitting  one’s  finger  
with  a  hammer,  and  those  with  mechanoreceptors  that  respond  to  extremes  of  
temperature  such  as  in  the  case  of  burns  (Almeida,  Roizenblatt,  &  Tufik,  2004).    Like  A-­
delta  fibers,  C  fibers  are  activated  by  a  variety  of  high-­intensity  mechanical,  chemical,  
and  extreme  hot  and  cold  stimuli,  however,  these  fibers  are  unmyelinated  (Katz  &  
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Rothenberg,  2005).    In  contrast,  A-­beta  fibers  do  not  normally  propagate  noxious  
potentials.    These  fibers  are  key  to  pain  circuitry  as  they  participate  in  the  mechanism  of  
segmental  suppression  by  causing  presynaptic  inhibition  of  pain  signals  (Katz  &  
Rothenberg,  2005).      
As  first-­order  neurons  enter  the  spinal  cord  from  the  peripheral  tissues,  they  
segregate  according  to  size  and  travel  the  spinal  cord  to  synapse  with  second-­order  
neurons  in  the  gray  matter  of  the  ipsilateral  dorsal  horn  of  the  spinal  cord  (Morgan,  
Mikhail,  &  Murray,  2006)  (Figure  3).    Second-­order  neurons  are  one  of  two  types,  those  
that  receive  only  noxious  input  or  those  that  receive  both  noxious  and  non-­noxious  
input.    Second-­order  neurons  cross  to  the  contralateral  aspect  of  the  spinal  cord  and  
form  the  spinothalamic  tract,  which  is  classically  considered  the  major  pathway  for  the  
propagation  of  pain  (Morgan,  Mikhail,  &  Murray,  2006).    The  spinothalamic  tract  
ultimately  delivers  signals  to  the  primary  sensory  cortex  of  the  brain  via  the  thalamus,  
where  the  discriminative  component  associated  with  pain  is  ultimately  perceived,  and  to  
the  limbic  cortical  areas  of  the  brain,  where  the  affective  aspects  of  the  pain  experience,  
such  as  depression,  anger,  anxiety,  and  despair,  are  perceived  (Katz  &  Rothenberg,  
2005).  
Components  of  Pain  
Pain  is  a  complex,  multifaceted  phenomenon.    It  is  not  solely  a  sensory  modality,  
rather  it  is  an  experience  comprised  of  multiple  components  (Morgan,  Mikhail,  &  Murray,  
2006).    There  are  four  broad  components  of  pain:  nociception,  perception  of  pain,  
suffering,  and  pain  behaviors  (Loeser  &  Melzack,  1999).    Nociception  is  a  physiologic    
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Figure  3.  Depiction  of  the  Pain  Pathway  (www.perioperativepain.com)  
  
  
term  describing  the  neural  processes  of  encoding  and  processing  noxious  stimuli  
(Loeser  &  Treede,  2008).    Once  a  harmful  stimulus  has  been  processed,  the  perception  
of  pain  leads  to  suffering  and  ultimately  pain  behaviors  if  the  perception  of  pain  
continues.    
These  four  main  components  of  pain  can  be  classified  into  one  of  two  categories:  
those  that  can  be  quantified  and  those  that  cannot.    Nociception,  perception  of  pain,  and  
suffering  are  internal  events  whose  validity  and  intensity  cannot  be  established  by  
observation  (Loeser,  2000).    Pain  behaviors,  however,  are  based  on  actions  rather  than  
personal  report  and  are  observable,  measurable,  and  objective  (Loeser,  2000).    When  
pain  is  experienced,  patients  exhibit  a  variety  of  behaviors  that  serve  to  communicate  
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the  presence  and  intensity  of  pain  being  experienced  (Keefe  &  Wren,  2013).    Pain  
behaviors,  therefore,  often  guide  pain  control  strategies  as  a  reference  point  can  be  
established  to  guide  further  intervention.    Envisioning  these  four  components  as  nested  
circles  (Figure  4)  aids  in  understanding  the  interplay  between  the  aspects  of  pain  that  
are  readily  quantified  and  those  that  are  not.      
  
Figure  4.  Depiction  of  the  Universe  of  Pain  (Loeser,  2000).  
  
  
Nociception.    Nociception  accounts  for  the  mechanisms  by  which  noxious  
stimuli  are  detected  by  the  peripheral  nervous  system,  encoded,  transferred,  and  
unconsciously  addressed  by  the  nervous  system  within  the  human  body  (Barrot,  2012).    
More  specifically,  nociception  is  the  detection  of  tissue  damage  by  specialized  
transducers  connected  to  A-­delta  and  C  fibers  (Loeser,  2000).    During  surgery,  for  
example,  tissue  damage  caused  by  surgical  incision  or  other  surgical  manipulation  is  
detected  primarily  by  A-­delta  and  C  fibers  in  the  peripheral  nervous  system  and  
subsequently  transmitted  to  the  central  nervous  system  for  interpretation.      
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Perception  of  pain.    The  perception  of  pain  refers  to  how  one  processes  and  
reacts  to  physiological  stimuli  (Linton,  2005).    This  process  begins  in  the  dorsal  horn  of  
the  spinal  cord  and  involves  the  entire  spinal  cord  and  brain  (Loeser,  2000).    While  
frequently  triggered  by  a  noxious  stimulus,  pain  can  also  be  associated  with  potential,  
rather  than  actual,  tissue  damage  (Loeser  &  Treede,  2008).    Furthermore,  noxious  
stimuli  culminating  in  pain  can  be  generated  at  any  point  in  the  pain  pathway  by  either  
central  or  peripherally  located  lesions  (Loeser  &  Melzack,  1999).    Once  perceived,  pain  
triggers  autonomic  and  somatic  reflexes  within  the  body  to  respond  to  the  painful  stimuli  
(Loeser  &  Melzack,  1999).    When  pain  is  perceived,  the  paraventricular  nucleus  of  the  
hypothalamus  is  excited  and  short-­term  adaptive  responses,  known  as  the  stress  
response,  are  initiated  in  the  hypothalamo-­pituitary-­adrenocortical  axis  (Chapman  &  
Gavrin,  1999).    The  stress  response  is  an  adaptive  pattern  of  neural  and  endocrine  
activation  and  behavioral  changes  that  occurs  in  the  brain  and  is  directed  toward  the  
restoration  of  homeostasis  (Chapman  &  Gavrin,  1999).  
The  perception  of  pain,  however,  is  more  than  simple  nerve  stimulation  (Linton,  
2005).    Cognitive  and  emotional  processing  of  pain  occurs  within  the  brain  similar  to  the  
processing  of  input  from  noxious  stimuli  (Julius  &  Basbaum,  2001).    Emotions  have  a  
powerful  impact  on  pain  perception,  as  pain  and  emotions  are  intimately  related  with  
robust  reciprocal  interaction  (Roy,  Piche,  Chen,  Peretz,  &  Rainville,  2009).      
Suffering.    In  most  instances,  pain  leads  to  suffering,  which  is  a  negative  
affective  response  generated  in  the  brain  (Loeser,  2000).    Although  commonly  used  
interchangeably,  the  concepts  of  pain  and  suffering  are  distinctly  different  (Cassell,  
1982).    Pain  is  a  perceived  threat  or  damage  to  one’s  biological  integrity  and  has  
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sensory  and  emotional  facets  (Chapman  &  Gavrin,  1999).    While  pain  can  lead  to  
suffering,  not  all  pain  causes  suffering.    Suffering  is  a  broader  concept  than  pain  and  
can  have  many  causes,  one  of  which  may  be  pain.    Suffering  connotes  enduring  an  
unpleasant  and/or  inconvenient  experience  (Chapman  &  Gavrin,  1999).    It  is  an  
overwhelming  state  of  severe  distress  that  is  both  personal  and  subjective,  and  
coincides  with  a  range  of  intense  emotions  (Thompson  &  Chochinov,  2012).      
The  stress  response  initiated  by  the  autonomic  and  somatic  reflexes  in  response  
to  the  perception  of  pain  are  often  short-­term  in  nature.    Should  the  perception  of  pain  
persist,  however,  dysregulation  of  the  neural  and  endocrine  pathways  of  the  stress  
response  can  ensue,  leading  to  alterations  in  signal  pathways,  abnormal  neural  firing  
patterns,  and  potentially  lower  firing  thresholds.    Ultimately,  such  alterations  may  
debilitate  one’s  sense  of  self,  which  is  subjective  sense  of  identity  based  on  past  
experiences,  resulting  in  suffering  (Chapman  &  Gavrin,  1999).    Suffering  develops  when  
discrepancies  between  expectation  for  one’s  self  and  reality  arise  (Chapman  &  Gavrin,  
1999).    Ultimately,  suffering  connotes  enduring  something  unpleasant  and  inconvenient,  
sustaining  loss  or  damage,  or  experiencing  a  disability  (Chapman  &  Gavrin,  1999).    
Pain  behaviors.    Pain  behaviors  are  real  and  are  influenced  by  previous  
experiences  that  have  resulted  in  suffering  (Loeser,  2000).    As  suffering  progresses,  
human  behaviors  can  develop  such  as  saying  “ouch”,  grimacing,  or  limping  in  response  
to  pain.    Such  behaviors  can  be  readily  quantified  when  attempting  to  infer  the  degree  of  
nociception,  pain  perception,  and  suffering  (Loeser  &  Melzack,  1999).    Failing  to  
respond  to  painful  stimuli  typically  associated  with  tissue  damage  as  one  would  expect  
is  another  example  of  a  pain  behavior  (Loeser,  2000).  
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Theories  of  Pain    
Several  theories  explaining  the  physiological  basis  of  pain  have  been  offered,  yet  
to  date  no  theory  completely  accounts  for  all  aspects  of  pain  perception  (Moayedi  &  
Davis,  2013).    Whether  a  specific  pathway  mediates  pain  or  a  non-­specific  pathway  in  
the  nervous  system  meditates  pain  remains  the  primary  dispute  between  competing  
pain  theories  (Chen,  2011).    Of  the  theories  pertaining  to  pain,  four  have  proven  to  be  
the  most  influential  regarding  pain  perception:  intensity  theory,  specificity  theory,  pattern  
theory,  and  the  gate  control  theory  of  pain  (Moayedi  &  Davis,  2013).    The  intensity  
theory,  specificity  theory,  and  pattern  theory  all  offer  rationale  for  the  peripheral  
identification  of  a  painful  stimulus.    While  each  theory  offers  a  unique  explanation  for  the  
transmission  of  pain  signals,  it  is  possible  that  all  three  theories  concurrently  play  a  role  
in  pain  perception  (Wildsmith  &  Armitage,  1987).    The  gate  control  theory  was  the  first  
theory  to  explain  the  central  modulation  of  pain  impulses.  
The  intensity  theory  of  pain.    The  intensity  theory  proposes  that  stimulation  of  
any  sensory  receptor  will  cause  pain  if  the  stimulus  is  excessive  or  sufficiently  intense  
(Wildsmith  &  Armitage,  1987).    According  to  the  intensity  theory,  peripheral  afferent  
neurons  are  not  differentiated  into  low-­threshold  and  high-­threshold  neurons,  therefore  
the  intensity  of  the  noxious  stimulus  alone  dictates  whether  or  not  the  stimulus  is  
deemed  innocuous  or  noxious  (Chen,  2011).    The  intensity  theory  holds  that  strong  
activation  of  any  non-­specialized  primary  afferent  neuron  will  elicit  pain,  as  all  the  non-­
specialized  primary  afferent  neurons  ultimately  converge  onto  central  neurons  (Prescott,  
Ma,  &  de  Koninck,  2014).    If  the  stimulus  is  weak,  a  non-­painful  sensation  will  be  
produced  (Chen,  2011).    Although  the  intensity  theory  was  eventually  rejected  as  
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evidence  of  primary  afferent  neuron  specialization  surfaced,  it  remains  true  that  the  
intensity  of  a  noxious  stimulus  is  a  factor  in  pain  (Prescott,  Ma,  &  de  Koninck,  2014).  
The  specificity  theory  of  pain.    The  specificity  theory  is  one  of  the  most  
influential  theories  of  pain,  as  it  suggested  that  a  pathway  specific  to  pain  exists  (Chen,  
2011).    The  specificity  theory  of  pain  proposes  that  all  sensations,  including  pain,  are  
receptor-­specific  with  associated  sensory  fibers  that  are  sensitive  only  to  one  specific  
stimulus,  thereby  creating  dedicated  pathways  for  the  transmission  of  specific  signals  
(Moayedi  &  Davis,  2013).    During  its  infancy,  scientists  supporting  the  specificity  theory  
provided  evidence  linking  specific  sensory  nerve  endings  in  the  skin  to  the  sensation  of  
pain,  bolstering  the  concept  of  nociception  (Perl,  2007).    The  concept  of  nociception  
was  key  to  the  specificity  theory,  which  emphasized  tissue  injury  as  a  common  source  
of  pain.    Per  the  specificity  theory,  nociceptors  in  the  skin  remain  at  or  near  threshold  
and  can  only  be  stimulated  by  a  unique,  specific  noxious  stimulus  (Chen,  2011).    Once  
the  nociceptors  are  stimulated,  the  transmission  of  specific  pain  signals  ensues  leading  
to  the  perception  of  pain.    The  intensity  of  the  perception  of  pain  depends  upon  which  
nociceptors  were  stimulated  and  how  intense  the  stimulus  was  (Prescott,  Ma,  &  De  
Koninck,  2014).    Unfortunately,  the  specificity  theory  failed  to  account  for  neurons  in  the  
central  nervous  system  that  respond  to  both  innocuous  and  noxious  stimuli  (Moayedi  &  
Davis,  2012).  
The  pattern  theory  of  pain.    The  pattern  theory  of  pain  proposed  that  there  is  no  
pathway  specifically  for  the  mediation  of  pain.    Rather,  the  transmission  of  pain  signals  
is  achieved  via  receptors  that  are  shared  with  other  senses.    The  pattern  theory  of  pain  
is  a  quantitative  theory  of  pain.    The  spatial  and  temporal  pattern  of  stimulation  of  the  
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peripheral  nerves  determines  the  intensity  of  the  stimulus  and  whether  it  is  deemed  
innocuous  or  noxious  (Moayedi  &  Davis,  2012).    Therefore,  the  pattern  theory  proposes  
that  sensory  impulses  are  coded  according  to  the  number  of  receptors  stimulated,  as  
well  as  the  rate  of  discharge  (Melzack,  1993).    The  pattern  of  primary  afferent  neuron  
activation  forms  the  basis  of  pain  signals  created  by  the  stimuli  (Prescott,  Ma,  &  De  
Koninck,  2014).    The  pattern  theory  serves  as  the  foundation  for  the  gate  control  theory  
(Melzack,  1993).      
The  gate  control  theory  of  pain.    During  the  mid-­twentieth  century,  Melzack  
and  Wall  (1965)  suggested  the  gate  control  theory  of  pain  to  explain  the  central  
modulation  of  pain  impulses.  The  gate  control  theory  provides  a  neural  basis  for  the  
transmission  of  sensory  information  from  the  periphery  to  the  brain,  thereby  helping  to  
reconcile  the  apparent  differences  between  the  earlier  pattern  and  specificity  theories  of  
pain  (Moayedi  &  Davis,  2013).    The  gate  control  theory  of  pain  has  evolved  over  time,  
yet  the  original  theory  in  its  most  simplistic  form  remains  intact  and  is  well  embraced  by  
the  scientific  anesthesia  community  as  the  most  widely  recognized  theory  of  pain.    The  
gate  control  theory  of  pain  is  a  pattern-­based  theory  that  proposes  that  low-­threshold  
and  high-­threshold  primary  afferent  neurons  both  converge  on  non-­specialized  central  
neurons  and  if  that  if  this  convergent  force  is  strong  enough,  pain  will  be  signaled  
(Prescott,  Ma,  &  De  Koninck,  2014).      
The  gate  control  theory  proposes  that  the  substantia  gelatinosa,  which  is  located  
in  the  dorsal  horn  of  the  spinal  cord,  has  the  capacity  to  modulate  the  transmission  of  
sensory  information  received  from  the  periphery  before  it  is  transmitted  via  the  spinal  
cord  to  the  brain  (Moayedi  &  Davis,  2013).    Melzack  and  Wall  asserted  that  the  
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transmission  of  pain  signals  via  first-­order  afferent  fibers  from  the  periphery  initiate  the  
stress  response.    Cells  within  the  substantia  gelatinosa,  however,  may  function  as  a  
“gate”  with  the  ability  to  modulate  received  signals  prior  to  sending  them  onto  the  brain.    
Such  modulation  may  ultimately  limit  the  stress  response  secondary  to  the  perception  of  
pain  (Roberge  &  McEwen,  1998).      
The  theory  states  also  that  the  transmission  of  painful  sensory  information  from  
peripheral  nerve  fibers  via  the  spinal  cord  can  be  influenced  by  both  intrinsic  neurons  
and  responses  from  the  brain  (Dickenson,  2002).    One  such  example  is  an  alteration  in  
the  release  of  enkelphalins,  which  can  impact  nociceptive  signal  transmission.    
Enkephalins  are  endogenous  opioids  that  act  as  chemical  neurotransmitters,  inhibiting  
the  release  of  Substance  P  in  a  manner  similar  to  exogenous  opioids.    Substance  P  is  
the  neurotransmitter  responsible  for  transmitting  the  pain  signal  from  first-­order  neurons  
to  second-­order  neurons.    An  increase  in  enkephalin  release,  therefore,  disrupts  the  
perception  of  pain  by  inhibiting  the  transmission  of  pain  signals  from  first-­order  to  
second-­order  neurons.      
Per  the  gate  control  theory,  pain  can  be  modulated  or  “gated”  at  a  number  of  
points  along  the  pain  pathway,  as  opioid  receptors  are  not  isolated  to  the  substantia  
gelatinosa.    While  opioid  receptors  are  primarily  located  in  the  dorsal  horn  of  the  
substantia  gelatinosa,  they  can  also  be  found  throughout  the  spinal  cord,  the  
hypothalamus,  the  limbic  system  and  in  parts  of  the  brain  stem.    Modulation  of  pain  can  
occur  at  all  of  these  sites  due  to  the  presence  of  opioid  receptors  at  these  locations  
(Wildsmith  &  Armitage,  1987).    Inhibitory  and  excitatory  pathways  originating  in  the  
brainstem  can  modulate  the  transmission  of  pain  signals  in  the  spinal  cord.    These  
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pathways  function  to  either  attenuate  or  augment  pain  signals  in  an  effort  to  maintain  
homeostasis.    The  gate  control  theory  offers  a  framework  for  clinicians  to  explore  the  
transmission  of  pain  signals  from  peripheral  to  central  neurons  when  attempting  to  
modulate,  or  exert  a  controlling  force  on,  the  experience  of  pain  (Dickenson,  2002).      
Classification  of  Pain      
Understanding  the  various  origins  of  pain  aids  in  treatment  planning.    While  the  
phenomenon  of  pain  can  be  parceled  into  endless  divisions,  pain  can  generally  be  
classified  as  one  of  three  categories:  the  temporal  element,  mechanism  of  pain  and  the  
etiology  of  pain.  
The  temporal  element  of  pain.    Pain  typically  subsides  when  either  the  noxious  
stimulus  is  removed  or  enough  time  has  elapsed  to  allow  the  body  to  heal.    Accordingly,  
pain  can  be  described  as  being  transient,  acute,  or  chronic.    Classifying  pain  in  terms  of  
its  temporal  nature  not  only  links  the  phenomenon  to  a  given  point  in  time  relative  to  the  
causative  factor,  but  it  allows  clinicians  to  better  comprehend  what  mechanisms  may  be  
involved  in  producing  the  pain  phenomenon.  
Transient  pain.    Transient  pain  is  pain  that  is  associated  with  little  to  no  tissue  
damage.    While  unpleasant,  this  type  of  pain  is  fleeting  in  nature  and  occurs  when  
afferent  pain  fibers  are  activated  by  a  brief,  high  intensity  stimulus  (Dray,  1995).    
Transient  pain  is  not  often  viewed  as  a  barrier  to  the  recovery  process  following  surgery.    
Rather,  it  is  thought  to  have  evolved  as  a  protective  mechanism,  as  a  means  of  
protection  from  physical  damage  by  the  environment  or  by  over  stress  of  the  body  
tissues  (Loeser  &  Melzack,  1999).    
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Acute  pain.    Acute  pain  is  more  persistent  than  transient  pain  and  is  facilitated  
by  the  inflammation  secondary  to  mild  tissue  damage,  which  makes  the  afferent  pain  
fibers  more  susceptible  to  activation  by  lower  intensity  stimuli  (Dray,  1995).    Surgical  
pain  begins  with  the  incision  and  can  continue  to  escalate  throughout  the  procedure.    
Continued  tissue  injury  beyond  the  initial  insult  initiates  a  cascade  of  inter-­related  
physiological  events  to  stave  off  infection,  limit  further  damage,  and  initiate  repair  
(Voscopoulos  &  Lema,  2010).    When  properly  managed,  acute  pain  does  not  
overwhelm  the  body’s  reparative  mechanisms  and  healing  occurs  without  interruption.    
Intraoperative  acute  pain.    Intraoperative  pain  exceeds  incisional  pain.    It  is  
reported  that  intraoperative  pain  rapidly  decreases  and  resolves  within  30  minutes  after  
incision  (Brennan,  2011).    Acute  pain  during  the  intraoperative  period  can  be  attributed  
to  tissue  dissection,  positioning,  the  tourniquet,  and  visceral  or  somatic  compression  
and/or  stretching  of  bodily  tissue  secondary  to  the  surgical  technique.    
Postoperative  acute  pain.    Following  surgery,  pain  may  not  be  solely  attributed  to  
the  surgical  incision.    Referred  pain  and  variations  in  pain  secondary  to  movement  are  
key  factors  in  acute  postoperative  pain.    Referred  pain  is  that  which  is  felt  in  a  different  
region  away  from  the  source  of  pain  (Arendt-­Nielson,  Fernandez-­de-­las-­Penas,  &  
Graven-­Nielsen,  2011).    Unfortunately,  pain  at  rest  and  evoked  pain  are  likely  
transmitted  by  different  afferent  fibers  and/or  different  receptors  (Brennan,  2002).    
Currently,  there  remains  no  sound  understanding  of  the  algogenic,  or  pain  producing,    
substances  that  are  released  to  activate  and  sensitize  the  nociceptive  nerve  terminals  in  
a  surgical  wound  (Brennan,  2002).      
  
  32  
While  much  regarding  acute  postoperative  pain  remains  uncertain,  many  
contributing  factors  have  been  reported  in  the  literature  including;;  genetics,  age,  gender,  
preoperative  anxiety,  psychological  distress,  personality  traits,  presence  of  preoperative  
pain,  and  surgical  factors  such  as  type  and  duration  of  surgery  (Ip,  Abrishami,  Peng,  
Wong,  &  Chung,  2009).    In  addition,  multiple  anesthesia-­related  factors  play  a  large  role  
in  defining  the  extent  of  acute  postoperative  pain,  such  as  the  amount  of  opioid  given,  a  
patient’s  plasma  opioid  concentration,  electroencephalogram  factors,  the  use  of  
adjuvant  analgesia  and  whether  or  not  local  anesthetic  was  utilized  (Law,  Sleigh,  
Barnard,  &  MacColl,  2011).      
Chronic  pain.    Chronic  pain  occurs  when  tissue  injury  exceeds  the  body’s  
capability  for  healing  (Loeser  &  Melzack,  1999).    Peripheral  and  ultimately  central  
nervous  system  sensitization  leads  to  the  transition  from  acute  to  chronic  pain  
(Voscopoulos  &  Lema,  2010).    Should  pain  persist  beyond  the  anticipated  healing  
period  associated  for  a  given  injury  or  surgery  (2  months  or  longer  after  most  surgical  
procedures),  a  diagnosis  of  chronic  or  persistent  postsurgical  pain  can  be  made  once  all  
other  causes  for  the  pain  have  been  excluded  (Wu  &  Raja,  2011).    
Mechanism  of  pain.    Pain  serves  as  an  early  warning  system,  designed  to  
signal  the  presence  of  potentially  damaging  or  lethal  stimuli  in  the  environment  (Katz  &  
Rothenberg,  2005).    Pain,  however,  can  be  nociceptive,  inflammatory  or  neuropathic  in  
nature,  which  refers  to  the  mechanism  by  which  the  pain  signals  are  transmitted.    
Regardless  of  mechanism,  repeated  pain  signals  have  the  capacity  to  initiate  prolonged  
physiologic  changes  in  both  the  peripheral  and  the  central  nervous  systems,  potentially    
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culminating  in  sensitization  or  the  amplification  and  prolongation  of  pain  (Woolf  &  Chong,  
1993).    
   Nociceptive  pain.    Nociceptive  pain  is  activated  only  by  noxious  stimuli  acting  
on  a  specialized  high-­threshold  sensory  pathway  (Scholz  &  Woolf,  2002).    When  a  
harmful  stimulus  is  applied  to  the  body,  primary  sensory  neurons  sensitive  to  heat,  
mechanical  stimuli,  protons,  and  cold  whose  cell  bodies  lie  in  the  dorsal  root  ganglia  
within  the  spinal  cord  are  activated  (Katz  &  Rothenberg,  2005).    The  signal  is  then  
transmitted  via  the  spinal  cord  to  the  brain  where  the  sensation  of  pain  is  experienced  
(Scholz  &  Woolf,  2002).    Nociceptive  pain  serves  a  positive  function,  signaling  the  body  
to  move  away  from  danger.    The  threshold  for  eliciting  nociceptive  pain  has  to  be  high  
enough  that  it  does  not  interfere  with  normal  activity,  however,  the  threshold  should  be  
low  enough  that  the  sensation  of  pain  is  evoked  before  tissue  damage  ensues  (Scholz  
&  Woolf,  2002).    Pain  associated  with  operative  procedures  is  aching,  sharp,  or  
throbbing  in  nature,  and  may  be  either  constant  or  intermittent.    
   Inflammatory  pain.    Inflammatory  pain  occurs  secondary  to  the  release  of  
inflammatory  mediators  following  damage  to  tissue.    Inflammatory  mediators  function  in  
one  of  two  ways:  they  directly  activate  nociceptors  thereby  evoking  pain,  or  they  
produce  sensitization  of  the  nervous  system  enabling  easier  activation  of  the  pain  
pathway  (Scholz  &  Woolf,  2002).    The  release  of  chemical  mediators  such  as  cytokines,  
growth  factors,  kinins,  purines,  amines,  prostanoids  and  ions  activates  or  modifies  the  
stimulus  response  properties  of  the  nociceptor  afferent  fibers,  leading  to  changes  in  the  
responsiveness  of  neurons  in  the  central  nervous  system  (Scholz  &  Woolf,  2002).    For  
example,  a  reduction  in  the  threshold  of  nociceptor  afferent  peripheral  terminals  leads  to  
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peripheral  sensitization,  often  secondary  to  the  release  of  chemical  inflammatory  
mediators  inflammation  from  the  site  of  surgical  trauma  (Raja,  Meyer,  &  Campbell,  
1988).    Operative  procedures  produce  a  barrage  of  afferent  pain  signals  and  generate  a  
secondary  inflammatory  response,  both  of  which  contribute  substantially  to  
postoperative  pain  (Reuben  &  Sklar,  2000).      
Neuropathic  pain.    Neuropathic  pain  represents  changes  in  the  pain  pathway  
that  generate  spontaneous  and  exaggerated  pain  with  no  discernable  protective  or  
reparative  role  (Scholz  &  Woolf,  2002).    Unlike  nociceptive  pain,  neuropathic  pain  
serves  no  adaptive  purpose  (Katz  &  Rothenberg,  2005).    It  arises  from  damage  to  or  
dysfunction  of  either  the  peripheral  or  central  nervous  system  secondary  to  injury,  
disease,  or  medical  treatment,  ultimately  resulting  in  injury  to  nerves,  the  spinal  cord,  or  
the  brain  (Katz  &  Rothenberg,  2005).    It  is  characterized  by  a  combination  of  
neurological  deficits  and  pain,  and  ultimately  becomes  a  pathological  condition.    
Neuropathic  pain  is  often  perceived  as  a  burning  or  tingling  sensation.    In  contrast  to  
nociceptive  pain,  which  typically  dissipates  over  time,  neuropathic  pain  frequently  
continues  to  escalate  and  may  become  chronic.      
Etiology  of  pain.    Not  all  pain  signals  are  transmitted  via  the  same  pathway  and  
therefore  cannot  be  treated  with  the  same  intervention.    Failing  to  appreciate  the  extent  
of  the  anticipated  postoperative  pain  following  a  given  procedure  often  leads  to  
inadequate  pain  control  and  poor  patient  experiences  (Gerbershagen,  Adukathil,  van  
Wijck,  Peelen,  Kalkman,  &  Meissner,  2013).    For  example,  all  orthopedic  surgeries  are  
not  equal  with  respect  to  the  intensity  and  duration  of  the  anticipated  postoperative  pain,  
as  postoperative  pain  will  vary  according  to  the  degree  of  bony  versus  soft  tissue  
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damage  encountered  during  the  surgical  procedure  (Chelly,  Ben-­David,  Williams,  &  
Kentor,  2003).    Pain  following  orthopedic  surgery,  such  as  ACL  reconstruction,  is  often  
categorized  as  severe  (Stein,  Srikumaran,  Tan,  Freehill,  &  Wilckens,  2012).    When  
developing  a  strategy  to  address  postoperative  pain,  it  is  imperative  to  consider  the  
procedure  the  patient  is  undergoing,  as  not  all  procedures  likely  require  equivalent  
analgesic  regimens.    Understanding  how  to  optimize  pain  control  following  orthopedic  
procedures  is  of  paramount  importance  to  improving  patient  outcomes  (Chelly,  Ben-­
David,  Williams,  &  Kentor,  2003).      
While  the  benefits  of  optimal  pain  control  are  well  recognized,  refining  
postoperative  pain  control  practices  continues  to  prove  challenging  (Joshi  &  Kehlet,  
2013).    A  key  aspect  to  achieving  optimal  pain  control  is  fully  comprehending  the  degree  
of  pain  generated  by  various  surgical  procedures,  particularly  in  relationship  with  the  
analgesic  technique  employed  (Joshi  &  Kehlet,  2013).    The  web-­based  PROSPECT  
initiative  (Procedure  Specific  Postoperative  Pain  Management)  may  represent  the  future  
of  pain  control,  as  Henrik  Jehlet  and  his  colleagues  have  addressed  the  issue  of  
procedure-­specific  pain  control  (Pasero,  2007).    Arming  clinicians  with  evidence-­based,  
procedure-­specific  pain  control  guidelines  should  allow  for  a  balance  between  the  
invasiveness  of  the  analgesic  technique  and  the  consequences  of  postoperative  pain  
(Joshi  &  Kehlet,  2013).    Such  strategies  should  improve  current  practices  that  are  often  
reliant  upon  less  robust  older  studies  and  anecdotal  evidence  (Roberts,  Brodribb,  &  
Mitchell,  2012).      
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  ACL  Reconstruction:  Surgical  Options    
The  primary  goal  of  ACL  reconstruction  is  to  restore  stability  to  the  knee.    
Stability  is  impacted  by  multiple  factors  and  largely  dependent  upon  the  patient’s  activity  
level,  ultimately  making  it  challenging  to  measure  (Reinhardt,  Hetsroni,  &  Marx,  2010).    
Nonetheless,  measurement  of  stability  during  the  postoperative  period  remains  one  of  
the  key  determinants  of  a  successful  ACL  reconstruction  (Macaulay,  Perfetti,  &  Levine,  
2012).    Desired  activity  level,  however,  is  not  the  sole  metric  considered  when  
contemplating  graft  selection  as  patient  age,  history  of  patellar  or  hamstring  problems,  
concerns  regarding  disease  transmission,  and  the  anticipation  of  postoperative  pain  all  
play  equally  important  roles  (Ryu  &  Provencher,  2011).    In  addition,  cost  effectiveness  
and  associated  morbidities,  such  as  donor  site  pain,  are  key  concerns.      
Several  options  exist  for  replacement  of  the  damaged  ligament  during  ACL  
reconstruction  in  adolescents,  namely  the  use  of  allograft  tendon,  the  bone-­patellar  
tendon-­bone  (BPTB)  technique  and  the  use  of  a  hamstring  tendon  autograft.    
Reconstruction  of  damaged  ligaments  using  any  of  these  techniques  for  ligament  
reconstruction  restores  stability  to  the  knee,  allowing  most  patients  to  return  to  living  an  
active  lifestyle  (Pallis,  Svoboda,  Cameron,  &  Owens,  2012).    
Synthetic  tendon.    Several  synthetic  grafts  have  been  utilized  for  ACL  
reconstruction,  yet  to  date  little  success  has  been  witnessed  clinically.    Graft  failure  
rates,  tunnel  osteomyelitis  and  component  deposits  throughout  the  body  has  ultimately  
led  to  the  discontinuation  of  most  these  products.    While  several  promising  new  
synthetic  grafts  have  been  introduced  in  the  past  few  years,  the  associated  complication  
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profile  historically  has  diminished  the  use  of  synthetic  grafts  for  ACL  reconstruction  
(Dheerendra  et  al,  2012).  
Allograft  tendon.    The  use  of  allograft  not  only  has  the  potential  to  decrease  
postoperative  pain  by  avoiding  donor  site  morbidity,  the  operative  time  is  likely  
shortened  since  graft  harvesting  is  circumvented  (Prodromos,  Fu,  Howell,  Johnson,  &  
Lawhorn,  2008).      In  addition  to  reducing  postoperative  pain,  the  use  of  allograft  may  
lead  to  improved  cosmesis  (Carey,  2011).    Furthermore,  the  potential  for  a  quicker  
return  to  function  during  the  immediate  postoperative  period  exists,  as  the  use  of  
allograft  is  generally  associated  with  less  postoperative  pain  (Ryu  &  Provencher,  2011).        
The  use  of  allograft  is  not  without  potential  disadvantage,  however,  as  utilization  
of  allograft  can  lead  to  an  immunologic  response  from  the  host,  thereby  delaying  graft  
incorporation.    In  addition,  the  use  of  allograft  introduces  the  risk  of  disease  
transmission,  as  procurement  and  processing  techniques  vary  largely  (Carey,  2011).  
Sterilization  methods  common  during  the  1990s  to  ameliorate  disease  were  known  to  
affect  the  collagen  structure  of  the  graft  as  well  as  the  mechanical  properties.    Allografts  
sterilized  with  osmotic  treatment,  oxidation,  acetone  solvent  drying,  and  gamma  
irradiation  all  had  a  rupture  rate  of  45%  at  the  6-­year  postoperative  interval  (Macaulay,  
Perfetti,  &  Levine,  2012).    The  grafts  that  did  not  rupture  were  found  to  not  have  any  
statistically  significant  difference  in  knee  stability  (Carey,  Dunn,  Dahm,  Zeger,  &  
Spindler,  2009).    Modern  techniques,  however,  avert  graft  damage  during  sterilization.    
As  a  result,  the  demand  for  allograft  has  continued  to  rise  over  the  last  decade  making  
allograft  availability  limited  at  times  (Dheerendra  et  al.,  2012).      
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Autograft  tendon.    Commonly  utilized  autograft  tissue  for  ACL  reconstruction  
includes  BPTB,  hamstring  tendons  comprised  of  semitendinosus  and  gracilis  tendons,  
quadriceps  tendons  and  ilio-­tibial  band  tendons.    While  all  of  these  various  autografts  
have  been  utilized  successfully  for  ACL  reconstruction,  the  two  most  commonly  
employed  autografts  continue  to  be  the  BPTB  and  the  hamstring  tendon  (Dheerendra,  
Khan,  Singhal,  Shivarathre,  Pydisetty,  &  Johnstone,  2012).    The  advantages  of  using  
autograft  for  ACL  reconstruction  include:  the  source  and  age  of  the  graft  is  known,  there  
is  no  risk  of  disease  transmission,  the  graft  is  typically  size-­matched  for  the  individual  
undergoing  ACL  reconstruction,  and  the  possibility  of  hamstring  regeneration  exists  
following  harvest  (Carey,  2011).    Disadvantages  include:  donor-­site  morbidity,  long-­term  
kneeling  pain  (depending  on  source  of  graft),  risk  of  patellar  fracture  (depending  on  
source  of  graft),  long-­term  knee  flexor  strength  deficit  and  risk  of  saphenous  nerve  
trauma  (Carey,  2011).  
Bone-­patellar  tendon-­bone  autograft.    The  use  of  BPTB  graft  for  ACL  
reconstruction  was  pioneered  by  Kurt  Franke  in  the  1960’s  and  has  long  stood  as  the  
gold  standard  to  which  all  other  graft  choices  are  compared  in  regards  to  effectiveness  
(Dheerendra  et  al.,  2012).    This  high  regard  can  be  attributed  to  the  high  strength  and  
stiffness,  consistency  of  the  size  of  the  graft,  ease  of  harvesting,  early  graft  
incorporation  and  solid  fixation  when  interference  screws  are  utilized  (Fineberg,  Zarins,  
&  Sherman,  2000).    BPTB  grafts  heal  quickly,  as  the  end  of  the  graft  is  bone,  with  bone-­
to-­bone  healing  typically  occurring  in  6-­8  weeks.    No  soft  tissue  repair  is  required  with  
this  approach.    The  BPTB  autograft  is  also  associated  with  less  postoperative  
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instrumented  laxity  and  predictable  function,  yet  graft  biomechanics  is  thought  to  be  
inferior  to  that  of  the  hamstring  autograft  (Reinhardt,  Hetsroni,  &  Marx,  2010).  
The  morbidity  attributed  to  the  use  of  a  BPTB  graft,  however,  has  led  surgeons  to  
explore  alternative  techniques.    Donor  site  pain,  anterior  knee  pain,  pain  when  kneeling,  
patellar  fracture,  and  numbness  or  quadriceps  weakness  secondary  to  injury  to  the  
infra-­patellar  branch  of  the  saphenous  nerve  are  among  the  primary  commonly  seen  
complications  following  the  use  of  this  technique  (Busam,  Provencher,  &  Bach,  2008).  
Although  the  long-­term  sustainability  of  BPTB-­supported  repairs  was  similar  to  
that  of  autograft  repairs,  one  of  the  well-­known  drawbacks  to  BPTB  repairs  is  chronic  
knee  pain,  making  the  use  of  hamstring  autograft  more  desirable,  as  long-­term  pain  at  
the  donor  site  has  not  been  a  common  issue  associated  with  the  use  of  hamstring  
autografts  (Bushnell,  Sakryd,  &  Noonan,  2010).      
Hamstring  autograft.    In  1982,  Lipscomb  began  employing  the  pes  
semitendinosus  and  gracilis  tendons  in  an  effort  to  avoid  the  donor  site  morbidity  
attributed  to  the  BPTB  technique  (Lipscomb,  Johnston,  Synder,  Warburton,  &  Gilbert,  
1982).    Following  harvest,  the  tendons  are  typically  looped  over  to  create  a  quadruple  
strand  structure,  which  is  then  sutured  together  to  make  a  final  graft  with  enough  size  
and  strength  for  successful  ACL  repair  (Dheerendra  et  al.,  2012).    Fixation  of  the  newly  
created  graft  is  then  achieved  with  either  an  interference  screw  or  endo-­button,  giving  
way  to  a  reconstructed  ACL  of  equal  strength  as  a  BTPB  graft,  if  not  stronger  (Hamner,  
Brown,  Steiner,  Hecker,  &  Hayes,  1999).    Although  the  harvest  of  a  hamstring  autograft  
is  typically  less  painful  than  that  of  a  BPTB  graft,  healing  occurs  at  a  much  slower  rate,  
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which  may  lead  to  premature  ACL  rupture  should  the  patient  attempt  rehabilitation  prior  
to  healing  of  the  bone  tunnels.    
Use  of  hamstring  autograft  has  emerged  as  the  technique  of  choice  for  ACL  
reconstruction  in  adolescents  due  to  the  overall  decreased  morbidity  and  proven  long-­
term  stability  when  compared  to  the  other  ligament  replacement  options  (Mehta,  
Mandala,  Foster,  &  Petsche,  2010;;  Pallis,  Svoboda,  Cameron,  &  Owens,  2012).    This  is  
a  departure  from  the  technique  typically  employed  in  the  adult  population,  as  use  of  
allograft  tendon  has  long  been  the  predominant  technique  employed.    The  advantages  
of  using  an  autograft  are  numerous  and  include  the  decreased  incidence  of  graft  failure,  
lower  infection  rate,  decreased  risk  of  disease  transmission  and  a  potential  faster  return  
to  full  activities  (Ryu  &  Provencher,  2011).  
BPTB  vs.  hamstring  autograft.    Hamstring  autografts  were  initially  thought  to  
be  inferior  to  the  BPTB  graft  in  regards  to  strength  and  stiffness.    Much  of  this,  however,  
was  found  to  be  due  to  the  use  of  inappropriately  sized  grafts  or  inadequate  fixation  
techniques  (Dheerendra  et  al.,  2012).    The  BPTB  autograft  has  been  shown  to  be  
approximately  175%  as  strong  as  a  normal  ACL,  while  a  doubled  hamstring  autograft  is  
typically  200%  as  strong  as  a  normal  ACL  (Larson,  1996).    Using  a  quadrupled  
hamstring  autograft,  Wilson,  Zafuta,  and  Zobitz  (1999)  reported  that  no  statistical  
significance  existed  in  the  stiffness  of  each  graft  and  found  the  load  failure  of  the  
hamstring  autograft  to  be  2,422  Newtons  compared  to  1,784  Newtons  of  the  BPTB  
graft.      
It  should  be  noted  that  there  is  a  lack  of  consistency  when  comparing  techniques  
in  the  literature,  as  fixation  techniques,  patient  outcome  measures  and  periods  of  follow-­
  41  
up  vary  greatly  when  reported  making  it  challenging  to  discern  the  true  superiority  of  a  
given  technique.    As  such,  the  best  evidence  to  date  from  methodologically  sound  meta-­
analysis  suggests  that  hamstring  autografts  are  superior  in  preventing  anterior  knee  
pain,  with  limited  evidence  that  BPTB  autografts  provide  more  stability  than  hamstring  
autografts  (Poolman,  Farrokhyar,  &  Bhandari,  2007).  
   Autograft  vs.  allograft  tendon.    Criteria  commonly  used  to  vet  graft  superiority  
include  rate  of  graft  failure,  knee  range  of  motion,  donor  site  morbidity,  hamstring  
muscle  strength,  anterior  knee  laxity,  return  to  pre-­injury  activity  level,  and  standardized  
functional  knee  outcome  scores  (Reinhardt,  Hetsroni,  &  Marx,  2010).    One  of  the  key  
determinants  for  surgeons  in  graft  choice  is  the  incidence  of  reconstructed  ligament  
rupture.    The  incidence  of  ligament  rupture  following  reconstruction  is  far  different  
between  adults  and  adolescent  patients,  as  ligament  rupture  following  reconstruction  is  
only  3%  in  adult  patients.    Conversely,  the  rate  of  rupture  following  ACL  reconstruction  
is  considerably  higher  in  active  adolescents,  with  10%  of  hamstring  autografts  and  20%  
of  allografts  rupturing  following  surgery.    Pallis  et  al.  (2012)  found  allograft  rupture  to  be  
7.7  times  more  likely  to  occur  than  BPTB  repair,  and  6.7  more  likely  to  occur  than  
autograft  repairs.    The  incidence  of  ligament  rupture  following  reconstruction  is  3%  in  
adult  patients.    Knowing  that  adolescents  who  sustained  their  injury  secondary  to  sports  
are  likely  to  return  to  sports  following  successful  reconstruction,  determining  the  method  
of  ligament  reconstruction  that  offers  the  best  long-­term  survivability  becomes  a  
decision  of  utmost  importance  to  the  orthopedic  surgeon  when  developing  a  
reconstruction  plan.    Ultimately,  superior  long-­term  outcomes  have  lead  to  the  increased  
utilization  of  a  hamstring  autograft  during  knee  ligament  reconstruction.      
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Function  level  following  ACL  reconstruction  remains  a  hotly  debated  topic.    Many  
proponents  of  autograft  use  argue  that  its  use  leads  to  superior  long-­term  outcomes.    
Carey  et  al.  (2009),  however,  reported  that  allograft  patients  reported  less  pain  at  1  and  
6  weeks,  better  function  at  1  week,  3  months,  and  1  year  and  fewer  activity  limitations  
throughout  the  recovery  period.    Still,  despite  multiple  similar  reports,  the  autograft  
remains  the  workhorse  among  young  patients  with  anticipated  high  physical  demands  
following  reconstruction  (Ryu  &  Provencher,  2011).  
Special  considerations  for  the  adolescent  population.    Historically,  children  
and  adolescents  with  ACL  injuries  have  been  treated  conservatively,  with  many  
orthopedic  surgeons  relying  on  non-­surgical  techniques  for  treatment,  such  as  bracing  
and  activity  restrictions.    Surgical  reconstruction  of  the  ACL  raises  concern  for  damage  
to  the  physis,  potentially  resulting  in  limb  length  discrepancy  and  angular  joint  deformity  
(Hudgens  &  Dahm,  2012).    Thus,  determining  how  to  best  provide  postoperative  pain  
control  in  adolescents  undergoing  knee  ligament  reconstruction  has  traditionally  not  
been  a  frequent  concern  for  pediatric  anesthetists.  
Recent  advances  in  epiphyseal-­sparring  surgical  techniques  have  enabled  
orthopedic  surgeons  to  safely  and  effectively  repair  ACL  defects  in  adolescents  that  
previously  seemed  irreparable.    New  techniques,  such  as  those  described  by  Brown  
and  Ahmad  (2008)  have  demonstrated  that  not  only  do  these  revolutionary  surgical  
techniques  successfully  avoid  the  potential  harms  posed  by  traditional  techniques,  they  
result  in  a  structurally  sound  repair  based  on  5  year  follow  up  results.    Subsequently,  an  
expeditious  rise  in  reconstructive  knee  surgeries  has  been  witnessed  in  the  adolescent  
population  in  response  to  the  growing  incidence  of  knee  ligament  injuries,  leading  to  a  
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400  percent  increase  in  the  number  of  adolescent  ACL  reconstructions  performed  over  
the  last  decade.  
While  surgical  reconstruction  caries  the  risk  of  growth  plate  disturbance,  delaying  
operative  repair  until  skeletal  maturation  increases  the  likelihood  of  subsequent  
instability  episodes  and  intra-­articular  damage  (McConkey,  Bonasia,  &  Amendola,  
2011).    Furthermore,  adolescents  are  known  to  be  a  poorly  compliant  group  in  regards  
to  activity  restrictions  should  attempts  to  delay  surgery  be  made  (Henry,  Chotel,  
Chouteau,  Fessy,  Berard,  &  Moyen,  2009).      Even  postoperatively,  adolescents  
continue  to  have  difficulty  modifying  recreational  activities  sufficiently  to  avoid  future  
instability  episodes  (McConkey,  Bonasia,  &  Amendola,  2011).    Therefore,  whether  or  
not  they  undergo  surgical  reconstruction,  adolescents  with  ACL  injury  remain  a  
vulnerable  to  continued  ACL  damage.      
Delaying  ACL  reconstruction  until  skeletal  maturity  is  an  alternative,  however,  
this  route  increases  the  risk  of  instability  and  intra-­articular  damage  (McConkey,  
Bonasia,  &  Amendola,  2011).    The  main  consideration  when  reconstructing  an  ACL  in  in  
the  adolescent  population  is  thought  to  be  related  to  surgical  approach  rather  than  graft  
selection  itself.    In  skeletally  immature  patients,  caution  must  be  taken  not  to  impose  
upon  or  damage  the  physis  in  an  effort  to  limit  the  potential  of  physeal  injury.    
Accordingly,  physeal  sparing  and  partial  transphyseal  techniques  are  commonly  
employed  when  reconstructing  the  ACL  in  the  adolescent  population.    Complications  
may  occur  regardless  of  the  choice  between  BTPB  or  hamstring  autograft  and  there  
remains  no  consensus  as  to  the  superior  autograft  choice.    Despite  the  emphasis  on  
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surgical  approach,  allografts,  synthetic  grafts  and  ligament  augmentation  devices  are  
not  commonly  used  for  the  pediatric  population  (Hui  &  Chowdhary,  2011).  
Recently,  Beasley  and  Chudik  (2003)  reported  that  tunnels  placed  centrally  and  
filled  with  soft  tissue,  such  as  a  hamstring  autograft,  are  less  likely  to  cause  growth  
disturbances  unlike  eccentrically  placed  tunnels  or  those  filled  with  cancellous  bone,  as  
soft  tissue  across  an  open  physis  usually  prevents  premature  closure.    While  the  trend  
remains  to  use  ephyseal-­sparing  techniques,  this  novel  approach  stays  true  to  the  
current  thinking  that  hamstring  autograft  is  the  superior  graft  choice  among  the  
skeletally  immature  population.  
The  impact  of  age  on  pain  management.    Type  of  surgery  alone  does  not  
determine  postoperative  analgesia  need,  as  age  and  psychological  distress  collectively  
predict  postoperative  analgesic  consumption  (Wu  &  Raja,  2011).    Although  no  
relationship  exists  between  age  and  pain  intensity  following  painful  surgical  procedures,  
distress  in  younger  patients  may  be  significantly  greater  (Stotts,  Puntillo,  Stanik-­Hutt,  
Morris,  Thompson,  White,  &  Wild,  2007).    While  children  suffer  postoperative  pain  in  the  
same  fashion  as  adults,  fear,  anxiety,  coping  mechanisms,  and  social  support  play  roles  
in  shaping  a  pain  control  plan  appropriate  for  the  specific  surgical  procedure  and  the  
pain  threshold  of  the  patient  (Verghese  &  Hannallah,  2010).    An  insensate  extremity  
from  regional  anesthesia  can  potentially  cause  increased  anxiety  or  distress  
postoperatively  (Samol,  Furstein,  &  Moore,  2012).    Children  over  the  age  of  6  years,  for  
example,  may  become  distressed  to  the  point  of  being  inconsolable  by  the  absence  of  
sensation  over  large  areas  of  their  body  (Wolf  &  Hughes,  1993).    It  is  therefore    
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imperative  to  consider  psychological  aspects  and  to  thoroughly  prepare  patients  in  
advance  of  any  pain  management  intervention.    
Technical  challenges  exist  when  considering  pain  management  modalities  in  
adolescents  as  well.    Regional  anesthesia  in  adolescents  has  proven  to  be  safe,  
provided  it  is  performed  by  an  experienced  clinician  and  attention  to  detail  is  taken  
(Bosenberg,  2012).    Until  recently,  however,  regional  anesthesia  was  not  used  routinely  
in  adolescents  because  of  the  need  for  general  anesthesia  to  keep  children  from  
moving  and  cooperating  with  the  clinician  performing  the  neural  blockade  (Suresh,  
Birmingham,  &  Kozlowski,  2012).  The  use  of  nerve  stimulators  and  ultrasound  has  
contributed  to  the  renewed  interest  in  regional  anesthesia  among  this  patient  
population,  as  these  tools  have  improved  the  success  rate  of  nerve  blocks  in  
adolescents  and  theoretically  make  placement  safer  in  the  anesthetized  patient  
(Kraemer  &  Rose,  2009).  
Pain  Management  Following  ACL  Reconstruction    
Description  of  pain  specific  to  ACL  reconstruction.    ACL  reconstruction  is  
known  to  be  associated  with  moderate  to  severe  postoperative  pain  (Espelund,  
Fomsgaard,  Haraszuk,  Mathiesen,  &  Dahl,  2013).    Most  of  the  intra-­articular  structures  
of  the  knee  have  free  nerve-­endings  that  are  capable  of  sensing  painful  stimuli  and  
producing  severe  pain  (Reuben  &  Sklar,  2000).    When  ACL  reconstruction  is  performed  
as  an  arthroscopic  procedure,  there  is  a  dramatic  decrease  in  in  tissue  trauma  and  
resultant  pain  (Brown,  Curry,  Ruterbories,  Avery,  &  Anson,  1997).    Although  the  surgical  
incisions  are  small  when  ACL  reconstruction  is  performed  arthroscopically,  pain  is  not  
eliminated,  as  a  variety  of  insults  to  native  tissue  still  occur.      
  46  
In  most  instances,  a  diagnostic  arthroscopy  is  done  prior  to  ACL  reconstruction  to  
verify  the  diagnosis  of  ACL  tear  and  to  determine  the  presence  of  loose  foreign  bodies  
in  the  knee  (Streich,  Friedrich,  Gotterbarm,  &  Schmitt,  2008).      Any  loose  bodies  or  ACL  
remnant  found  during  arthroscopy  are  removed  prior  to  ACL  reconstruction.    In  and  of  
itself,  this  generally  does  not  induce  a  great  amount  of  pain,  rather  patients  generally  
report  that  the  knee  is  slightly  sore  should  this  procedure  be  performed  without  any  
additional  surgical  reconstruction  or  manipulation.    Depending  on  the  individualized  plan  
for  the  patient,  an  autograft  may  be  employed  for  ACL  reconstruction.    If  an  autograft  is  
utilized,  pain  in  the  postoperative  period  can  be  elevated  secondary  to  autograft  
harvest.    As  part  of  the  reconstruction,  tunnels  are  drilled  through  the  femur  and  tibia  to  
route  and  secure  the  replacement  ACL  (Streich,  Friedrich,  Gotterbarm,  &  Schmitt,  
2008).    Once  the  replacement  ligament  is  in  place,  the  new  ligament  is  secured  to  bone  
with  screws.    The  screws  are  metal,  plastic,  or  a  calcium-­based  product  that  turns  to  
bone  over  time.    Much  of  the  postoperative  pain  following  ACL  reconstruction  can  be  
attributed  to  the  drilling  through  bone  necessary  to  complete  this  procedure.  
Today,  many  medical  centers  are  performing  ACL  reconstruction  on  an  
outpatient  basis,  making  it  imperative  clinicians  develop  an  appropriate  postoperative  
pain  control  plan.    With  proper  pain  control,  patients  tolerate  this  surgical  procedure  on  
an  outpatient  basis  well  (Beck,  Nho,  Balin,  Badrinath,  Bush-­Jospeh,  Bach,  &  Hayden,  
2004).    Pain  following  ACL  reconstruction  has  been  reported  to  peak  on  the  second  
postoperative  day,  with  no  significant  diminution  until  the  fourth  days  postoperatively  
(Brown,  Curry,  Ruterbories,  Avery,  &  Anson,  1997).    Femoral  PNB  is  routinely  employed  
to  reduce  pain,  however,  anesthetizing  the  femoral  nerve  fails  to  account  for  the  
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posterior  aspect  of  the  knee  capsule  and  autograft  donor  sites  (Frost,  Grossfeld,  Kirkley,  
Litchfield,  Fowler,  &  Amendola,  2000).      As  such,  multimodal  approaches  typically  
include  prescribing  oral  narcotics  and  nonsteroidal  anti-­inflammatory  drugs  (NSAIDs)  for  
pain  control  after  discharge.  Acknowledging  the  presence  and  extent  of  autograft  donor  
site  pain  is  key  in  effectively  controlling  postoperative  pain.  
   Considerations  for  inpatient  vs.  outpatient.    As  efforts  continue  to  contain  
healthcare-­related  costs,  an  ever-­increasing  number  of  surgeries  are  being  performed  
on  an  outpatient  basis  (Beck,  Nho,  Balin,  Badrinath,  Bush-­Joseph,  Bach,  &  Hayden,  
2004).    One  of  the  many  challenges  associated  with  this  initiative  is  effectively  providing  
postoperative  pain  control  away  from  the  clinical  arena.    Providing  adequate  pain  
control  on  an  outpatient  basis  can  be  difficult,  as  modalities  for  pain  management  are  
limited  once  the  patient  has  been  discharged  from  the  hospital.    While  in  the  hospital,  a  
wide  array  of  pain  control  interventions  is  available  to  abate  postoperative  pain.    Upon  
discharge,  however,  the  list  of  available  interventions  becomes  far  more  limited,  as  
parenteral  opioids  and  neuraxial  anesthetics  are  no  longer  a  viable  option  (Mall  &  
Wright,  2009).    The  most  common  pain  control  protocols  are  comprised  of  oral  narcotics  
with  or  without  NSAIDs  (Frost,  Grossfeld,  Kirkley,  Litchfield,  Fowler,  &  Amendola,  2000).  
The  use  of  NSAIDs  following  ACL  reconstruction  with  a  hamstring  autograft,  however,  
remains  controversial  due  to  concerns  of  impaired  bone  and  soft  tissue  healing  (Chen  &  
Dragoo,  2013).    As  such,  clinicians  have  historically  been  forced  to  rely  on  oral,  single-­
drug  approaches  for  pain  control  following  surgery,  which  may  fail  to  provide  adequate  
pain  control.    
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Oral,  single-­drug  approaches  have  limited  success,  as  parents  often  fail  to  
provide  their  children  with  appropriate  dosages  of  medication,  resulting  in  suboptimal  
pain  control  (Gorodzinsky,  Davies,  &  Drendel,  2013).    Poor  pain  control  following  
discharge  can  prove  detrimental,  as  inadequate  pain  control  may  impede  rehabilitation,  
delay  recovery,  lead  to  poor  outcomes,  increase  the  use  of  health  care  resources  and  
decrease  overall  patient  satisfaction  (Reuben  &  Sklar,  2000).    One  of  the  keys  to  
success  with  pain  control  following  outpatient  surgery  is  the  administration  of  effective  
doses  of  analgesia.    In  an  effort  to  avert  the  limitations  associated  with  single-­drug  
approaches  to  pain  management,  multimodal  approaches  are  often  utilized  to  extend  
pain  control  several  days  into  the  postoperative  phase  (Chandrakantan  &  Glass,  2011).      
Intravenous  opioids.    To  date  opioids  remain  the  cornerstone  of  systemic  
analgesia  when  treating  moderate  to  severe  acute  pain  (Macintyre,  Scott,  Schug,  
Visser,  &  Walker,  2010).    Despite  the  fact  that  effective  dosing  of  opioids  is  limited  by  
deleterious  side  effects,  the  use  of  opioids  for  acute  pain  control  remains  based  on  
guidelines  from  the  early  1990s  that  reinforced  the  generous  use  of  opioids  for  acute  
pain  control  (Gould,  Crosby,  Harmer,  Lloyd,  Lunn,  Rees,  Roberts,  &  Webster,  1992).    
Controversy  exists  regarding  the  role  of  inhibitory  systems,  however,  implying  that  
opioids  may  not  be  completely  effective  in  treating  neuropathic  pain  should  it  progress  
to  that  point  (Dickenson,  2002).    Furthermore,  while  long  considered  the  gold  standard  
in  abating  pain,  opioids  are  not  without  negative  consequence,  as  they  elicit  unwanted  
side  effects  such  as  nausea,  vomiting,  pruritus,  somnolence,  urinary  retention  and  
hypoventilation  (Hanna,  Murphy,  Kumar,  &  Wu,  2009).      
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Such  side  effects  often  prompt  clinicians  to  seek  out  alternative  treatment  
modalities  to  augment  the  analgesic  plan.    Non-­opioid  analgesics  such  as  
Acetaminophen,  Ibuprofen,  Naproxen,  Diclofenac,  and  Ketorolac  are  commonly  
employed  to  treat  mild  pain  and  have  proven  to  be  effective  adjuncts  when  used  in  
combination  with  other  agents  to  treat  moderate  to  severe  postoperative  pain  as  well  
(Verghese  &  Hannallah,  2010).      Both  opioid  and  non-­opioid  analgesics  can  be  
administered  via  multiple  routes,  thereby  affording  clinicians  the  ability  to  tailor  delivery  
to  a  specific  patient  or  situation.    The  combination  of  non-­opioid  analgesics  and  low-­
dose  narcotics  may  be  administered  in  an  effort  to  minimize  unwanted  side  effects.  
Local  infiltration.    Infiltration  with  local  anesthetics  is  a  technique  that  has  long  
been  employed  by  surgeons  as  a  means  of  providing  analgesia  at  the  surgical  site.    The  
goal  of  injecting  local  anesthetics  is  to  modulate  the  transmission  of  pain  from  the  nerve  
fibers  in  the  surgical  field  to  the  central  nervous  system,  thereby  decreasing  the  
experience  of  pain.    Local  anesthetics  prevent  transmission  of  nerve  impulses  by  
inhibiting  passage  of  sodium  ions  through  ion-­selective  sodium  channels  in  nerve  
membranes  (Stoelting  &  Miller,  2006).    Utilizing  local  anesthetics  provides  an  extended  
period  of  pain  relief  following  surgery,  effectively  reducing  postoperative  pain  and  
overall  narcotic  requirements  (Roberge  &  McEwen,  1998).    Additionally,  the  local  
anesthetic  lidocaine  not  only  modulates  pain  transmission,  it  may  have  a  transient  anti-­
inflammatory  effect  in  of  itself,  further  decreasing  pain  (Lavelle,  Lavelle,  &  Lavelle,  
2007).  
Intra-­articular  injection,  which  entails  injection  of  medication  directly  into  the  joint  
to  decrease  postoperative  pain,  is  far  less  technically  challenging  than  PNB,  which  
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explains  its  frequent  use  historically  (Lavelle,  Lavelle,  &  Lavelle,  2007).    Anatomic  
landmarks  are  utilized  to  guide  where  the  anesthetic  should  ideally  be  deposited.    Blind  
infiltration  of  this  manner,  however,  fails  to  consistently  control  pain,  as  there  is  no  
guarantee  that  the  anesthetic  is  deposited  in  the  precise  anatomic  location  necessary  to  
achieve  its  intended  goal.      
Intra-­articular  injections  have  frequently  been  compared  to  femoral  PNB,  with  no  
clear  consensus  being  noted  in  the  literature  as  to  whether  one  technique  is  superior  to  
the  other.    Anatomic  studies,  however,  demonstrate  that  the  posterior  capsula  of  the  
knee  and  hamstrings  are  innervated  by  the  sciatic  nerve,  thereby  implying  anesthetizing  
the  sciatic  nerve  would  improve  analgesia  (Nelissen  &  Hogendoorn,  2001).    While  
effective,  the  efficacy  of  intra-­articular  injections  is  limited  to  the  early  postoperative  
period,  thereby  limiting  their  ability  to  manage  pain  several  days  postoperatively  (Koh,  
Kang,  Chang,  Do,  Cheol,  &  Kim,  2011).    Furthermore,  when  compared  to  the  
combination  of  femoral  and  sciatic  PNB,  intra-­articular  injection  failed  to  provide  
comparable  analgesia  (Tran  et  al.,  2005).    
Regional  anesthesia.    Many  of  the  qualities  inherent  to  PNB  techniques  make  
them  the  ideal,  cost-­effective  outpatient  analgesic  intervention  (Klein,  Evans,  Nielsen,  
Tucker,  Warner,  &  Steele,  2005).    The  use  of  regional  anesthesia  affords  clinicians  the  
ability  to  reduce,  if  not  eliminate,  the  incidence  of  opioid-­induced  negative  sequelae  that  
routinely  delay  discharge  following  ambulatory  surgery  (Hadzic,  Williams,  Karaca,  
Hobeika,  Unis,  Dermksian,  Yufa,  Thys,  &  Santos,  2005).    The  ability  to  provide  site-­
specific  analgesia  coupled  with  the  ability  to  reduce  opioid  requirements  yields  patients  
who  are  comfortable  and  symptom-­free  in  the  postoperative  phase  (Samol,  Furstein,  &  
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Moore,  2012).    As  a  result,  the  use  of  continuous  PNB  has  greatly  reduced  the  need  for  
hospital  admission  following  surgery,  in  addition  to  reducing  the  incidence  of  morbidity  
(Ganesh,  Rose,  Wells,  Ganley,  Gurnaney,  Maxwell,  DiMaggion,  Milovcich,  Scollon,  
Feldman,  &  Cucchiaro,  2007).    
Over  the  last  decade,  PNB  has  gained  increasing  favor  amongst  clinicians  caring  
for  pediatric  and  adolescent  patients  as  a  technique  for  managing  postoperative  pain  
(Silvain,  Camporesi,  &  Agostino,  &  Salvo,  2006).    In  the  pediatric  population,  PNB  is  
often  achieved  following  the  initiation  of  general  anesthesia.    Interventions  may  be  
useful  not  only  in  preventing  or  reducing  pain,  but  may  speed  up  the  healing  process  as  
well  (Loeser  &  Melzack,  1999).    Compared  with  opioid  analgesia,  continuous  PNB  has  
proven  to  improve  postoperative  analgesia,  reducing  overall  opioid  requirements  and  
the  associated  nausea,  vomiting,  pruritus  and  sedation  (Richman,  Liu,  Courpas,  Wong,  
Rowlingson,  McGready,  Cohen,  &  Wu,  2006).    Most  current  outpatient  pain  control  
modalities  have  proven  to  be  either  ineffective  or  fraught  with  opioid-­induced  adverse  
effects.    PNB,  however,  has  proven  to  supply  adequate  pain  control  while  effectively  
decreasing  the  frequency  of  undesired  opioid-­related  side  effects.      
Neuraxial  anesthesia.    In  many  institutions,  ACL  reconstruction  is  routinely  
performed  under  epidural  anesthesia  (Mulroy,  Larkin,  Batra,  Hodgson,  &  Owens,  2001).    
Benefits  of  neuraxial  anesthesia  include  improved  post  operative  pain  control;;  
decreased  intraoperative  anesthetic  requirements;;  blunted  adverse  physiologic  
response  to  surgery;;  earlier  ambulation;;  decreased  opioid  requirement  and  side  effects;;  
and  decreased  hypercoagulable  events  (Zwass,  2005).    Neuraxial  anesthesia  is  not  
without  risk,  however,  as  potential  exists  for  neurologic  injury  from  trauma,  infection,  
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ischemia,  hypotension,  seizures,  and  cardiac  arrest  (Gunter,  2002).    While  an  epidural  
anesthetic  is  effective,  its  utility  is  limited  in  regards  to  outpatient  surgery,  as  it  must  be  
discontinued  prior  to  patient  discharge,  thereby  limiting  its  ability  to  provide  lasting  
analgesia  in  the  postoperative  period.  
Peripheral  nerve  blockade.    Compared  to  neuraxial  analgesia,  PNB  is  well  suited  
for  outpatient  surgery.    The  use  of  PNB  affords  the  anesthetist  the  ability  to  reduce,  if  
not  eliminate,  the  need  for  opioids.    The  reduction  in  opioid  requirement  associated  with  
PNB  decreases  the  incidence  of  opioid-­induced  nausea  and  vomiting,  a  common  cause  
of  discharge  delay  following  ambulatory  surgery  (Hadzic  et  al.,  2005).    In  addition,  by  
diminishing  the  use  of  opioids  patients  are  likely  to  be  more  alert  during  the  recovery  
phase  due  to  the  lack  of  opioid-­induced  lethargy,  leading  to  a  decreased  time  required  
to  meet  discharge  criteria.    Therefore,  the  ability  to  provide  site-­specific  analgesia  
coupled  with  the  ability  to  reduce  opioid  requirements  yields  patients  who  are  
comfortable  and  symptom-­free  in  the  recovery  room  (Samol,  Furstein  &  Moore,  2012).        
In  regards  to  ACL  reconstruction,  PNB  has  been  found  to  be  paramount  in  
controlling  pain  following  hamstring  autograft.    Pain  at  the  donor  site  is  most  reliably  
relieved  by  sciatic  PNB,  due  to  the  ability  of  sciatic  PNB  to  reliably  anesthetize  the  
posterior  thigh  (Bushnell,  Sakryd,  &  Noonan,  2011).    Following  ACL  reconstruction,  the  
addition  of  a  sciatic  PNB  to  femoral  PNB  significantly  improves  postoperative  pain  
(Williams,  Kentor,  Vogt,  Williams,  Chelly,  Valalik,  Harner,  &  Fu,  2003).    Dang,  Guilley,  
Dernis,  Langlois,  Lambert,  Nguyen  and  Pinaud  (2006)  demonstrated  better  pain  relief  at  
rest  and  decreased  morphine  consumption  when  combining  continuous  femoral  and  
sciatic  PNB.    Unfortunately,  in  this  study,  data  from  patients  with  single-­injection  and  
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continuous  sciatic  PNB  were  not  analyzed  separately.    Nonetheless,  PNB  offers  
superior  analgesia  over  opioid-­based  analgesia,  with  significant  reductions  in  
postoperative  pain  routinely  attributed  to  the  use  of  PNB  (Kettner,  Wilschke,  &  Marhofer,  
2011).  
Pain  Management  Following  ACL  Reconstruction  with  Hamstring  Autograft  in  
Adolescents  
Historically,  acute  pediatric  pain  was  poorly  managed  due  to  fear  of  severe  
adverse  events  such  as  central  nervous  system  and  respiratory  depression  (Kraemer  &  
Rose,  2009).    Today,  it  is  recognized  that  untreated  pain  can  be  a  significant  cause  of  
morbidity  and  even  mortality  after  surgical  trauma  (Verghese  &  Hannallah,  2010).    
Subsequently,  clinicians  are  now  armed  with  a  variety  of  modalities  to  abate  
postoperative  pain.  In  addition  to  parental  interventions,  clinicians  may  employ  local  
anesthetics  and  regional  anesthesia,  which  prevent  nociception  from  becoming  pain  
(Loeser  &  Melzack,  1999).    The  ability  of  local  anesthetics  to  prevent  nociception  from  
becoming  pain  is  evidenced  by  the  decrease  in  intraoperative  need  for  systemic  opioids  
when  local  anesthetics  are  utilized  as  part  of  a  balanced  anesthetic  (Sumpelmann  &  
Munte,  2003).    Quite  often,  multimodal  analgesia  with  NSAIDs  acting  on  the  periphery,  
PNB,  and  opiates  acting  centrally  are  utilized  in  combination  to  maximize  acute  pain  
control  in  adolescent  patients  (Kraemer  &  Rose,  2009).    The  use  of  multi-­modal  
analgesia  can  readily  be  adapted  for  outpatient  surgery,  major  surgery,  the  critically  ill  
child,  or  the  very  young  child  (Lonnqvist  &  Morton,  2005).  
Hamstring  autograft  donor  site  pain:  factors  to  consider.    Utilization  of  a  
hamstring  autograft  results  in  significant  pain  at  the  donor  site  that  must  be  accounted  
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for  in  the  immediate  postoperative  period  (Bushnell,  Sakryd,  &  Noonan,  2010).    Multiple  
variables  likely  impact  the  extent  of  autograft  donor  site  pain.    Two  keys  factors  to  
consider  when  formulating  a  pain  management  plan,  however,  are  the  autograft  
technique  utilized,  being  either  BPTB  or  hamstring  autograft,  and  the  severity  of  pain  
associated  with  each  of  these  two  techniques.    Remaining  cognizant  of  these  two  
factors  affords  the  discerning  clinician  the  ability  to  target  pain  sites  specifically  and  to  
do  so  for  an  adequate  duration  such  that  rebound  pain  can  be  averted.  
Technique-­specific  pain.    When  considering  pain  attributed  to  either  the  BPTB  
or  hamstring  autograft  technique,  much  of  the  focus  is  on  long-­term  pain,  as  anterior  
knee  pain  and  pain  when  kneeling  are  well  known  issues  following  ACL  reconstruction  
(Dheerendra,  et  al.,  2012).    As  such,  pain  in  the  immediate  postoperative  period  specific  
to  donor  site  location  or  technique  is  rarely  considered.    Donor  site  pain  following  
autograft  harvest  for  ACL  reconstruction  is  significantly  more  common  should  a  BPTB  
graft,  rather  than  a  hamstring  autograft,  be  employed  (Macauley,  Perfetti,  &  Levine,  
2012).    In  fact,  absolute  pain  scores  in  general  have  been  reported  as  being  higher  
when  comparing  BPTB  to  hamstring  autograft  techniques  (Reinhardt,  Hetsroni,  &  Marx,  
2010).    Likewise,  Feller,  Webster  and  Gavin  (2001)  reported  a  significant  reduction  in  
postoperative  pain  scores  existed  when  a  hamstring  autograft  was  utilized  compared  
BPTB  autografts.    The  smaller  incision  and  decrease  in  bone  destruction  involved  with  
hamstring  graft  harvest  may  account  for  the  fact  that  there  typically  is  less  postoperative  
pain  when  a  hamstring  tendon  is  used  as  opposed  to  other  autograft  techniques.  
Characteristics  of  donor  site  pain.    There  remains  no  consensus  as  to  the  
duration  of  donor  site  pain  following  hamstring  autograft  harvest  (Tran,  Ganley,  Wells,  
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Ganesh,  Minger,  &  Cucchiaro,  2005;;  Bushnell,  Sakryd,  &  Noonan,  2010).    It  has  been  
reported  that  ACL  reconstruction  continues  to  be  painful  for  the  first  48  hours  
postoperatively,  but  definitive  studies  regarding  pain  duration  are  lacking  (Frost,  et  al.,  
2000).    While  it  is  acknowledged  that  pain  at  the  donor  site  can  be  significant,  to  date  
there  has  been  little  published  regarding  the  impact  sciatic  PNB  has  on  pain  scores  
following  hamstring  autograft  harvest  (Williams,  Bottegal,  Kentor,  Irrgang,  &  Williams,  
2007).    What  is  known,  however,  is  that  rebound  pain  scores  following  hamstring  
autograft  harvest  can  be  significant  should  the  duration  of  analgesia  be  insufficient  
(Dauri,  Fabbi,  Mariani,  Faria,  Carpenedo,  Sidiropoulou,  Coniglione,  Silvi,  &  Sabato,  
2009).    Such  scenarios,  however,  can  be  successfully  averted  should  analgesia  be  
extended.    Hoenecke,  Pudilo,  Moris,  and  Fronek  (2002)  have  demonstrated  success  
abating  donor  site  pain  following  patellar  tendon  graft  harvest  utilizing  a  continuous  
bupivacaine  infiltration  at  the  donor  site.    Similarly,  Wegener,  van  Ooij,  van  Dijk,  
Hollmann,  Preckel,  and  Stevens  (2011)  reported  that  postoperative  pain  relief  following  
total  knee  arthroplasty  was  much  improved  should  sciatic  PNB  be  employed,  with  those  
patients  receiving  continuous  sciatic  PNB  reporting  significantly  less  pain  than  those  
who  did  not.  
Peripheral  nerve  blockade.    A  decade  ago,  adolescent  patients  undergoing  
orthopedic  surgery  were  admitted  to  the  hospital  postoperatively  to  ensure  adequate  
pain  control.    Quite  often,  these  patients  were  given  either  an  epidural  or  intravenous  
opioids  to  control  postoperative  pain.    PNB  has  revolutionized  the  ability  to  provide  site-­
specific  pain  control.    Due  to  recent  advances  in  ultrasound-­guided  techniques,  the  
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same  cadre  of  peripheral  nerve  blocks  used  in  adults  can  now  be  used  safely  and  
effectively  in  adolescent  patients  (Ivani  &  Mossetti,  2009).    
At  present,  it  is  estimated  that  50-­60%  of  all  operations  are  performed  in  the  
ambulatory  setting  (Khoury,  Dagher,  Ghanem,  Naccache,  Jawish,  &  Yazbeck,  2009).    
Adolescents  are  generally  good  candidates  for  outpatient  surgery  due  to  their  inherent  
ability  to  recover  rapidly  from  surgery.    Pediatric  orthopedic  surgery,  however,  has  
historically  rarely  been  done  in  the  outpatient  setting  due  to  the  inability  to  adequately  
control  postoperative  pain  (Khoury  et  al.,  2009).    The  utilization  of  PNB  has  proven  
beneficial  in  this  setting,  as  it  affords  patients  excellent  pain  control  while  decreasing  the  
incidence  of  undesired  opioid-­related  side  effects.    Not  only  does  the  use  of  PNB  lead  to  
a  more  desirable  recovery  for  the  patient,  it  decreases  the  time  required  to  meet  
discharge  criteria,  thereby  decreasing  overall  costs.    PNB  has  also  been  found  to  
improve  the  ability  to  perform  orthopedic  surgery  on  pediatric  patients  on  an  outpatient  
basis  (Khoury  et  al.,  2009).    With  the  advent  of  improved  technology  and  anesthetics  
that  possess  better  safety  profiles,  PNB  now  plays  a  key  role  in  pain  control  for  
adolescent  patients  undergoing  orthopedic  surgery  on  an  outpatient  basis  (Ivani  &  
Mossetti,  2009).  
Nerve  block  distribution.    While  femoral  PNB  has  proven  to  be  an  effective  
means  of  decreasing  pain  following  ACL  reconstruction,  it  fails  to  abate  pain  arising  at  
the  harvest  site  should  a  hamstring  autograft  be  utilized  (Frost,  Grossfeld,  Kirkley,  
Litchfield,  Fowler,  &  Amendola,  2000).    Graft  harvest  and  graft  fixation  both  contribute  to  
significant  postoperative  pain  in  the  sciatic  nerve  distribution  (Williams  et  al.,  2003).    
Therefore,  clinicians  should  consider  additional  modalities  to  ensure  adequate  pain  
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control  in  the  postoperative  period.    Various  approaches  to  managing  pain  at  the  donor    
harvest  site  exist,  yet  only  sciatic  nerve  block  reliably  covers  the  posterior  thigh  and  
subsequently  the  hamstring  donor  site  (De  Tran,  Clemente,  &  Finlayson,  2007).  
Duration  of  PNB.    Several  clinical  trials  suggest  the  addition  of  sciatic  PNB  
following  total  knee  arthroplasty  (TKA)  improves  postoperative  analgesia,  however,  the  
extent  of  the  role  sciatic  PNB  plays  in  pain  control  remains  undetermined  (Ben-­David,  
Schmalenberger,  &  Chelly,  2004).    While  a  different  surgical  procedure,  much  of  the  
pain  experienced  by  patients  during  the  postoperative  period  is  similar  that  of  patients  
undergoing  knee  ligament  reconstruction  due  to  the  anatomical  areas  disrupted  during  
surgery.    Ben-­David  et  al.  (2004)  reported  that  following  TKA,  pain  scores  were  greatly  
reduced  in  patients  receiving  a  sciatic  CPI  when  compared  to  those  who  received  only  a  
single-­injection  sciatic  nerve  block.    Wegener  et  al.  (2011)  investigated  whether  the  
addition  of  sciatic  PNB  to  continuous  femoral  PNB  would  shorten  the  time-­to-­discharge  
readiness  following  TKA.    Although  no  impact  on  time-­to-­discharge  readiness  was  
appreciated,  a  distinction  in  postoperative  pain  control  was  noted,  as  a  single-­injection  
sciatic  PNB  reduced  severe  pain  on  the  day  of  the  surgery,  whereas  continuous  sciatic  
PNB  reduced  moderate  pain  during  mobilization  on  the  initial  two  postoperative  days.  
To  date,  sciatic  PNB  has  been  reported  to  most  reliably  decrease  hamstring  
donor  site  pain,  however,  there  remains  no  consensus  as  to  the  duration  of  action  
required  to  effectively  control  donor  site  pain  throughout  the  postoperative  period  (Tran,  
Ganley,  Wells,  Ganesh,  Minger,  &  Cucchiaro,  2005;;  Bushnell,  Sakryd,  &  Noonan,  
2010).    While  both  single-­injection  sciatic  PNB  and  continuous  sciatic  PNB  alleviate  pain  
the  day  of  surgery,  only  continuous  sciatic  PNB  has  the  ability  to  reduce  pain  on  
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subsequent  postoperative  days.    Proponents  of  continuous  sciatic  PNB  assert  that  the  
extended  duration  of  analgesia  afforded  by  the  use  of  a  sciatic  CPI  catheter  improves  
overall  pain  control  postoperatively  and  decreases  the  need  for  supplemental  pain  
medications  (Ganesh  &  Cucchiaro,  2007).    Ganesh  and  Cucchiaro’s  (2007)  contention  
that  the  duration  of  action  of  single-­injection  sciatic  PNB  may  fail  to  outlast  the  pain  
arising  from  the  hamstring  donor  site  has  prompted  some  clinicians  to  employ  
continuous  sciatic  PNB.      
The  use  of  continuous  sciatic  PNB  is  not  without  its  detractors,  however.    
Advocates  of  single-­injection  sciatic  PNB,  which  can  last  up  to  24  hours  or  longer,  note  
that  in  adult  studies  sciatic  PNB  offered  significant  advantages  in  pain  control  only  
during  the  initial  24  hours  following  knee  surgery  (Wegener  et  al.,  2011).    Furthermore,  
concerns  regarding  increased  risk  of  falls,  decreased  active  knee  movement  and  the  
masking  of  compartment  syndrome  precludes  routine  use  of  continuous  sciatic  PNB  by  
many  clinicians  (Liu  &  Wu,  2007).    Not  only  are  these  potential  risks  undesirable,  they  
can  be  costly  should  they  occur  and  may  require  further  medical  or  surgical  intervention  
to  correct.    
PNB  under  general  anesthesia.    While  improvements  in  pain  control  have  given  
rise  to  improved  patient  outcomes  postoperatively,  many  questions  remain  as  to  
appropriate  resource  management  and  utilization.    The  ability  to  hastily  resolve  these  
issues  is  further  hampered  by  the  prolific  rate  at  which  advances  in  surgical  approaches  
occur,  such  as  epiphyseal  sparring  approaches  to  ligament  reconstruction  that  allow  
patients  to  undergo  repair  at  much  earlier  age  than  previously  possible.    The  gap  in  
knowledge  created  by  such  rapid  advancements  is  demonstrated  by  the  lack  of  
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literature  defining  best  practice  for  providing  donor  site  pain  control  when  hamstring  
autografts  are  harvested  in  the  adolescent  population.  
Traditionally,  regional  anesthesia  has  been  performed  in  awake  or  sedated  
patients,  as  it  was  thought  that  this  was  safest  for  patients,  as  they  would  be  able  to  
serve  as  a  monitor  of  untoward  events.    Recently,  this  line  of  reasoning  has  been  
challenged,  with  opponents  asserting  that  this  premise  is  based  on  antiquated  
knowledge  and  the  utilization  of  venerable  paresthesia  techniques.    Due  to  the  variance  
witnessed  in  practice,  the  American  Society  of  Regional  Anesthesia  (ASRA)  developed  
a  practice  advisory  based  on  existing  scientific  literature,  pathophysiological  principles,  
and  expert  opinion  (Bernards,  Hadzic,  Suresh,  &  Neal,  2008).    The  advisory  panel  
examined  the  ability  of  anesthetized  and  heavily  sedated  patients  to  indicate  the  
presence  of  the  signs  and  symptoms  of  impending  neurologic  injury  or  intravascular  
injection  of  local  anesthetic.    Subsequently  the  advisory  panel  offered  revised  practice  
guidelines  to  promote  best  practice  amongst  clinicians.      
Bernards,  Hadzic,  Suresh,  and  Neal  (2008)  found  that  the  potential  ability  of  
general  anesthesia  or  heavy  sedation  to  obscure  early  signs  of  systemic  local  
anesthetic  toxicity  is  not  a  valid  reason  to  forgo  performing  peripheral  or  neuraxial  nerve  
blockade  in  anesthetized  or  heavily  sedated  patients.    However,  because  general  
anesthesia  or  heavy  sedation  removes  all  opportunity  for  adults  to  communicate  
symptoms  of  potential  nerve  injury,  Bernards  et  al.  (2008)  offered  that  PNB  should  not  
be  routinely  performed  in  adults  under  general  anesthesia  or  heavy  sedation,  but  that  
the  risk-­to-­benefit  ratio  of  performing  PNB  under  these  conditions  may  improve  in  select  
patient  populations,  such  as  pediatric  patients.    Based  largely  on  these  
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recommendations,  PNB  is  routinely  performed  under  general  anesthesia  at  Cincinnati  
Children’s  Hospital  Medical  Center.    
Stimulation-­based  PNB.    Prior  to  the  introduction  of  ultrasound  in  
anesthesia  practice,  the  most  reliable  technique  available  to  identify  peripheral  nerves  
was  nerve  stimulation  (Gurnaney,  Ganesh,  &  Cucchiaro,  2007).    A  portable  
transistorized  nerve  stimulator  with  variable  current  would  allow  clinicians  to  assess  the  
proximity  of  the  tip  of  a  block  needle  to  the  nerve.    By  connecting  the  cathode  to  the  
stimulating  electrode,  a  circuit  can  be  created  once  the  anode  is  connected  to  the  
patient’s  skin.      Depolarizing  the  nerve  membrane  results  in  contraction  of  the  effector  
muscles  (motor  fibers)  or  in  paresthesia  (sensory  fibers).    It  was  believed  that  these  
responses  could  be  used  to  confirm  the  proximity  of  a  needle  or  catheter  to  the  nerve.    
However,  limitations  exist  with  peripheral  nerve  stimulation  techniques.    Utilizing  nerve  
stimulation  for  guidance  when  performing  PNB  is  useful  only  when  a  motor  response  is  
elicited,  therefore  should  muscle  relaxants  be  utilized,  the  utility  of  nerve  stimulation  is  
negated.      
   Historically,  once  a  motor  response  achieved  at  or  less  than  0.5  mA,  it  was  
thought  that  the  tip  of  the  needle  was  in  sufficient  proximity  of  the  nerve  to  achieve  
successful  blockade  with  the  injection  of  the  local  anesthetic.    Clinical  data  suggest  that  
reliance  on  a  nerve  stimulator  for  performance  of  peripheral  nerve  blockade  does  not  
eliminate  the  potential  for  nerve  injury  (Urmey,  2000).    The  relationship  between  the  
lowest  current  amperage  used  to  obtain  a  motor  response,  the  success  rate  and  the  
incidence  of  neurological  complications  with  PNB  has  also  been  challenged.    In  fact,  it  
has  been  argued  that  it  may  not  be  necessary  to  perform  needle  manipulations  to  
  61  
achieve  a  low  stimulation  threshold  (0.5  mA),  as  this  may  increase  the  risk  of  intraneural  
injection  (Gurnaney,  Ganesh,  &  Cucchiaro,  2007).    The  advent  of  ultrasound-­guidance  
has  greatly  improved  clinicians’  ability  to  safely  and  effectively  perform  PNB,  as  nerve  
stimulation-­based  techniques  do  not  prevent  intravascular,  intraneural  or  pleural  
puncture.  
Ultrasound-­guided  PNB.  The  failure  rate  for  nerve  stimulation-­based  
techniques  ranges  from  4-­23%  depending  on  the  study  and  their  definition  of  success.    
This  high  margin  for  failure  led  clinicians  to  seek  out  improved  techniques  and  
approaches  to  peripheral  nerve  blockade.    The  advent  of  ultrasound-­guided  PNB  
techniques  marked  the  dawn  of  a  new  era  of  pain  control  modalities.    The  utilization  of  
ultrasound  guidance  affords  the  practitioner  the  ability  to  visualize  target  nerves  and  
visualize  real-­time  perineural  spread  of  local  anesthetic.    Because  of  this,  ultrasound  
has  the  ability  to  improve  upon  the  false  negative  rate  due  to  real-­time  visualization  
during  needle  insertion  and  injection  of  the  local  anesthetic.    The  ability  to  visualize  
structures  not  only  improves  the  block  success  rate,  quality  and  onset  time.    It  also  
allows  this  to  occur  with  a  reduced  number  of  needle  insertions  being  necessary.    
Ultrasound  is  not  without  its  limitations.    Performing  ultrasound-­guided  PNB  requires  
mastery  of  additional  knowledge  and  sound  hand-­eye  coordination.    Ultrasound-­guided  
PNB  also  requires  a  sound  understanding  of  “sonoanatomy”  prior  to  utilizing  these  
techniques  in  the  clinical  arena  (Ivani  &  Ferrante,  2009).  
The  recent  advances  in  technology  and  knowledge  in  ultrasound-­guided  PNB  
have  further  sparked  a  renewed  enthusiasm  and  interest  in  regional  anesthesia,  as  
evidenced  by  the  plethora  of  scholarly  articles,  and  the  abundance  of  studies  and  
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publications  devoted  to  continuing  medical  educating  and  developing  superior  regional  
anesthetic  techniques.    One  such  area  of  focus  is  the  utilization  of  PNB  for  adolescent  
patients.    The  use  of  ultrasound  guidance  now  affords  clinicians  the  opportunity  to  
perform  many  peripheral  nerve  blocks  that  would  have  been  difficult  to  perform  in  
adolescents  based  on  pure  landmark  techniques  due  to  the  potential  for  injection  into  
contiguous  sensitive  vascular  areas  (Tsui  &  Suresh,  2010).    This  has  greatly  impacted  
anesthetic  practices,  as  adolescent  patients  who  receive  PNB  have  shown  earlier  
functional  recovery  following  surgery  (Ganesh  &  Gurnaney,  2009).  
Like  any  other  acquired  technical  skill,  ultrasound-­guided  PNB  is  a  modality  that  
must  be  utilized  often  to  remain  proficient  with  this  clinical  skillset.    While  it  is  imperative  
the  practitioner  remains  cognizant  of  potential  adverse  outcomes  associated  with  
regional  blockade,  the  ability  to  visualize  the  anatomy  allows  the  practitioner  to  go  
forward  with  a  newfound  confidence  and  sense  of  safety  when  performing  regional  
blockade.    
Continuous  perineural  infusion  (CPI)  catheters.    While  effective  at  abating  
pain,  single-­injection  PNB  is  not  without  its  confines.    As  highlighted  by  Richman  et  al.  
(2006),  single-­injection  PNB  is  limited  by  the  duration  of  action  of  the  local  anesthetic  
utilized.    This  limitation  has,  at  times,  led  to  the  underuse  of  PNB  for  post-­operative  pain  
control.      
A  number  of  studies  have  demonstrated  that  resting  and  break-­through  pain  
scores  are  lower  with  continuous  PNB  versus  conventional  techniques  (Swenson,  Bay,  
Loose,  Bankhead,  Davis,  Beals,  Bryan,  Burks,  &  Greis,  2006).    The  success  of  
continuous  PNB  using  CPI  catheters  and  elastomeric  pumps  in  adult  outpatient  
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orthopedics  has  been  replicated  in  the  adolescent  population  (Dadure,  Pirat,  Raux,  
Troncin,  Rochete,  Ricard,  &  Capdevila,  2003).    Ludot,  Berger,  Pichenot,  Belouadah,  
Madi,  and  Malinovsky  (2008)  were  able  to  show  that  analgesia  achieved  via  a  
disposable  pump  connected  to  a  CPI  catheter  effectively  controlled  pain  and  enabled  
adolescents  to  undergo  surgery  on  an  ambulatory  basis  (Ludot  et  al.,  2008).    Ganesh  
and  Cucchiaro  (2007)  demonstrated  that  the  use  of  CPI  catheters  facilitates  early  
discharge  from  the  hospital  and  decreases  overall  opioid  requirement  throughout  
recovery.  
Multiple  catheters.    Ganesh  and  Cucchiaro  (2007)  reported  the  feasibility  of  
optimizing  postoperative  pain  control  in  adolescents  via  multiple  continuous  PNBs.  
Multiple,  simultaneous  CPI  catheters  have  been  used  safely  and  effectively  in  
adolescents  (van  Geffen,  Scheuer,  Muller,  Garderniers,  &  Gielen,  2006).    The  safety  
and  efficacy  of  continuous  PNB  with  a  CPI  infusion  catheter  and  elastomeric  infusion  
pump  allows  for  broad  application  in  ambulatory  and  adolescent  patients  (Swenson,  
2010).    Careful  selection  of  local  anesthetic  concentration  when  utilizing  multiple  CPI  
catheters  not  only  improves  the  ability  to  extend  postoperative  analgesia,  but  also  
averts  undesired  motor  blockade  (McLeod,  Dale,  Robinson,  Checketts,  Columb,  Luck,  
Wigderowitz,  Rowley,  2009).    The  primary  concern  when  utilizing  multiple  CPI  catheters  
is  local  anesthetic  toxicity.    Keeping  plasma  concentrations  of  local  anesthetic  within  
safe  ranges  and  providing  adequate  pain  relief  are  not  concepts  at  odds  when  utilizing  
multiple  CPI  catheters  simultaneously  (Ganesh  &  Cucchiaro,  2007).    In  fact,  the  
effective  dose  of  local  anesthetic  when  employing  simultaneous  femoral  and  sciatic  
PNB  is  substantially  lower  than  commonly  employed  concentrations  in  the  clinical  arena  
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(McLeod  et  al.,  2009).    Therefore,  proper  knowledge  of  dosing  guidelines  can  improve    
patient  safety  and  prevent  undesired  local  anesthetic  side  effects  (Ganesh  &  Cucchiaro,  
2007).    
Discharging  to  home  with  indwelling  CPI  catheters.    Dadure,  Bringuier,  Raux,  
Rochette,  Troncin,  Canaud,  Lubrano-­Lavadera,  and  Capdevila  (2009)  reported  that  
children  have  been  discharged  home  with  indwelling  CPI  catheters  without  significant  
complication.    Although  discharging  patients  with  an  insensate  extremity  remains  
controversial  and  puts  greater  emphasis  on  patient/guardian  selection,  the  data  suggest  
that  the  risk  of  injury  to  these  patients  is  relatively  minimal  (Ludot  et  al.,  2008;;  Klein  et  
al.,  2005).    Furthermore,  patients  with  continuous  PNB  do  not  fall  more  frequently  than  
either  patients  without  PNB  or  other  surgical  patients  (Chelly,  Miller,  Conroy,  Hudson,  &  
Williams,  2008).    Appropriate  patient  selection  and  thorough  patient  education  prior  to  
discharge  have  also  been  the  keys  to  success  (Verghese  &  Hannallah,  2010).    Although  
the  potential  for  complication  exists  with  any  procedure,  studies  in  large  cohorts  of  
pediatric  patients  discharged  with  indwelling  CPI  catheters  have  failed  to  highlight  the  
severe  complications  reported  in  adult  studies,  as  only  minor  side  effects  have  been  
commonly  noted  in  the  pediatric  population  (Dadure  &  Capdevila,  2012).    
The  Risks  and  Benefits  of  PNB    
   Risks.    Although  there  is  a  paucity  of  reported  complications  following  lower  
extremity  PNB,  these  interventions  are  not  without  risk  (Enneking,  Chan,  Greger,  
Hadzic,  Lang,  &  Horlocker,  2005).    As  with  any  medical  procedure,  the  benefits  of  PNB  
must  be  weighed  against  the  potential  risks.  
  
  65  
Injury.    The  widespread  use  of  single-­injection  and  continuous  PNB  is  
associated  with  few  complications,  yet  neurological  deficits,  CPI  catheter-­related  issues,  
and  local  anesthetic  toxicity  still  occur  (Jeng,  Torrillo,  &  Rosenblatt,  2010).    Injury  and  
complication  following  PNB,  however,  is  not  common.    Auroy,  Narchi,  Messiah,  Litt,  
Rouvier,  and  Samii  (1997)  estimated  that  the  potential  for  serious  complication  per  
10,000  peripheral  nerve  blocks  performed  to  be  0  to  2.6  deaths,  0.3  to  4.1  cardiac  
arrests,  0.5  to  4.8  neurologic  injuries,  and  3.9  to  11.2  seizures.    While  neurologic  injury  
is  often  one  of  the  most  feared  complications  following  PNB,  it  should  be  noted  that  it  is  
often  difficult  to  determine  how  much  of  a  neurologic  deficit,  if  any,  is  attributable  to  the  
use  of  a  CPI  catheter,  as  all  surgical  procedures  are  associated  with  a  variable  
incidence  of  nerve  injury  regardless  of  the  use  of  continuous  PNB  (Ilfeld,  2011).    
Potential  complications  include  local  anesthetic  toxicity,  hemorrhagic  complications,  
neurologic  complications,  and  infectious  complications  (Enneking,  Chan,  Greger,  
Hadzic,  Lang,  &  Horlocker,  2005).    In  addition,  further  potential  complications  include  
infusion  pump  malfunction,  skin  irritation  or  allergic  reaction  secondary  to  dressing  
material,  unintentional  catheter  dislodgement,  or  fluid  leakage  at  the  insertion  site  of  a  
CPI  catheter  (Ilfeld,  2011).  
   Infection.    Infectious  complications  secondary  to  PNB  are  exceedingly  rare  (Hebl  
&  Niesen,  2011).    To  date,  there  have  been  no  reports  in  the  literature  of  infection  
following  single-­injection  PNB  (Enneking,  Chan,  Greger,  Hadzic,  Lang,  &  Horlocker,  
2005).    Though  rare,  transient  symptoms  of  bacteremia  have  been  reported  in  the  
literature  following  the  use  of  CPI  catheters  (Enneking,  Chan,  Greger,  Hadzic,  Lang,  &  
Horlocker,  2005).    In  the  literature,  there  is  consensus  that  a  major  risk  factor  to  CPI  
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catheter  infection  is  duration  of  catheter  use  (Lai,  Jaeger,  Jones,  Kaderbek,  &  Malchow,  
2011).    In  most  cases  of  reported  bacteremia  symptoms  resolve  upon  removal  of  the  
catheter  and  no  long-­term  sequelae  were  reported.    Psoas  abscess  requiring  drainage  
and  antibiotic  therapy  has  rarely  been  reported  in  the  literature  following  the  use  of  CPI  
catheters  for  continuous  femoral  PNB  (Adam,  Jaziri,  &  Chauvin,  2003).  
   Benefits.    Value  is  a  matter  of  perspective.    Significant  pain  following  ACL  
reconstruction  can  be  detrimental  to  the  patient’s  postoperative  course  and  lead  to  
much  patient  dissatisfaction  (Koh,  Chang,  Seo,  Kim,  Seong,  &  Kim,  2012).    From  a  
surgeon’s  standpoint,  longevity  and  durability  of  a  surgical  reconstruction  are  key  
considerations  when  comparing  available  options.    From  the  anesthetist’s  perspective,  
costs  of  time  and  materials  alone  must  not  be  considered,  as  efficacy  of  a  chosen  
modality  can  lead  to  future  cost  savings  and  increased  patient  satisfaction.      
Costs.    Costs  secondary  to  PNB  are  often  attributed  to  the  billable  time  to  
perform  PNB,  in  addition  to  all  the  necessary  equipment  (Mariano,  2008).    One  great  
advantage  of  PNB,  however,  is  the  ability  to  discharge  the  patient  postoperatively,  
which  decreases  cost  to  both  the  patient  and  the  hospital.    Continuous  PNB  offers  the  
ability  to  prolong  the  analgesic  effect  of  a  single-­injection  PNB  and  may  be  the  ideal  
choice  for  analgesia  following  outpatient  orthopedic  procedures.        
Use  of  a  sciatic  CPI  is  more  costly  than  single-­injection  sciatic  PNB,  as  additional  
equipment  is  required,  including  catheters,  needles,  an  infusion  pump,  dressing  
supplies  and  additional  local  anesthetic.    When  considering  costs  secondary  to  
continuous  PNB,  the  measurable  differences  between  various  pumps  and  local  
anesthetics  should  be  considered  carefully,  as  fixed  rate  elastomeric  pumps  are  an  
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attractive  option  with  respect  to  cost  and  ease  of  use  for  patients  (Swenson,  2010).    
Improving  postoperative  pain  control,  however,  is  thought  to  result  in  more  efficient  use  
of  health  resources  and  to  decrease  overall  costs  (Strassels,  Chen,  &  Carr,  2002).    
Utilization  of  a  single-­injection  sciatic  PNB,  while  requiring  less  equipment,  may  also  
lead  to  more  costs  as  increased  pain  medications  may  be  required  to  compensate  for  
the  limited  duration  of  analgesia  offered.    Ultimately,  when  trying  to  minimize  actual  
costs  attributed  to  a  given  procedure,  strategies  should  focus  on  variable  costs,  such  as  
pain  management,  as  most  overhead  is  considered  to  be  a  fixed  cost  (Macario,  Vitez,  
Dunn,  &  McDonald,  1995).    Given  the  precarious  economic  landscape  of  healthcare,  it  
is  imperative  clinicians  remain  cognizant  of  the  financial  implications  tied  to  all  clinical  
decisions.    This  has  never  been  more  true  for  anesthetists,  as  changes  in  Medicare  will  
soon  tie  a  percentage  of  reimbursement  to  patients’  perceptions  of  quality  of  care,  
based  on  post-­discharge  surveys  with  an  emphasis  on  pain  management  (Geiger,  
2012).      
Value  of  PNB  to  patients  and  family.    The  patient  should  always  be  an  active  
participant  in  all  decision-­making  processes  related  to  their  care.    The  patient’s  
perceived  quality  of  care  is  influenced  by  a  host  of  factors,  ultimately  combining  to  
determine  their  overall  satisfaction  following  ACL  reconstruction  (Farber,  2010).    Knee  
pain  during  the  immediate  postoperative  phase  can  result  in  significantly  decreased  
patient  satisfaction  scores  (Kocer,  Steadman,  Briggs,  Zurakowski,  Sterett,  &  Hawkins,  
2002).      Therefore,  from  the  patient’s  perspective,  PNB  may  be  perceived  as  highly  
valuable  due  to  the  ability  to  prevent  pain  while  reducing  the  risk  of  nausea  and  vomiting  
after  surgery  (Mariano,  2008).    
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Porter  (2010)  contends  that  value  should  always  be  defined  around  the  customer,  
and  depends  on  results,  not  inputs.    Utilizing  PNB  to  facilitate  same-­day  discharge  
following  ACL  reconstruction  is  well  aligned  with  this  shifting  paradigm,  as  ACL  
reconstructions  performed  as  an  outpatient  procedure  is  well  tolerated  by  patients.    In  
addition,  performing  ACL  reconstructions  as  an  outpatient  provides  a  cost-­efficient  
alternative  to  performing  this  surgery  as  inpatient  (Nakamura,  Conte-­Hernandez,  &  
Galloway,  1997).    Furthermore,  since  value  is  defined  as  outcomes  relative  to  costs,  it  
encompasses  efficiency,  thereby  making  the  utilization  of  PNB  a  valuable  endeavor  
(Porter,  2010).  
Parents  whose  children  are  undergoing  surgery  report  greater  satisfaction  when  
the  procedure  is  performed  on  an  outpatient  basis  (Khoury,  Dagher,  Ghanem,  
Naccache,  Jawish,  &  Yazbeck,  2009).    PNB  offers  clinicians  the  ability  to  discharge  
patients  home  following  painful  surgical  procedures  with  an  effective  pain  control  plan.    
PNB  reduces  postoperative  pain,  particularly  during  movement  of  the  operative  
extremity  (Macfarlane,  Prasad,  Chan,  &  Brull,  2009).    Furthermore,  optimal  pain  control  
has  been  reported  to  be  key  in  accelerating  rehabilitation  following  knee  reconstruction  
(Wegener  et  al.,  2011).  
One  of  the  major  factors  influencing  parental  satisfaction  is  parental  preparation  
and  involvement  in  postoperative  pain  control  (Khoury  et  al.,  2009).    Patient  and  
parental  preferences  are  often  more  important  than  small  differences  in  outcomes  when  
determining  the  optimal  individualized  plan  for  a  patient  (Rice,  Waterman,  &  Lubowitz,  
2012).    Even  in  the  absence  of  significant  differences  in  pain  scores,  when  comparing  
postoperative  pain  modalities,  patients  and  their  parents  report  higher  satisfaction    
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scores  when  continuous  PNB  is  utilized  to  abate  orthopedic  surgical  pain  (Seet,  Leong,  
Yeo,  &  Fook-­Chong,  2006).      
Value  of  PNB  to  surgeons.    Anesthesia  is  a  service  that  benefits  patients  and  
surgeons  alike.    Without  some  form  of  anesthesia  most  surgery  cannot  occur.    
Therefore,  orthopedic  surgeons  are  both  consumers  and  providers  of  healthcare  
services.    It  is  the  charge  of  anesthesia  providers  to  provide  a  safe,  effective  anesthetic  
that  does  not  hinder  the  patient’s  intraoperative  and  postoperative  course.    Early  
rehabilitation  is  reliant  upon  regaining  motion,  as  immediate  weight  bearing  is  commonly  
allowed  in  the  postoperative  period  as  tolerated  by  the  patient  (Mehta,  Mandala,  Foster,  
&  Petsche,  2010).    PNB  has  been  reported  to  hasten  postoperative  rehabilitation,  
making  is  a  valuable  resource  to  surgeons  (Macfarlane,  Prasad,  Chan,  &  Brull,  2009).    
Both  immediate  and  long-­term  postoperative  knee  movement  is  reported  to  significantly  
improve  when  comparing  PNB  with  systemic  modalities  for  pain  management  (Kettner,  
Wilschke,  &  Marhofer,  2011).    Another  point  to  consider  is  that  stress  may  be  
pathological  and  contribute  to  postoperative  morbidity  and  mortality.    When  determining  
postoperative  care,  it  should  be  noted  that  PNB  has  the  ability  to  obtund  the  
neuroendocrine  stress  response  (Bosenberg,  2011).    These  are  all  aspects  impacting  
care  that  should  be  discussed  with  surgeons  when  considering  utilizing  various  
modalities  to  manage  postoperative  pain.      
Surgery  itself  is  costly,  however,  in  the  United  States  surgical  treatment  of  ACL  
rupture  is  more  cost-­effective  than  conservation  treatment  (Farshad,  Gerber,  Meyer,  
Schwab,  Blank,  &  Szucs,  2011).    ACL  reconstruction  is  often  performed  on  an  
outpatient  basis  as  a  means  of  containing  cost.    A  significantly  lower  incidence  of  
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hospital  admission  following  ACL  reconstruction  in  the  adolescent  population  has  been  
reported  when  PNB  is  utilized  (Schloss,  Bhalla,  Klingele,  Phillips,  Prestwich,  &  Tobias,  
2013).    Furthermore,  in  an  ambulatory  setting,  the  use  of  allograft  is  far  most  costly  for  
the  consumer  than  the  use  of  autograft  despite  the  decrease  in  overall  operative  room  
time,  as  the  time  necessary  for  harvest  was  not  needed  (Macaulay,  Perfetti,  &  Levine,  
2012).    This  is  one  of  many  reasons  leading  to  the  predominance  of  autograft  use  for  
ACL  reconstruction  in  adolescents.    Should  increased  pain  secondary  to  autograft  
harvest  result  in  hospital  admission,  ACL  reconstruction  with  a  hamstring  autograft  
becomes  more  costly  than  ACL  reconstruction  with  allograft  (Cole,  Ginn,  Chen,  Smith,  
Curl,  Martin,  &  Poehling,  2005).    
Value  of  PNB  to  anesthetists.    PNB  affords  clinicians  the  ability  to  provide  
targeted  analgesia,  thereby  providing  optimal  pain  control  while  avoiding  undesired  
sequelae  associated  with  alternative  pain  modalities  (Macfarlane,  Prasad,  Chan,  &  
Brull,  2009).    Regardless  of  the  skill  level  of  the  clinician,  PNB  requires  additional  time  
(Ilfeld  &  Madison,  2011).    Nonetheless,  ultrasound-­guided  PNB  has  been  reported  to  be  
highly  cost-­effective  (Ehlers,  Jenson,  &  Bendtsen,  2012).    Furthermore,  decreasing  
nursing  time,  or  time  spent  in  the  PACU  due  to  poor  pain  control,  leads  to  decreased  
overall  costs,  in  addition  to  minimizing  postoperative  admission  rates  (Mariano,  2008).      
The  time  spent  in  PACU  is  often  quantified  as  the  time  until  discharge  criteria  is  
met,  which  indicates  the  length  of  time  elapsed  from  the  end  of  surgery  until  a  patient  is  
deemed  ready  for  discharge  home  following  surgery.    The  length  of  this  time  period  
varies  among  patients  and  involved  anesthetic  technique.    Not  only  do  these  times  drive  
costs,  they  are  often  used  as  a  measure  of  efficacy  when  comparing  anesthetic  
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techniques  (Pavlin,  Rapp,  Polissar,  Malmgren,  Koerschgen,  &  Keyes  1998).    Therefore,    
should  PNB  decrease  overall  time  required  to  meet  discharge  criteria,  its  use  could  
prove  highly  valuable  to  patients  and  hospitals  alike.    
Chapter  Summary    
ACL  reconstruction  due  to  injury  in  the  adolescent  population  continues  to  rise  at  
an  exponential  rate.    While  the  increase  in  knee  injuries  among  adolescents  can  largely  
be  attributed  to  the  competitive  nature  of  sports  today,  the  actual  mechanism  of  injury  
remains  variable.    Regardless  of  the  cause  of  injury,  ACL  reconstruction  is  often  the  
treatment  of  choice  for  adolescents.    The  primary  goal  following  surgery  is  the  
restoration  of  stability  to  the  knee  at  a  pre-­injury  level  or  better.    Knee  stability  and  
returning  to  a  desired  activity  level,  however,  are  not  the  sole  considerations  when  a  
surgeon  contemplates  graft  selection  for  ACL  reconstruction.    Patient  age,  history  of  
patellar  or  hamstring  problems,  concerns  regarding  disease  transmission,  cost  
effectiveness,  and  postoperative  pain  are  all  equally  important  considerations  in  this  
decision.      
Amongst  the  many  options  available  for  reconstructing  an  injured  ACL,  the  use  of  
a  hamstring  autograft  has  surfaced  as  the  favored  technique  for  the  adolescent  
population.    Hamstring  autografts  are  associated  with  decreased  morbidity  and  proven  
long-­term  stability  when  compared  to  the  other  ACL  replacement  options.    
Unfortunately,  pain  at  the  hamstring  donor  site  can  be  significant  during  the  
postoperative  period  and  providing  analgesia  for  two  separate  sources  of  pain  can  
prove  challenging.      
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Employing  the  tenets  of  the  gate  control  theory,  acute  postoperative  pain  can  be  
managed  via  a  variety  of  interventions  (Kim,  Jeong,  Jung,  &  Kim,  2011).    To  date  a  
multitude  of  pain  control  strategies  have  been  employed  to  abate  pain  at  the  hamstring  
donor  site,  including  systemic  opioid  and  non-­narcotic  adjuvants,  superficial  wound  
infiltration  with  local  anesthetic  intra-­articular  injection,  neuraxial  anesthesia,  and  PNB.    
Only  sciatic  PNB,  however,  has  proven  to  routinely  and  reliable  abate  pain  at  the  
hamstring  donor  site  (Bushnell,  Sakryd,  &  Noonan,  2010).    Despite  the  recognized  
superiority  of  sciatic  PNB,  the  technique  employed  remains  inconsistent  amongst  
clinicians,  as  questions  remain  regarding  the  severity  and  duration  of  pain  at  the  donor  
site.    Subsequently,  failure  to  incorporate  the  existing  knowledge  regarding  sciatic  PNB  
into  clinical  practice  has  led  to  substantial  numbers  of  patients  suffering  unnecessarily  
(Pizzo  &  Clark,  2012).      
   Determining  the  duration  of  sciatic  PNB  required  to  effectively  control  pain  
following  ACL  reconstruction  with  a  hamstring  autograft,  without  impeding  active  knee  
movement,  will  help  define  best  practice  going  forward.    The  purpose  of  this  research  is  
to  compare  the  effect  of  single-­injection  sciatic  PNB  to  continuous  sciatic  PNB  on  1)  
postoperative  pain  control  as  measured  by  self-­reported  pain  scores,  pain  medication  
use,  and  unplanned  hospital  admission  due  to  poor  pain  control,  2)  active  knee  flexion,  
and  3)  patient  satisfaction  with  pain  control  following  ACL  reconstruction  with  a  
hamstring  autograft.    The  results  of  this  research  have  the  potential  to  positively  impact  
pain  control  for  the  adolescent  population  undergoing  this  surgical  procedure  and  foster  
responsible  utilization  of  limited  resources.    
  




Chapter  Three:  Methodology  
  
Chapter  Introduction  
A  lack  of  comparative  effectiveness  studies  exists  in  the  literature  regarding  the  
ideal  duration  of  sciatic  PNB  following  hamstring  autograft  harvest  resulting  in  
disagreement  among  clinicians  as  to  best  practice.    Considered  an  otherwise  basic  and  
effective  technique,  single-­injection  sciatic  PNB,  when  used  for  ACL  reconstruction,  may  
fail  to  outlast  the  pain  arising  from  the  hamstring  donor  site  leading  clinicians  to  employ  
continuous  sciatic  PNB  with  a  CPI  catheter  to  extend  postoperative  analgesia.    The  
costs  related  to  continuous  sciatic  PNB,  however,  can  lead  to  significant  increases  in  
the  patient’s  overall  healthcare-­related  expenses  (Hudson,  Chelly,  &  Williams,  2011).    
Additionally,  advocates  of  the  single-­injection  sciatic  PNB  cite  concerns  associated  with  
sciatic  CPI  catheters  known  to  be  detrimental  to  rehabilitation  such  as  decreased  active  
knee  movement  and  increased  risk  of  falls  thereby  precluding  its  routine  use.    
Determining  the  duration  of  sciatic  PNB  required  to  effectively  control  pain  following  
ACL  reconstruction  with  a  hamstring  autograft,  without  impeding  active  knee  movement,  
will  help  define  best  practice  going  forward.    This  chapter  describes  the  theoretical  
basis,  research  methods,  and  statistical  analyses  that  will  be  employed  to  compare  the  
effect  of  single-­injection  sciatic  PNB  to  continuous  sciatic  PNB  on  postoperative  pain  
control,  active  knee  movement,  and  patient  satisfaction  following  hamstring  autograft  
harvest  for  ACL  reconstruction  in  the  adolescent  population.  
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Theoretical  Framework  
The  ability  to  inhibit  excitatory  influences  and  enhance  inhibitory  influences  within  
the  pain  pathway  provides  the  theoretical  foundation  for  alleviating  pain  via  peripheral  
nerve  blockade.    The  gate  control  theory  of  pain  proposes  that  small  neuronal  C  fibers  
activate  excitatory  systems  that  subsequently  excite  output  cells  which  enhances  pain.    
Conversely,  large  neuronal  A  fibers  mediate  inhibitory  processes  and  descending  
control  systems  from  the  central  nervous  system,  thereby  mitigating  further  
enhancement  of  pain  by  excited  output  cells  (Dickenson,  2002).    More  specifically,  the  
cells  of  the  substantia  gelatinosa  in  the  dorsal  horn  of  the  spinal  column  are  believed  to  
function  as  the  gate  control  mechanism  with  the  capacity  to  modulate  pain  signals  
before  they  are  sent  to  the  central  nervous  system  (Roberge  &  McEwen,  1998).    
Melzack  and  Wall  (1965)  asserted  that  pain  could  be  modulated  or  “gated”  not  only  in  
the  dorsal  horn,  but  also  at  a  number  of  points  in  the  pain  pathway.    Hence,  the  gate  
control  theory  of  pain  suggests  that  certain  interventions,  including  regional  anesthesia,  
have  the  ability  to  “close  the  gate”  by  modulating  the  pain  pathway,  ultimately  altering  
the  perception  of  pain.      
Melzack  and  Wall  (1965)  acknowledged  that  medications  impacting  either  
excitation  or  inhibition  of  substantia  gelatinosa  activity  may  be  of  particular  importance  
in  attempts  to  control  pain.    PNB  does  not  directly  affect  activity  in  the  substantia  
gelatinosa,  however,  the  reception  of  pain  signals  in  the  central  nervous  system  is  
altered  by  this  procedure  thereby  interfering  with  signal  transmission  from  the  peripheral  
nervous  system  (Schechter,  Berde  &  Yaster,  2003).    Pain  impulses  generated  by  tissue  
damage,  such  as  that  caused  by  surgery,  travel  from  the  site  of  insult,  to  the  spinal  cord,  
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and  finally  to  the  brain,  ultimately  producing  a  pain  response  in  the  body.    Theoretically,  
regional  anesthesia  can  delay  and/or  minimize  the  transmission  of  a  pain  signal  for  
hours  after  the  initial  trauma.    Through  the  administration  of  local  anesthetic  
medications,  regional  anesthesia  serves  to  greatly  reduce  the  actual  impulse  
transmitted  to  the  spinal  cord,  thus  keeping  the  “gate”  mostly  closed  (Roberge  &  
McEwen,  1998).    
Application  of  Theory  to  Anesthesia  Practice    
Since  the  time  the  gate  control  theory  of  pain  was  first  introduced,  regional  
anesthesia  has  witnessed  tremendous  growth  and  has  become  an  integral  component  
of  anesthesia  practice.    Over  the  last  two  decades,  regional  anesthesia  in  the  pediatric  
population  has  evolved  from  a  specialty  performed  infrequently  to  a  practice  performed  
routinely  in  many  pediatric  institutions  worldwide  (Samol,  Furstein,  &  Moore,  2012).    
This  evolution  is  largely  in  part  to  the  advent  of  ultrasound-­guidance  in  regional  
anesthesia  practice,  which  has  fostered  the  development  of  new  and  improved  
techniques,  such  as  continuous  PNB  with  CPI  catheters.    Recently,  several  pediatric  
institutions  have  found  success  in  discharging  patients  home  with  local  anesthetic  
infusing  via  indwelling  CPI  catheters  (Samol,  Furstein,  &  Moore,  2012).      
Advances  in  regional  anesthesia  mirror  the  progression  in  surgical  techniques.    
While  ACL  reconstruction  has  been  a  surgical  mainstay  in  the  adult  population,  it  has  
only  recently  been  performed  with  any  regularity  in  the  adolescent  population.    Many  
anesthesia  providers  caring  for  adolescents  undergoing  ACL  reconstruction  aptly  
employ  pain  control  techniques  known  to  successfully  control  pain  in  adults  undergoing  
ACL  reconstruction.    The  adult  population,  however,  typically  receives  an  allograft  rather  
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than  an  autograft  for  ACL  reconstruction.    Therefore,  while  the  pain  control  techniques  
routinely  employed  in  the  adult  population  provide  adequate  pain  control  for  allograft  
reconstructions,  hamstring  autograft  donor  site  pain  has  not  been  a  primary  concern  in  
the  adult  population.  
The  gap  in  knowledge  regarding  management  of  hamstring  autograft  donor  site  
pain  in  adolescents  is  demonstrated  by  a  lack  of  literature  of  the  same.    While  
improvements  in  pain  control  for  adolescents  have  given  rise  to  better  patient  outcomes  
postoperatively,  many  questions  remain  as  to  appropriate  resource  management  and  
utilization,  as  both  the  cost  and  duration  of  action  vary  greatly  between  various  PNB  
techniques.    To  date,  no  comparison  of  single-­injection  sciatic  PNB  versus  continuous  
sciatic  PNB  use  for  abating  hamstring  autograft  harvest  pain  has  been  performed  in  a  
randomized,  prospective  manner.    This  study  has  the  potential  to  help  define  best  
practices  surrounding  the  use  of  a  sciatic  PNB  to  address  postoperative  pain  following  
hamstring  autograft  harvest  in  adolescents  for  ACL  reconstruction.  
Research  Hypotheses  
The  purpose  of  this  research  is  to  compare  the  effect  of  single-­injection  sciatic  
PNB  to  continuous  sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  self-­
reported  pain  scores,  pain  medication  use,  and  unplanned  hospital  admission  due  to  
poor  pain  control,  2)  active  knee  flexion,  and  3)  patient  satisfaction  with  pain  control  
following  ACL  reconstruction  with  a  hamstring  autograft.    The  following  aims  will  be  
undertaken:  
Specific  Aim  1.    The  first  aim  of  the  study  is  to  explore  the  impact  of  sciatic  PNB  
technique  on  hamstring  donor  site  pain  control  postoperatively.    There  is  evidence  that  
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sciatic  PNB,  regardless  of  technique,  significantly  reduces  pain  when  compared  to  
intravenous  opioids  during  the  initial  24-­hour  postoperative  period  following  knee  
surgery  (Wegener  et  al.,  2011).    As  such,  single-­injection  sciatic  PNB,  which  can  last  up  
to  24  hours,  should  provide  adequate  analgesia  precluding  the  need  for  oral  narcotic  or  
nonsteroidal  anti-­inflammatory  medications  following  ACL  reconstruction  with  a  
hamstring  autograft  during  the  immediate  postoperative  phase.    It  remains  unknown,  
however,  if  any  benefit  is  gained  during  the  initial  72  hour  postoperative  period  from  
extending  analgesia  for  the  hamstring  donor  site  via  continuous  sciatic  PNB.      
H1.1.    Pain  scores  during  the  initial  72  hours  following  hamstring  autograft  harvest  
will  be  lower  in  patients  receiving  continuous  sciatic  PNB  when  compared  to  those  
receiving  single-­injection  sciatic  PNB.  
H1.2.    The  use  of  oral  pain  medication  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  lower  in  patients  receiving  continuous  sciatic  PNB  
when  compared  to  those  receiving  single-­injection  sciatic  PNB.  
H1.3.    The  incidence  of  unplanned  admission  to  the  hospital  due  to  poor  pain  
control  during  the  initial  72  hours  following  hamstring  autograft  harvest  will  be  lower  in  
patients  receiving  continuous  sciatic  PNB  when  compared  to  those  receiving  single-­
injection  sciatic  PNB.      
Specific  Aim  2.    The  second  aim  of  the  study  is  to  explore  the  impact  of  sciatic  
PNB  duration  on  active  knee  flexion  postoperatively.    While  continuous  sciatic  PNB  with  
a  CPI  catheter  extends  the  duration  of  analgesia,  it  also  extends  the  duration  of  
anesthesia  leading  to  a  decrease  in  motor  function  and  subsequently  active  knee  
flexion.    The  sciatic  nerve  innervates  the  hamstrings,  which  are  responsible  for  knee  
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flexion  (Distad  &  Weiss,  2013).    The  decrease  in  active  knee  flexion  may  impede  the  
ability  of  the  patient  to  begin  rehabilitation  on  the  first  postoperative  day.    This  is  an  
important  consideration  because  early  rehabilitation,  which  includes  contraction  of  the  
quadriceps  and  hamstring  muscles  as  well  as  weight  bearing  exercises  with  the  aid  of  
crutches,  leads  to  faster  recovery  of  long-­term  range  of  motion  and  a  lower  incidence  of  
knee  laxity  following  ACL  reconstruction  when  compared  to  delayed  rehabilitation  
(Shaw,  Williams,  &  Chipchase,  2005;;  Pinczewski  et  al.,  2007).      
H2.1.    Active  knee  flexion  during  the  initial  72  hours  following  hamstring  
autograft  harvest  will  not  be  delayed  in  patients  receiving  continuous  sciatic  PNB  when  
compared  to  those  receiving  single-­injection  sciatic  PNB.  
Specific  Aim  3.    The  third  aim  of  the  study  is  to  explore  the  impact  of  sciatic  
PNB  duration  on  patient  satisfaction  with  postoperative  pain  control.    
H3.1.    Patient  satisfaction  with  pain  control  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  improved  in  patients  receiving  continuous  sciatic  
PNB  when  compared  to  those  receiving  single-­injection  sciatic  PNB.  
Research  Design  
   This  study  employs  an  experimental  posttest-­only  design  with  repeated  follow-­up,  
with  the  gate  control  theory  of  pain  serving  as  the  theoretical  foundation  (Figure  5).    An  
experimental  posttest-­only  design  with  repeated  follow-­up  is  appropriate  for  this  study,  
as  the  outcome  is  not  relevant  until  after  the  intervention  is  complete.    This  study  seeks  
to  examine  the  impact  of  two  different  techniques  of  sciatic  PNB  during  the  
postoperative  period  on  pain  control,  active  knee  flexion,  and  patient  satisfaction.      
  











Figure  5.  Schematic  Diagram  of  Study  Design.  
  
  
Setting.    Following  Institutional  Review  Board  approval  from  both  Cincinnati  
Children’s  Hospital  Medical  Center  in  Cincinnati,  Ohio  and  Virginia  Commonwealth  
University  in  Richmond,  Virginia  this  study  will  take  place  at  the  Liberty  Campus  of  
Cincinnati  Children’s  Hospital  Medical  Center  (CCHMC)  in  Cincinnati,  Ohio.    The  Liberty  
Campus  of  CCHMC  is  a  pediatric  ambulatory  surgical  center  where  ACL  reconstruction  
is  routinely  performed  on  an  outpatient  basis.    With  approximately  250  ACL    
reconstructions  with  a  hamstring  autograft  performed  there  over  the  last  two  years,  the  
composition  of  adolescent  patients  undergoing  ACL  reconstructive  surgery  at  the  
Liberty  Campus  of  CCHMC  parallels  that  of  the  population  at  large.      
The  patient  population  undergoing  ACL  reconstruction  at  the  Liberty  Campus  of  
CCHMC  is  comprised  of  both  healthy,  active  adolescents  as  well  as  those  with  a  host  of  
congenital  deficiencies  requiring  surgical  intervention.    Both  genders  and  a  variety  of  
age  ranges  routinely  present  for  ACL  reconstruction  with  hamstring  autograft  at  the  
Liberty  Campus  of  CCHMC.    In  addition,  a  variety  of  ethnic  backgrounds  and  levels  of  
D      R      XA      O1      O2      O3  
D      R      XB      O1      O2      O3  
  
Key:     D  =  Preoperative  data  collection  
R  =  Randomization  
X  =  Intervention  (XA  =  single-­injection  sciatic  PNB,  
XB  =  continuous  sciatic  PNB)  
O  =  Observation  of  the  dependent  variables 
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preoperative  physical  activity  are  represented  by  the  population  routinely  undergoing  
ACL  reconstruction  at  this  facility.    Therefore,  use  of  a  convenience  sample  from  the  
Liberty  Campus  of  CCHMC  is  appropriate  for  this  study.    Polit  and  Beck  (2012)  note  a  
convenience  sample  may  not  produce  a  sample  typical  of  the  population  with  regard  to  
critical  variables,  however,  it  is  anticipated  the  sample  in  this  study  will  be  diverse  and  
will  be  representative  of  patients  who  comprise  the  target  population  given  the  study-­
defined  inclusion  and  exclusion  criteria.      
Two  pediatric  orthopedic  surgeons  perform  all  ACL  reconstruction  and  hamstring  
autograft  procedures  using  identical  procedures.    Any  anesthesia  team  member  from  
the  Department  of  Anesthesia  at  CCHMC  determined  to  be  proficient  in  ultrasound-­
guided  PNB,  defined  as  having  previously  performed  a  minimum  of  ten  successful  
femoral  and  ten  successful  sciatic  nerve  blocks,  will  be  performing  all  PNB  defined  in  
the  study  protocol.    
   Target  population.    The  target  population  for  this  study  is  adolescents  
undergoing  ACL  reconstruction  utilizing  a  hamstring  autograft  for  ACL  reconstruction  on  
an  outpatient  basis.    
Selection  criteria.    Inclusion  criteria  includes  patients  of  both  genders  of  any  
ethnic  group  between  the  ages  of  10  years  and  18  years  scheduled  to  undergo  
unilateral  ACL  reconstruction  with  hamstring  autograft.    Patients  must  have  an  
American  Society  of  Anesthesiologists  (ASA)  physical  classification  of  I  or  II.    The  ASA  
physical  classification  system  is  a  means  of  assessing  patient  fitness  prior  to  surgery  
with  classifications  ranging  from  I  to  V,  and  has  been  recommended  as  a  reliable  
measure  of  comorbidity  (Rius  et  al.,  2004).  Patients  who  previously  underwent  ACL  
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reconstruction  either  with  or  without  a  hamstring  autograft  on  the  contralateral  leg  will  be  
included  in  the  study.      
Exclusion  criteria  include  any  preexisting  allergy  to  local  anesthetic,  the  
administration  of  oral  sedation  preoperatively,  admission  to  the  hospital  either  before  or  
after  surgery,  the  existence  of  an  imminent  life  threatening  condition  that  impacts  the  
ability  to  obtain  informed  consent,  unsuccessful  single-­injection  PNB  or  placement  of  
CPI  catheter,  or  patient  refusal.    Additionally,  the  presence  of  any  other  condition  which  
in  the  opinion  of  the  primary  investigator  (PI)  would  not  be  suitable  for  participation  in  
the  study,  including  but  not  limited  to  coagulopathy,  preexisting  central  or  peripheral  
nervous  systems  disorders,  and  local  infection  or  sores  at  the  anticipated  site  of  needle  
insertion,  would  lead  to  exclusion.    Patients  returning  for  revision  of  a  previous  ACL  
reconstruction  will  be  excluded,  as  use  of  a  hamstring  autograft  from  the  contralateral  
leg  is  often  employed  during  ACL  revision.    If  any  additional  surgical  procedures  are  
being  performed  concurrently  and  are  not  typically  part  of  ACL  reconstruction,  the  
subject  will  be  excluded  from  the  study.      
Acceptable  surgical  procedures  that  may  accompany  ACL  reconstruction  include  
arthroscopy,  arthrotomy,  partial  and/or  full  meniscal  repair,  partial  and/or  full  
meniscectomy,  removal  of  loose  body,  and  open  reduction  and  internal  fixation.    These  
procedures  will  be  allowed,  as  they  are  often  necessary  steps  in  proper  ACL  
reconstruction.    Arthroscopy  allows  the  surgeon  to  examine  the  interior  of  the  joint  via  
very  small  incisions.    An  arthrotomy  is  when  the  surgeon  cuts  into  the  joint  to  gain  
further  access  for  exploration  or  more  extensive  repairs.    ACL  injury  has  long  been  
associated  with  the  occurrence  of  degenerative  arthritis  that  may  benefit  form  
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intervention  during  arthroscopy  (Johnson,  Urban,  Caborn,  Vanarthos,  &  Carlson,  1998).    
The  medial  meniscus  is  the  secondary  restraint  to  anterior  tibial  translation  and  
meniscal  tears  are  the  most  common  injury  associated  with  an  ACL  injury  (Millett,  Willis,  
&  Warren,  2002).    Approximately  60  percent  of  ACL  injuries  occur  in  combination  with  
damage  to  the  meniscus,  and  up  to  46  percent  have  damage  to  the  collateral  ligaments  
(Spindler  &  Wright,  2008).    Therefore,  partial  and/or  full  meniscal  repair,  partial  and/or  
full  meniscectomy,  and  removal  of  loose  bodies  are  commonly  required  during  ACL  
reconstruction  to  provide  optimal  outcomes.  
Recruitment.    The  PI  will  work  closely  with  the  research  coordinator  and  the  
three  co-­investigators  (Appendix  A)  to  screen  and  identify  appropriate  subjects  listed  on  
the  daily  operating  room  schedule  at  the  Liberty  Campus  of  CCHMC  according  to  the  
inclusion  and  exclusion  criteria  defined  in  the  study  protocol  (Table  2).    Once  a  potential  
subject  is  identified,  either  the  PI  or  the  research  coordinator  will  discuss  the  purpose  
and  procedures  of  the  study  with  the  patient  and  his  or  her  guardian(s).    Hospital-­
approved  interpreters  will  be  utilized  for  non-­English  speaking  patients  and/or  
guardian(s).    Participants  and  their  guardians  will  be  informed  of  the  voluntary  nature  of  
participation  and  the  ability  to  drop  out  of  the  study  at  any  time  without  negative  
consequences.    If  the  guardian(s)  express  interest  in  participating  in  the  study,  they  will  
be  asked  to  read  the  written  informed  consent.    When  appropriate,  assent  or  consent  to  
participate  will  be  obtained  from  the  patient.    Written  assent  will  be  obtained  from  the  
patient  if  the  patient  is  ≥  7  years  of  age  and  is  able  to  provide  written  assent,  which  
represents  standard  policy  with  regards  to  age  of  assent  at  CCHMC.  
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Table  2    
Inclusion  and  Exclusion  Criteria  
Inclusion  Criteria   Exclusion  Criteria  
Either  male  or  female  
Additional  surgical  procedures  are  being  
performed  concurrently  not  related  to  ACL  
reconstruction  
Any  racial  or  ethic  group   Preexisting  allergy  to  local  anesthetic  
Age  10  to  18  years  (inclusive)  on  the  day  of  
recruitment   Sedation  administered  preoperatively  
Scheduled  to  undergo  unilateral  ACL  
reconstruction  with  hamstring  autograft  
The  subject  is  scheduled  for  overnight  
hospital  admission  
ASA  I-­II  
An  imminent  life  threatening  condition  exists  
that  impacts  the  ability  to  obtain  informed  
consent  
Written  informed  consent  to  participate  in  
the  study  obtained  from  the  subject’s  legally  
authorized  representative  and  when  
appropriate,  the  subject  has  given  assent  or  
consent  to  participate  
  
Any  other  condition  exists,  which  in  the  
opinion  of  the  PI,  would  not  be  suitable  for  
participation  in  the  study,  including  but  not  
limited  to  coagulopathy,  preexisting  central  
or  peripheral  nervous  systems  disorders,  
and  local  infection  or  sores  at  the  
anticipated  site  of  needle  insertion  
  
Unsuccessful  PNB  or  CPI  catheter  
placement  
  
   Patient  refusal  
  
A  $20.00  gift  card  will  be  distributed  as  incentive  to  all  participants  who  enroll  in  
this  study.    The  recruitment  period  for  the  study  has  been  set  for  18  months  based  on  
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the  number  of  cases  done  in  one  year,  and  assuming  a  seventy-­five  percent  patient  
enrollment  rate.    Similar  on-­going  studies  at  the  Liberty  Campus  of  CCHMC,  the  site  for    
this  proposed  study,  are  experiencing  a  recruitment  success  rate  of  approximately  80%  
without  the  aid  of  participant  incentives.  
   Study  protocols.    The  intervention  in  this  study  will  be  one  of  two  techniques  for  
sciatic  PNB:  single-­injection  PNB  or  continuous  sciatic  PNB  with  a  CPI  catheter  (Figure  
6).    All  study  participants  will  receive  standard  care,  including  standard  anesthetic  care  
as  recommended  by  the  ASA  and  the  AANA,  and  the  surgical  procedures  will  be  in  
accordance  with  those  set  forth  by  the  American  College  of  Surgeons.    No  sedative  
medication  will  be  given  to  patients  preoperatively  per  standard  practice.    Patients  
receiving  midazolam,  an  anxiolytic,  or  any  sedative  preoperatively  will  be  excluded  from  
the  study  as  this  may  affect  scores  obtained  in  the  initial  postoperative  period.    
Following  the  induction  of  general  anesthesia,  the  patient’s  airway  will  be  secured.    The  
amount  of  inhalation  anesthetic  and  intravenous  opioids  each  patient  receives  
throughout  the  intraoperative  portion  of  the  study  will  be  at  the  discretion  of  the  clinical  
team  providing  anesthetic  care.      
All  sciatic  PNB  will  be  performed  following  the  induction  of  general  anesthesia,  
but  prior  to  the  start  of  surgery.    For  patients  randomized  to  the  single-­injection  sciatic  
PNB  group,  ultrasound  will  be  utilized  to  identify  the  sciatic  nerve  in  the  sub-­gluteal  
region.    Once  the  sciatic  nerve  is  identified,  1  mL/kg  (to  a  maximum  volume  of  20  mLs)  
of  0.2%  ropivacaine  without  epinephrine  will  be  injected  into  the  perineural  space  
surrounding  the  sciatic  nerve.      
  

































Figure  6.  Study  Group  Protocols.  
  
  
For  patients  randomized  to  the  continuous  sciatic  PNB  group,  ultrasound  will  be  
utilized  to  assist  the  anesthesia  team  with  placing  the  catheter  tip  adjacent  to  the  sciatic  
nerve  in  the  sub-­gluteal  region  in  preparation  for  continuous  infusion  of  local  anesthetic  
postoperatively.    Once  proper  placement  of  the  sciatic  CPI  catheter  is  verified,  1  mL/kg  
(to  a  maximum  volume  of  20  mLs)  of  0.2%  ropivacaine  without  epinephrine  will  be  
administered  incrementally  over  two  minutes.    An  infusion  of  0.125%  ropivacaine  will  be  
  
Single-­injection  sciatic  PNB:    Single-­injection  sciatic  PNB  will  be  performed  
by  the  anesthesia  team  under  ultrasound-­guidance  utilizing  1  mL/kg  (to  a  
maximum  volume  of  20  mLs)  of  0.2%  ropivacaine  without  epinephrine.    PNB  
will  be  performed  following  the  induction  of  general  anesthesia,  but  prior  to  
the  start  of  surgery.    
  
Continuous  sciatic  PNB:    The  anesthesia  team  will  place  sciatic  CPI  
catheters  under  ultrasound-­guidance  such  that  the  catheter  tip  is  adjacent  to  
the  sciatic  nerve  for  continuous  infusion  postoperatively.    PNB  will  be  
performed  following  the  induction  of  general  anesthesia,  but  prior  to  the  start  
of  surgery.    Sciatic  CPI  catheters  will  be  injected  with  1  mL/kg  (to  a  maximum  
volume  of  20  mLs)  of  0.2%  ropivacaine  without  epinephrine  with  catheter  
placement.    An  infusion  of  0.125%  ropivacaine  will  begin  to  infuse  at  the  end  
of  surgery  at  a  rate  of  6-­8  mL/hr  (based  on  patient  weight)  for  48  hours  
postoperatively.    
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started  at  the  end  of  surgery  at  a  rate  of  6-­8  mL/hr  (based  on  patient  weight)  for  48  
hours  postoperatively.    While  assessments  will  be  made  through  72  hours  
postoperatively,  CPI  catheters  will  only  remain  in-­situ  for  48  hours,  as  the  incidence  of  
infection  increases  should  an  indwelling  CPI  catheter  remain  greater  than  48  hours  
(Jeng,  Torrillo,  &  Rosenblatt,  2010).  
Following  sciatic  PNB,  continuous  femoral  PNB  will  be  performed.    Patients  in  
both  study  groups  will  receive  continuous  femoral  PNB  with  a  CPI  catheter  to  provide  
analgesia  to  the  anterior  aspect  of  the  knee,  as  this  is  an  accepted  standard  of  practice  
following  ACL  reconstruction.    Ultrasound  will  be  utilized  to  assist  the  anesthesia  team  
with  placing  the  catheter  tip  adjacent  to  the  femoral  nerve  in  the  inguinal  region  in  
preparation  for  continuous  infusion  of  local  anesthetic  postoperatively.    Once  proper  
placement  of  the  femoral  CPI  catheter  is  verified,  1  mL/kg  (to  a  maximum  volume  of  20  
mLs)  of  0.2%  ropivacaine  without  epinephrine  will  be  administered  incrementally  over  
two  minutes.    An  infusion  of  0.125%  ropivacaine  will  be  started  at  the  end  of  surgery  at  
a  rate  of  6-­8  mL/hr  (based  on  patient  weight)  for  48  hours  postoperatively.    
The  recommended  dosing  range  of  ropivacaine  is  0.2-­0.4  mg/kg/hr  (Chelly,  
2009).    Therefore,  patients  weighing  60  kg  or  more  will  receive  infusions  of  0.125%  
ropivacaine  at  a  rate  of  8  mL/hr  via  both  femoral  and  sciatic  CPI  catheters  (as  
applicable).    Patients  weighing  less  than  60  kg  will  receive  infusions  of  0.125%  
ropivacaine  at  6  mL/hr.    These  parameters  ensure  that  the  total  local  anesthetic  dose  
remains  within  the  recommended  dosing  guidelines  should  a  patient  be  randomized  to  
receive  both  continuous  femoral  PNB  and  continuous  sciatic  PNB.    In  addition,  
establishing  weight  based  infusion  rates  allows  for  the  study  group  receiving  one  CPI  
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catheter  and  the  group  receiving  two  CPI  catheters  to  be  as  similar  as  possible  thereby  
improving  the  ability  to  compare  the  outcomes  of  each  study  group.    
Patients  will  not  be  blinded  as  to  what  study  group  they  have  been  randomized  to  
participate  in.    Blinding  of  subjects  can  be  beneficial  in  studies  because  it  minimizes  the  
introduction  of  biases  stemming  from  awareness.    Blinding  is  not  always  possible,  
however.    For  example,  in  this  study  it  would  be  challenging  to  blind  subjects  to  the  
sciatic  nerve  block  treatment  group,  as  one  group  will  have  an  indwelling  sciatic  CPI  
catheter  and  the  other  will  not.    One  means  of  blinding  study  participants  would  be  to  
insert  sciatic  CPI  catheters  in  all  patients  and  infuse  local  anesthetic  in  one  group  and  a  
placebo  in  the  other  group,  however,  the  costs  and  potential  risks,  such  as  opportunity  
for  infection,  potential  tissue  damage  and  potential  for  abscess  formation  secondary  to  
infusion  of  a  placebo,  makes  blinding  of  study  participants  prohibitive.      
Variables.    The  independent  variable  (IV)  in  this  study  is  sciatic  PNB  technique,  
either  single-­injection  sciatic  PNB  or  continuous  sciatic  PNB.    The  dependent  variables  
(DVs)  in  this  study  are  pain  control,  active  knee  flexion,  and  patient  satisfaction  during  
the  72  hours  following  hamstring  autograft  harvest.    The  control  variable  (CV)  will  be  
continuous  femoral  PNB  (Table  3).    
A  confounding  variable  is  a  variable  that  is  extraneous  to  the  research  question,  
yet  confuses  the  relationship  between  independent  and  dependent  variables  (Polit  &  
Beck,  2012).    Confounding  variables  in  this  study  include,  but  may  not  be  limited  to:  
patient  age,  patient  gender,  body  mass  index  (BMI)  score,  ASA  status,  prior  surgical  
history,  individual  patient  tolerance  of  pain,  level  of  activity  preoperatively,  orthopedic  
surgeon,  intraoperative  analgesic  requirement,  the  total  time  required  for  surgery  (as  an    
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Table  3    
Study-­Related  Variables  
Variable   Type     Measure(s)   Type  of  Data  
Sciatic  PNB  technique   Independent  variable  
1  =  Single-­injection  sciatic  PNB  
2  =  Continuous  sciatic  PNB   Categorical  
Pain  control   Dependent  variable  
Self-­reported  pain  scores  
  
Self-­reported  oral  pain  medication  
use  
  











Active  knee  flexion   Dependent  variable  
1  =  Able  to  bend  with  no  pain    
2  =  Able  to  bend,  but  with  
            pain    
3  =  Too  much  pain  to  bend    
Ordinal  
Patient  satisfaction   Dependent  variable  
1  =  Not  at  all  satisfied  
2  =  Not  satisfied  
3  =  Partially  satisfied  
4  =  Satisfied  
5  =  Highly  satisfied  
Ordinal  
Continuous  femoral  PNB   Control  variable  
1  =  Continuous  femoral  PNB  
0  =  Failed  continuous  femoral    
            PNB  
Dichotomous  
Age   Confounding  variable   Age  in  years   Continuous  
Gender   Confounding  variable  
1  =  Male  
2  =  Female   Dichotomous      
BMI   Confounding  variable  
Weight  (kg)    
Height2  (m2)   Ratio    
ASA  status   Confounding  variable  
1  =  ASA  I  
2  =  ASA  II   Ordinal    
  89  
Table  3  continued  
Previous  surgery  of  any  type   Confounding  variable  
0  =  No  
1  =  Yes   Dichotomous  
Tolerance  of  pain   Confounding  variable  
1  =  Low  pain  tolerance  
2  =  Moderate  pain  tolerance  
3  =  High  pain  tolerance  
Ordinal  




1  =  Not  active  at  all  
2  =  Not  active    
3  =  Partially  active  
4  =  Active    
5  =  Highly  active  
Ordinal  
Orthopedic  surgeon   Confounding  variable  
1  =  Wall  





Total  of  intravenous  opioids  
administered  during  the  
intraoperative  period  (converted  to  
mg  of  morphine  equivalent)  
Continuous  
Length  of  surgery   Confounding  variable   Length  of  surgery  in  minutes   Continuous  
Tourniquet  inflation  time   Confounding  variable   Total  inflation  time  in  minutes   Continuous    
Tourniquet  pressure   Confounding  variable   Tourniquet  set  pressure  (mmHG)   Continuous  
Tourniquet  pressure:SBP   Confounding  variable  
Tourniquet  pressure  (mmHg)  
minus  SBP  at  time  of  inflation   Ratio    
Prior  ACL  with  hamstring  autograft  
on  contralateral  leg  
Moderator  
variable    
0  =  No  
1  =  Yes   Dichotomous  
Prior  ACL  without  hamstring  
autograft  on  contralateral  leg  
Moderator  
variable  
0  =  No  
1  =  Yes   Dichotomous  
  
indicator  of  the  complexity  of  the  surgical  repair),  the  total  time  of  tourniquet  inflation,  
the  pressure  setting  of  the  tourniquet,  and  the  difference  between  tourniquet  pressure  
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and  systolic  blood  pressure  at  the  time  of  tourniquet  inflation.    All  of  these  confounding  
variables  have  the  potential  to  impact  the  patient  outcomes  being  measured  in  this  
study.    ASA  classification  system  has  been  demonstrated  to  be  a  reliable  predictor  of  
postoperative  functional  status  and  morbidity  following  surgery  on  the  lower  extremity,  
such  as  ACL  reconstruction  (Hooper,  Rothwell,  Hooper,  &  Frampton,  2012).    Therefore,  
for  the  purposes  of  this  study  only  patients  classified  as  ASA  I-­II  will  be  deemed  eligible,  
thereby  limiting  any  negative  influences  on  pain  and  knee  movement  secondary  to  
variation  in  physical  characteristics  and  health.    Activity  level  prior  to  surgery,  yet  after  
the  injury,  may  serve  as  an  indicator  of  the  severity  of  the  ACL  injury.    A  decreased  
activity  level  after  ACL  injury,  but  before  surgery,  could  indicate  unwillingness  to  
ambulate  in  the  presence  of  pain,  despite  the  functional  capacity  to  do  so.    Either  of  
these  explanations  for  alterations  in  activity  level  may  impact  a  patient’s  active  knee  
flexion  following  ACL  reconstruction  with  hamstring  autograft.    Therefore,  activity  level  
prior  to  surgery  will  be  assessed  during  the  pre-­anesthetic  evaluation.      
As  this  is  a  sizable  list  of  confounding  variables,  these  variables  will  be  
categorized  into  two  groups  to  ease  future  analyses  (Table  4).    Additionally,  clustering  
the  confounding  variables  into  two  distinct  categories  may  aid  in  discerning  which  group  
of  variables  most  impacts  the  outcome  variables.    Categorizing  the  confounding  
variables  will  also  allow  the  entire  dataset  to  be  presented  in  a  less  cumbersome  
manner  when  discussing  the  results  of  the  study.      
A  moderating  variable  affects  the  strength  or  direction  of  a  relationship  between  
the  independent  and  dependent  variables  (Polit  &  Beck,  2012).    The  list  of  moderator  
variables  that  may  influence  the  relationship  between  the  independent  and  dependent    
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Table  4    
Categories  of  Confounding  Variables  
Patient  Characteristics   Surgery-­Related  Characteristics  
Age   Orthopedic  surgeon  
Gender   Length  of  surgery    
BMI   Tourniquet  inflation  time    
ASA  status   Tourniquet  pressure    
Previous  surgery  of  any  type   Pressure  of  tourniquet  compared  to  systolic  blood  pressure  at  time  of  tourniquet  inflation    
Tolerance  of  pain     
Level  of  physical  activity  preoperatively     
Intraoperative  analgesic  requirement     
  
variables  in  this  particular  study  includes  prior  ACL  repair,  either  with  or  without  the  
utilization  of  a  hamstring  autograft.    Patients  who  previously  underwent  ACL  
reconstruction  either  with  or  without  a  hamstring  autograft  on  the  contralateral  leg  will  
not  be  automatically  excluded,  however,  such  prior  surgical  experience  will  be  noted  as  
a  moderator  variable,  as  the  prior  experience  may  potentially  influence  the  relationship  
between  technique  for  sciatic  PNB  and  the  patient’s  postoperative  pain  scores,  
medication  use,  active  knee  movement,  and  satisfaction  with  pain  control.        
Measures.    The  data  for  the  IV  is  categorical  and  will  be  noted  to  be  either  
single-­injection  or  continuous  sciatic  PNB.    The  CV,  continuous  femoral  PNB,  will  be  
dichotomous,  with  1  =  indicating  successful  placement  of  the  femoral  CPI  catheter  and  
0  =  failed  femoral  PNB.      
The  primary  DV,  pain  control,  will  be  measured  via  three  separate  assessments:  
self-­reported  pain  scores,  frequency  of  oral  pain  medication  use,  and  the  incidence  of  
unplanned  hospital  admission  due  to  poor  pain  control.    Data  for  self-­reported  pain  
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scores  will  be  ordinal  in  nature,  using  the  0  (no  pain)  to  10  (worst  pain)  verbal  Numerical  
Rating  Scale  (NRS).    The  patient  or  their  guardian  will  record  these  scores  on  the  
supplied  data  collection  tool  once  every  6  hours  for  72  hours  postoperatively.    Likewise,  
patients  or  their  guardian  will  record  this  continuous  data  (time  and  dose  of  each  oral  
pain  medication  taken)  on  the  supplied  data  collection  tool.    Unplanned  admission  due  
to  poor  pain  control  will  also  be  used  to  measure  pain  control.    This  measure  provides  
an  objective  measure  of  pain  control,  whereas  the  other  two  measures  are  subjective  in  
nature.    The  data  for  this  measure  is  dichotomous  and  will  be  noted  by  the  research  
coordinator  during  the  72-­hour  postoperative  period.  
Ordinal  data  will  be  collected  via  self-­report  in  regards  to  active  knee  flexion.    
Once  every  12  hours,  the  patient  will  record  the  ability  to  actively  bend  the  knee  (active  
flexion)  using  the  following  three  measure:  0  =  able  to  bend  the  knee  without  feeling  
pain,  1  =  able  to  bend  the  knee,  but  feel  pain  doing  so,  2  =  too  much  pain  to  try  to  bend  
the  knee.    Patient  satisfaction  with  pain  control  will  be  recorded  on  the  data  collection  
tool  once  every  12  hours  for  72  hours  postoperatively.    Data  for  satisfaction  scores  will  
ordinal,  as  the  patients  will  use  a  5-­point  Likert  scale  ranging  from  0  (not  at  all  satisfied)  
to  4  (highly  satisfied)  to  scale  responses.      
Data  for  the  confounding  and  moderating  variables  will  be  collected  as  well.    
Data  regarding  patient  age  will  be  continuous  and  measured  in  years.    Dichotomous  
data  for  gender  will  be  noted,  with  1  =  male  and  2  =  female.    BMI  scores  will  be  
calculated  by  dividing  the  weight  in  kilograms  by  the  height  in  meters  squared.    ASA  
physical  status  data  will  be  ordinal  in  nature,  with  1  =  ASA  I  and  2  =  ASA  II.    
Dichotomous  data  indicating  whether  the  patient  has  had  any  previous  surgery  of  any  
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type  will  be  collected,  with  0  =  no  and  1  =  yes.    Data  pertaining  to  self-­reported  
tolerance  of  pain  will  be  ordinal  in  nature,  with  1  =  low  tolerance  of  pain,  2  =  moderate  
tolerance  of  pain,  and  3  =  high  tolerance  of  pain.    Data  regarding  preoperative  level  of  
physical  activity  will  be  self-­reported  and  gathered  preoperatively.    This  data  will  be  
ordinal  with  1  =  not  active  at  all,  2  =  not  active,  3  =  partially  active,  4  =  active,  5  =  highly  
active  when  compared  to  pre-­injury  activity  levels.    The  orthopedic  surgeon  performing  
surgery  will  be  noted,  being  either  Dr.  Wall  or  Dr.  Parikh.    The  total  intraoperative  
analgesia  requirement/administration  will  be  noted.      All  doses  of  opioids,  either  while  in  
the  hospital  or  following  discharge,  will  be  converted  to  morphine  equivalents  to  
facilitate  analysis.    The  length  of  surgery  will  be  noted  in  minutes  as  well  as  the  total  
pneumatic  tourniquet  inflation  time  will  be  noted  in  minutes.    Both  the  length  of  surgery  
and  the  length  of  tourniquet  inflation  have  been  associated  with  postoperative  pain,  with  
pain  increasing  as  surgery  length  or  tourniquet  inflation  time  increases.    Tourniquet  
inflation  times  less  than  120  minutes  are  recommended  to  prevent  ischemic  nerve  injury  
(Horlocker,  Hebl,  Gail,  Jankowski,  Burkle,  Berry,  Zepeda,  Stevens,  &  Schroeder,  2006).    
The  tourniquet  inflation  pressure  will  be  noted  in  mmHg.    Data  regards  the  difference  
between  the  tourniquet  inflation  pressure  and  the  systolic  blood  pressure  at  the  time  of  
inflation  will  be  recorded.    Inflating  the  tourniquet  greater  than  100  mmHg  above  the  
systolic  blood  pressure  has  been  associated  with  postoperative  pain  and  nerve  injury  
(Chidambaran,  Rosing,  Soler,  &  Sadhasivam,  2012).    Dichotomous  data  regarding  
patient  history  of  prior  ACL  reconstruction  with  or  without  a  hamstring  autograft  on  the  
contralateral  leg  will  be  collected.  
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Sample  size.    Power  analysis  was  performed  to  estimate  an  adequate  sample  
size  to  support  statistical  conclusion  validity  and  so  that  correct  inferences  can  be  made  
about  the  relationships  between  study  variables.    The  standardized  effect  size  was  
calculated  to  equal  0.5  (Figure  7).    Assuming  an  alpha  of  0.05,  power  of  0.80  and  a  
standardized  effect  size  of  0.5,  64  patients  will  be  required  for  each  treatment  group.    
Projected  sample  sizes  were  increased  approximately  ten  percent  from  64  per  group  to  
total  of  70  subjects  per  group  in  an  effort  to  account  for  patient  attrition  and  lost  data,  














Figure  7.  Power  Analysis  Calculations.  
  
  
Despite  the  presence  of  multiple  cofounding  variables,  the  calculated  sample  
size  is  sufficient  to  determine  if  a  significant  difference  in  outcomes  measures  exists  
secondary  to  sciatic  PNB  technique.    Additionally,  the  sample  size  does  not  need  to  be  
altered  based  on  the  equation:  N  >  50  +  8k,  where  N  is  the  number  of  cases  and  k  is  the  
number  of  predictors  (Warner,  2013).    In  this  study  there  is  only  one  predictor,  sciatic  
PNB  technique,  which  is  anticipated  to  impact  outcomes  following  ACL  reconstruction.    
Two-­tailed:  alpha  =  0.05  
Power  =  0.80  
Effect  size:  estimated  as  50%  difference  being  clinically    
   relevant,  50%  change  in  average  pain  score  (0.5)  
Standard  deviation  =  1  (change  in  score  of  1  out  of  5)  
Standardized  effect  size  =  0.5/1  =  0.5  
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Following  the  enrollment  of  the  initial  30  subjects  (with  15  in  each  study  group),  
an  interim  analysis  utilizing  the  statistical  tests  later  described  will  be  performed  to  
determine  if  statistically  significant  differences  exist  between  the  outcome  measures  of  
each  sciatic  PNB  technique.    Performing  an  interim  analysis  limits  the  number  of  
patients  exposed  to  study  procedures.    If  statistically  significant  differences  exist  such  
that  one  of  the  two  sciatic  PNB  techniques  clearly  produces  superior  patient  outcomes,  
the  study  will  be  stopped.    However,  should  the  outcomes  measures  of  each  sciatic  
PNB  technique  be  found  to  be  equivalent  and  without  statistically  significant  differences  
enrollment  will  continue.      
   Randomization.    It  is  acknowledged  that  great  variation  in  demographic  
composition  exists  from  patient  to  patient,  hence  attempts  will  be  made  to  match  the  
study  groups  to  each  other  in  regards  to  the  previously  listed  confounding  variables  in  
an  effort  to  eliminate  factors  that  might  obscure  the  relationships  between  the  
independent  and  dependent  variables  (Polit  &  Beck,  2012).    Enrolled  subjects  will  vary  
in  their  physical  characteristics  to  the  greatest  extent  possible  given  the  inclusion  and  
exclusion  criteria  and  the  composition  of  the  available  convenience  sample,  thereby  
allowing  for  broad  application  of  knowledge  gained  from  this  study  in  the  clinical  arena.      
   One  hundred  and  forty  adolescents  undergoing  ACL  reconstruction  with  a  
hamstring  autograft  on  an  outpatient  basis  at  the  Liberty  Campus  of  CCHMC  will  be  
randomized  to  one  of  two  study  groups:  patients  receiving  single-­injection  sciatic  PNB  
and  patients  receiving  continuous  sciatic  PNB.    Group  assignments  will  be  computer  
generated  and  will  take  into  consideration  key  demographic  elements,  such  as  age,  
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gender,  BMI,  and  ASA  status,  to  ensure  equally  matched  groups.    Patients  will  be  
assigned  to  the  study  groups  in  a  1:1  allocation  ratio.    
Data  Collection  
Once  enrolled  in  the  study,  a  unique  study  identification  number  will  be  assigned  
to  each  study  participant.    Assigning  a  unique  patient  identifier  to  each  study  participant  
allows  any  data  gathered  pertaining  to  them  to  be  attached  to  this  number  rather  than  
any  patient  identifiers,  further  ensuring  that  a  breach  in  confidentiality  does  not  occur  
(Polit  &  Beck,  2012).    After  obtaining  written  consent  from  the  guardian(s),  the  medical  
record  of  the  patient  will  be  reviewed  for  further  inclusion  and  exclusion  criteria.    
All  data  gathered  will  be  used  specifically  for  research  purposes  (Table  5).    Data  
collected  preoperatively  will  include  age,  gender,  BMI,  ASA  physical  status,  previous  
surgical  history,  self-­reported  tolerance  of  pain,  self-­reported  level  of  activity  since  time  
of  ACL  injury,  and  the  name  of  the  orthopedic  surgeon  scheduled  to  perform  ACL  
reconstruction.    This  data  will  be  collected  from  the  patent’s  medical  record  during  the  
preoperative  phase  and  directly  from  the  patient  and/or  guardian(s)  when  appropriate.    
Data  on  study  group  assignment,  analgesic  requirement,  the  length  of  surgery,  length  of  
pneumatic  tourniquet  inflation  time,  pneumatic  tourniquet  inflation  pressure,  and  systolic  
blood  pressure  at  time  of  pneumatic  tourniquet  inflation  will  be  gathered  during  the  
intraoperative  phase.      
In  an  effort  to  discern  the  impact  of  sciatic  PNB  technique  on  the  outcome  
measures,  data  on  self-­reported  pain  scores,  doses  of  oral  pain  medications,  unplanned  
admission  to  the  hospital  due  to  poor  pain  control,  and  patient  satisfaction  will  be  
gathered  while  the  patient  remains  in  the  post  anesthesia  care  unit  (PACU).    Data    
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Table  5    











Age   Sciatic  PNB  technique   Pain  score   Pain  score    
Gender   Analgesic  requirement  
Use  of  oral  pain  
medications  
Use  of  oral  pain  
medications  
BMI   Length  of  surgery  
Unplanned  
admission  due  to  
poor  pain  control  
Unplanned  
admission  due  to  
poor  pain  control  
ASA  status   Tourniquet  time   Patient  satisfaction     Active  knee  flexion  
Previous  surgery  of  
any  type   Tourniquet  pressure      Patient  satisfaction  
Tolerance  of  pain  
Pressure  of  
tourniquet  compared  
to  systolic  blood  
pressure  at  time  of  
tourniquet  inflation  
  
     
Level  of  physical  
activity  
preoperatively    
        
Orthopedic  surgeon             
  
collection  will  continue  for  72  hours  postoperatively.    In  addition  to  the  previously  listed  
measures,  data  regarding  active  knee  flexion  will  be  collected.    Patients  will  document  
data  measures  on  supplied  data  collection  instruments.    All  data  collected  following  
discharge  will  be  collected  via  telephone  interview  by  the  research  coordinator.    Data  
  98  
will  be  collected  using  the  same  data  collection  tool  given  to  the  study  participants  to  
avoid  instrumentation  and  maintain  interrater  reliability.    This  information  will  be  
collected  from  the  patient  or  guardian  once  every  24  hours  by  the  research  coordinator  
during  the  72-­hour  postoperative  period  that  data  is  scheduled  to  be  collected;;  this  
period  begins  at  the  time  of  discharge  from  the  PACU.  
   Only  one  research  coordinator,  who  has  prior  experience  and  understanding  of  
the  postoperative  assessments  involved,  will  be  utilized  to  gather  and  enter  data,  
eliminating  need  to  assess  for  interrater  reliability.    Limiting  the  number  of  clinicians  
gathering  data  involved  should  result  in  minimal  variability  and  inconsistency  in  results  
and  assessments.    The  blinded  research  coordinator  will  gather  patient  reported  
outcomes  data  once  every  24  hours  for  72  hours  postoperatively.    Assessments  will  
start  in  the  recovery  room  and  continuing  via  telephone  following  discharge  once  every  
24  hours  for  three  consecutive  days.    In  addition  to  pain  scores,  pain  medication  use,  
and  hospital  readmission,  data  regarding  active  knee  flexion  and  patient  satisfaction  will  
be  collected.    Every  effort  will  be  made  to  keep  the  research  coordinator  gathering  
postoperative  outcome  data  blinded  to  the  treatment  group,  however,  it  is  
acknowledged  that  unblinding  may  inadvertently  occur  during  telephone  follow-­up  with  
the  patient  and/or  guardian.  
Instruments.    The  goal  of  the  data  collection  tool  is  to  promote  accurate  data  
recording,  limit  the  likelihood  of  missing  information,  and  to  promote  efficient  and  
accurate  data  entry  into  REDCapTM  (Park  City,  Utah).    Prior  to  the  start  of  study  
enrollment,  the  data  collection  tool  will  be  piloted  in  an  effort  to  reduce  error  in  the  
measurement  process.    Five  volunteers  undergoing  ACL  reconstruction  with  a  
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hamstring  autograft  at  the  Liberty  Campus  of  CCHMC  will  be  sought  out  to  trial  the  data  
collection  tool.    Refinement  of  the  data  collection  tool  will  center  on  reliability  and  validity  
of  the  tool.    Focusing  on  stability,  internal  consistency,  and  interrater  reliability  during  
the  pilot  of  the  tool  will  allow  for  estimates  of  the  tool’s  reliability.    Stability,  or  test-­retest  
reliability,  is  determined  by  administering  the  tool  two  different  times  to  the  same  
individuals  and  determining  the  correlation  between  the  two  sets  of  scores  (Kimberlin  &  
Winterstein,  2008).    Cronbach’s  alpha,  which  is  a  function  of  the  average  
intercorrelations  of  items  and  the  number  of  items  in  the  scale,  is  the  most  widely  used  
method  for  estimating  internal  consistency  (Kimberlin  &  Winterstein,  2008).      Interrater  
reliability  requires  completely  independent  ratings  of  the  same  event  by  more  than  one  
individual  (Kimberlin  &  Winterstein,  2008).    Tests  of  the  tool’s  validity  will  focus  on  
construct  validity,  content  validity,  and  criterion-­related  validity.    Evaluation  of  construct  
validity  requires  an  examination  of  the  relationship  between  the  outcome  measures  
being  evaluated  and  variables  related  to  the  construct  being  measured  by  the  
instrument  (Kimberlin  &  Winterstein,  2008).    As  there  is  no  statistical  test  to  determine  
whether  a  measure  adequately  represents  a  construct,  content  validity  typically  relies  
upon  the  judgment  of  experts  in  the  field  (Kimberlin  &  Winterstein,  2008).    Assessment  
of  criterion-­related  validity  will  focus  on  the  tool’s  ability  to  accurately  predict  how  well  
the  scores  of  a  given  measure  correlate  with  the  scores  of  the  other  measures  of  the  
same  construct.    Revisions  will  be  made  to  the  data  collection  tool  as  necessary  prior  to  
the  start  of  the  study.    
Patients  and  their  guardian  will  be  given  data  collection  instruments  to  complete  
postoperatively  at  the  time  of  enrollment  to  facilitate  recall  when  conveying  information  
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to  the  study  staff  during  telephone  conversations.    The  patient  and  their  guardian(s)  will  
receive  training  regarding  the  data  collection  tool  both  during  the  time  of  enrollment  and  
again  prior  to  discharge  from  the  hospital.    At  the  time  of  enrollment,  essential  phone  
numbers,  including  home  phone  and  cell  phone  numbers,  will  be  collected.    Should  the  
patient  and/or  guardian  lose  the  data  collection  sheet,  additional  copies  can  be  emailed  
to  them  upon  request.    Hospital-­approved  interpreters  will  be  utilized  for  non-­English  
speaking  patients  and/or  guardian(s).    
Data  management.    All  data  is  collected  from  the  study  participant  will  be  
entered  into  REDCapTM  by  the  research  coordinator.    REDCapTM  is  a  secure  web  
application  for  building  and  managing  databases  securely  that  was  specifically  designed  
to  support  clinical  and  translational  research  (Harris,  Taylor,  Thielke,  Payne,  Gonzalez,  
&  Conde,  2009).    Confidentiality  of  the  data  will  be  maintained  through  the  use  of  a  
password-­protected  computer  and  any  hard  copies  of  subject  information  stored  in  a  
locked  office  accessible  only  to  members  of  the  Department  of  Anesthesia.      
The  study  records  will  be  made  available  for  review  only  to  the  Institutional  
Review  Board  and  the  Food  and  Drug  Administration  (FDA)  per  CCHMC  policy.    The  
FDA  is  a  branch  of  the  federal  government  that  establishes  regulations  and  guidelines  
for  clinical  research  to  protect  participants  from  unreasonable  risks.    Furthermore,  the  
FDA  ensures  consumers  have  reliable  information  and  that  medical  treatments  are  not  
only  safe,  but  effective  as  well.    The  subjects’  names  or  any  other  identifiers  will  not  be  
used  in  published  information  relating  to  this  study  and  will  be  treated  as  confidential  per  
the  Health  Insurance  Portability  and  Accountability  ACT  (HIPAA)  of  1996.    Per  the  
HIPAA  Privacy  Rule,  prior  to  dissemination  of  results,  all  health  information  will  be  
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deemed  individually  unidentifiable  by  employing  the  approved  Safe  Harbor  method  of  
de-­identification  that  entails  the  removal  of  18  types  of  identifiers.      
Protection  of  Human  Subjects      
Risks  to  the  subjects.    The  risks  related  to  this  study  are  no  more  than  the  risks  
related  to  regional  anesthesia  in  general.    Furthermore,  unless  otherwise  
contraindicated  or  refused  by  the  patient,  regional  anesthesia  of  some  nature  is  
administered  to  most  patients  regardless  of  their  enrollment  in  this  study.    While  the  
general  risks  for  PNB  apply  to  both  the  single-­injection  and  continuous  sciatic  PNB  
techniques,  sciatic  PNB  is  considered  relatively  low  risk  and  both  techniques  of  sciatic  
PNB  have  well-­established  safety  records  and  are  currently  routinely  utilized  in  clinical  
practice.      
   Risks  related  to  the  drug  utilized  in  the  current  study  (ropivacaine)  are  
characteristic  of  those  associated  with  other  amide-­type  local  anesthetics,  which  
include:  uticaria,  pruritus,  erythema,  angioneurotic  edema,  tachycardia,  sneezing,  
nausea,  vomiting,  elevated  temperature,  and  possibly  anaphylactoid  symptomology.  
The  risks  related  to  the  use  of  ropivacaine  in  this  study  are  no  different  than  would  be  
expected  with  any  administration  of  this  drug.    As  with  the  administration  of  any  local  
anesthetic,  high  doses  or  unintentional  intravascular  injection  may  lead  to  high  plasma  
levels  and  related  myocardial  depression,  decreased  cardiac  output,  heart  block,  
hypotension,  bradycardia,  ventricular  arrhythmias,  including  ventricular  tachycardia  and  
ventricular  fibrillation,  and  possibly  cardiac  arrest.  
Addition  risks  include  a  low  risk  of  mild  discomfort  at  the  PNB  needle  insertion  
site  or  inconvenience  to  the  subject  secondary  to  sensory  and/or  motor  blockade.    
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Temporary  soreness  at  the  site  of  injection  and/or  CPI  catheter  placement  is  not  
uncommon,  as  PNB  needles  must  pass  through  various  layers  of  tissue  and  muscle  to  
reach  the  targeted  nerve.    This  soreness  typically  requires  no  intervention  and  quickly  
resolves.    Additionally,  unforeseen  risks  may  include,  but  are  not  limited  to:  needle  
trauma,  intraneural  injection,  intravascular  injection,  local  anesthetic  toxicity,  hematoma,  
infection,  and  poor/failed  block.    All  complications  or  untoward  events  that  occur  during  
the  course  of  this  study  will  be  reported.    
Protection  against  risk.    As  a  safety  check,  only  experienced,  qualified  
clinicians  will  be  performing  all  PNB  associated  with  this  study.    Furthermore,  all  PNB  
will  be  performed  under  ultrasound  guidance  to  ensure  real-­time  advancement  of  the  
nerve  block  needle  and  visualization  of  injected  local  anesthetic.  
Vulnerable  populations.    Patients  from  10  years  of  age  to  18  years  of  age  
(inclusive)  will  be  recruited  for  this  study.    The  only  way  study  participants  will  be  
identified  is  by  their  unique  study  identification  number.    All  information  collected  will  be  
treated  as  confidential,  as  provided  by  law.      
Exploratory  and  Confirmatory  Analytical  Strategies    
The  hypothesis  that  scores  during  the  initial  72  hours  following  hamstring  
autograft  harvest  will  be  different  in  patients  receiving  single-­injection  sciatic  PNB  than  
those  receiving  continuous  sciatic  PNB  will  be  tested  with  two  separate  tests.    Both  
Pearson’s  correlation  and  the  Wilcoxon-­Mann-­Whitney  test  will  be  utilized  to  test  his  
hypothesis,  as  controversy  surrounds  the  analysis  of  Likert  scale  data.    It  has  been  
argued  that  only  nonparametric  statistics  should  be  used  on  Likert  scale  data,  as  the  
intervals  between  the  scale  values  may  not  be  equal  (Jamison,  2004).    Taking  this  into  
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consideration,  the  pain  scores  recorded  for  each  patient  will  be  totaled  and  an  average  
pain  score  will  be  calculated  for  each  study  participant.    This  will  allow  the  data  to  be  
measured  on  a  continuous  scale,  thereby  meeting  the  criteria  of  Pearson’s  correlation.    
Pearson’s  correlation  is  a  parametric  test  that  measures  the  degree  and  direction  of  
linear  relationship  between  two  variables  (Gravetter  &  Wallnau,  2000).    The  Wilcoxon-­
Mann-­Whitney  test  will  also  be  used  to  analyze  pain  scores  recorded  at  each  12-­hour  
interval  to  determine  if  there  is  a  difference  in  outcomes  related  to  the  duration  of  
analgesia  provided  by  sciatic  PNB  technique.    This  test  is  appropriate  when  there  is  one  
IV  with  two  independent  groups  and  the  DV  is  ordinal  in  nature.    The  Wilcoxon-­Mann-­
Whitney  test  is  a  nonparametric  test  of  the  null  hypothesis  that  two  populations  are  the  
same  against  an  alternative  hypothesis.    This  test  uses  the  relative  position  of  the  data  
in  a  rank  ordering,  rather  than  the  actual  values.    Using  both  parametric  and  
nonparametric  tests  will  increase  confidence  when  drawing  conclusions  should  both  
tests  lead  to  the  same  results.  
The  hypothesis  that  the  dose  of  oral  pain  medication  during  the  initial  72  hours  
following  hamstring  autograft  harvest  will  be  different  in  patients  receiving  single-­
injection  sciatic  PNB  than  those  receiving  continuous  sciatic  PNB  will  be  tested  with  the  
independent  samples  t-­test.    The  independent  samples  t-­test  is  appropriate  when  there  
is  on  IV  with  two  independent  groups  and  the  DV  is  continuous  in  nature  (Field,  2009).    
The  independent  samples  t-­test  is  used  to  compare  differences  between  separate  
groups  when  there  are  two  experimental  groups  (single-­injection  sciatic  PNB  and  
continuous  sciatic  PNB)  and  different  study  participants  have  been  used  in  each  group  
(Field,  2009).      
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The  hypothesis  that  unplanned  hospital  admissions  due  to  poor  pain  control  
during  the  initial  72  hours  following  hamstring  autograft  harvest  will  be  different  in  
patients  receiving  single-­injection  sciatic  PNB  than  those  receiving  continuous  sciatic  
PNB  will  be  tested  with  the  chi-­square  test.    The  chi-­square  test  is  used  to  determine  if  
there  is  a  relationship  between  two  categorical  variables  (Field,  2009).    As  the  data  for  
this  DV  are  categorical,  the  focus  during  analysis  is  placed  on  frequencies  rather  than  
means.    The  chi-­square  test  can  be  used  to  determine  if  there  is  a  significant  difference  
between  the  expected  frequencies  and  observed  frequencies  in  one  or  more  categories  
(Field,  2009).  
      The  hypothesis  that  active  knee  flexion  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  different  in  patients  receiving  single-­injection  sciatic  
PNB  than  those  receiving  continuous  sciatic  PNB  will  be  tested  using  the  chi-­square  
test.    The  hypothesis  that  patient  satisfaction  with  pain  control  during  the  initial  72  hours  
following  hamstring  autograft  harvest  will  be  different  in  patients  receiving  single-­
injection  sciatic  PNB  than  those  receiving  continuous  sciatic  PNB  will  also  be  tested  
using  the  Wilcoxon-­Mann-­Whitney  test.    The  Wilcoxon-­Mann-­Whitney  test  is  appropriate  
to  test  both  these  hypotheses,  as  this  test  is  designed  to  evaluate  the  difference  
between  two  treatments  (single-­injection  sciatic  PNB  and  continuous  sciatic  PNB)  using  
data  from  an  independent  measures  study  (Gravetter  &  Wallnau,  2000).    During  
analyses,  testing  may  be  altered  based  on  the  recommendations  of  the  statistician  to  
better  analyze  the  collected  data.    Intention-­to-­treat  analysis  will  not  be  employed,  as  
this  may  skew  results  and  it  is  often  difficult  to  obtain  outcome  data  for  study  
participants  who  have  dropped  out  of  the  study  (Polit  &  Beck,  2012).      
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Resolution  of  Challenges  
As  with  any  study,  multiple  challenges  can  be  expected.    Enrolling  adolescents  
into  clinical  studies  can  be  challenging.    Parents  are  often  reluctant  to  provide  written  
consent  for  their  child  to  participate  in  a  clinical  trial,  as  they  prefer  the  care  provided  to  
their  child  adhere  to  the  current  accepted  gold  standards  of  care.    Explaining  that  the  
two  techniques  of  sciatic  PNB  being  compared  in  this  study  are  not  experimental,  rather  
they  are  well-­established  techniques  that  offer  reliable  pain  control  may  alleviate  
concerns  related  to  enrollment  in  this  study.    While  adolescents  may  be  reluctant  to  
undergo  regional  anesthesia,  this  reluctance  may  be  overcome  once  the  patient  learns  
he  or  she  will  be  under  general  anesthesia  when  PNB  is  done.    In  addition,  all  
participants  who  enroll  in  the  study  will  receive  a  $20.00  gift  card.    Incentives  have  been  
found  to  have  a  substantial  effect  on  study  participation  (Polit  &  Beck,  2012).    While  
previously  found  as  a  form  of  undue  influence  or  coercion,  the  use  of  incentives  is  
innocuous  when  the  risk  of  participation  is  relatively  low,  the  research  is  not  degrading,  
and  the  incentive  is  relatively  small  (Grant  &  Sugarman,  2004).    
Attrition  of  study  participants  is  also  a  concern,  however,  several  tactics  can  be  
employed  to  minimize  the  attrition  rate.    Multiple  points  of  contact  for  the  patient  and  
their  guardian(s)  will  be  collected  at  the  time  of  study  enrollment  to  provide  the  research  
coordinator  multiple  avenues  for  contacting  the  study  participant  for  data  collection.    
Requiring  the  study  participant  and  his  or  her  guardian  to  sign  an  agreement  at  the  time  
of  enrollment  that  sates  contact  with  the  research  coordinator  will  be  maintained  during  
the  72  hour  postoperative  period  may  dissuade  attrition.    An  alternative  approach  would  
be  to  withhold  dispensing  the  $20  incentive  until  the  data  collection  period  is  complete  
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and  all  data  has  been  gathered.    Utilizing  home  health  nurses  to  maintain  study  
participant  contact  is  yet  another  approach  to  decreasing  attrition.    Currently,  the  
practice  at  the  Liberty  Campus  of  CCHMC  is  to  train  patient’s  guardians  how  to  safely  
remove  CPI  catheters  at  home.    Should  attrition  become  rampant  home  health  nurses  
could  be  utilized  for  CPI  catheter  removal,  thereby  serving  as  a  point  of  contact  with  
study  participants.    The  costs  associated  with  this  tactic,  however,  would  likely  prove  to  
be  prohibitive.  
Potential  threats.    Several  threats  to  internal  validity  have  been  considered.    To  
ensure  internal  validity,  prior  to  commencement  of  the  study  all  levels  of  measurement  
will  be  reassessed  to  confirm  that  the  tool  aligns  with  the  constructs  within  the  design  of  
the  study.    During  the  study  design,  methodology  was  compared  with  similar  previously  
performed  studies  to  assess  for  potential  pitfalls  and  bolster  this  study’s  level  of  
robustness.    Outcome  measure  data  will  be  reviewed  during  the  interim  analysis  to  
discern  whether  or  not  the  research  study  has  been  developed  in  a  manner  that  
adequately  addresses  the  specific  aims  of  the  study.    Study  participants  will  be  
randomized  to  avoid  threats  to  internal  validity,  thereby  enabling  the  ability  to  draw  valid  
inferences  about  differences  in  outcomes.    Randomization  is  the  most  effective  method  
of  controlling  individual  characteristics  and  removes  selection  bias,  in  addition  to  
decreasing  the  chance  for  homogeneity  (Polit  &  Beck,  2012).    Although  convenience  
sampling  may  lead  to  the  use  of  subjects  who  are  atypical  of  the  target  population,  
utilizing  a  prospective  randomization  plan  increases  the  generalizability  of  the  results,  
thereby  ensuring  external  validity.    During  analyses,  patient  demographics  can  be  
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compared  to  that  of  the  target  population  to  ascertain  whether  or  not  the  study  is  indeed  
generalizable.      
The  threat  of  history  is  likely  to  equally  affect  both  groups  in  the  study  and  have  
minimal  to  no  effect  on  outcome  measures.    Attrition  during  the  postoperative  phase  is  
likely,  however,  the  anticipated  attrition  rate  is  low.    Although  participant  attrition  
remains  a  concern,  maturation  is  minimized  by  the  relatively  short  data  collection  
period.    Data  collection  continues  only  72  hours  postoperatively,  attenuating  the  impact  
of  the  passage  of  time  during  the  study.    
To  negate  potential  threats  to  construct  validity  via  researcher  expectancies,  only  
the  research  coordinator  will  have  contact  with  the  patient  and  their  guardian  during  the  
postoperative  data  collection  phase.    The  research  coordinator  will  remain  blinded  to  the  
study  group  the  patient  was  randomized  to  throughout  the  course  of  the  study.    Novelty  
and  compensatory  effects  should  be  diminished  due  to  adequate  sample  sizes  and  the  
fact  that  all  patients  receive  at  least  one  CPI  catheter  (femoral  nerve).    Criterion-­related  
validity  is  supported,  as  the  utilization  of  sciatic  PNB  for  pain  control  following  hamstring  
autograft  is  grounded  in  the  literature.    The  study  is  designed  to  offer  predictive  validity,  
as  it  differentiates  between  the  efficacy  of  single-­injection  sciatic  blockade  and  
continuous  sciatic  blockade  following  hamstring  autograft.      
Finally,  adherence  to  study  protocols  is  essential  to  safeguarding  fidelity,  or  the  
extent  to  which  the  intervention  has  been  implemented  as  intended.    Should  study  
protocols  be  violated,  variability  due  to  PNB  technique  can  be  suppressed  and  
variability  due  to  other  factors  can  be  inflated,  possibly  leading  to  erroneous  conclusions  
(Polit  &  Beck,  2012).    Prior  to  the  start  of  the  study,  a  presentation  will  be  made  to  the  
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anesthesia  department  reviewing  the  study,  as  well  all  study-­related  protocols.    Time  
will  be  allotted  for  a  question  and  answer  period  to  ensure  no  questions  or  concerns  go  
unanswered.    After  the  enrollment  of  each  patient,  the  PI  will  be  in  contact  with  all  
clinical  team  members  providing  anesthesia  care  for  each  study  patient  to  further  
ensure  study  protocols  are  adhered  to  and  that  there  are  no  unintentional  deviations.    
Chapter  Summary  
   This  chapter  discussed  the  methods  by  which  an  experimental,  posttest-­only  with  
repeated  follow-­up  design  will  be  employed  to  compare  the  effect  of  single-­injection  
sciatic  PNB  to  continuous  sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  
self-­reported  pain  scores,  pain  medication  use,  and  unplanned  hospital  admission  due  
to  poor  pain  control,  2)  active  knee  flexion  following  ACL  reconstruction  with  a  
hamstring  autograft,  and  3)  patient  satisfaction  with  pain  control  following  ACL  
reconstruction  with  a  hamstring  autograft  in  the  adolescent  population.    Details  of  the  
methods  by  which  it  would  be  determined  whether  the  duration  of  sciatic  PNB  impacts  
hamstring  donor  site  pain  control,  postoperative  active  knee  flexion,  and  patient  
satisfaction  were  discussed.    All  study-­related  variables  and  the  associated  measures  
thereof  were  described.    Rationale  for  the  target  population,  selection  criteria  and  
recruitment  was  provided.    Study  protocols,  data  collection  methods,  and  planned  
statistical  analysis  were  offered.    In  addition,  anticipated  efforts  to  protect  human  
subjects  were  reviewed.    Chapter  Four  will  discuss  in  detail  data  preparation  and  the  
statistical  analysis  of  the  collected  data.      
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Chapter  Four:  Results  
  
Chapter  Introduction  
Sciatic  PNB  has  proven  to  be  the  most  reliable  means  of  abating  the  significant  
pain  attributed  to  hamstring  autograft  harvest  (Bushnell,  Sakryd,  &  Noonan,  2010).    To  
date,  the  ideal  duration  of  sciatic  PNB  following  hamstring  autograft  harvest  remains  
undetermined  leading  to  disagreement  among  clinicians  as  to  best  practice.    The  
purpose  of  this  research  was  to  compare  the  effect  of  single-­injection  sciatic  PNB  to  
continuous  sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  self-­reported  
pain  scores,  pain  medication  use,  and  unplanned  hospital  admission  due  to  poor  pain  
control,  2)  active  knee  flexion,  and  3)  patient  satisfaction  with  pain  control  following  ACL  
reconstruction  with  a  hamstring  autograft.      
This  study  employed  an  experimental  posttest-­only  design  with  repeated  follow-­
up,  with  subjects  enrolled  in  this  study  receiving  one  of  two  techniques  for  sciatic  PNB:  
single-­injection  PNB  or  continuous  sciatic  PNB  with  a  CPI  catheter.    Data  was  gathered  
preoperatively,  during  the  intraoperative  phase,  and  postoperatively  for  72  hours.      
This  chapter  describes  the  data  preparation  and  statistical  analyses  that  were  
employed  to  compare  the  effect  of  single-­injection  sciatic  PNB  to  continuous  sciatic  
PNB  on  the  stated  outcomes  of  interest  at  a  predetermined  interim  analysis  point  which  
consisted  of  30  patients  total.    The  chapter  begins  with  a  brief  review  of  the  data  
collection  procedures,  followed  by  a  description  of  the  data  cleaning  process.    In  
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addition,  the  results  of  the  data  analyses  as  they  relate  to  the  specific  aims  and  
research  hypotheses  are  summarized.      
Data  
Review  of  data  collection.    Following  Institutional  Review  Board  approval  from  
both  CCHMC  in  Cincinnati,  Ohio  and  VCU  in  Richmond,  Virginia,  data  was  collected  
from  a  convenience  sample  of  adolescents  scheduled  to  undergo  unilateral  ACL  
reconstruction  utilizing  a  hamstring  autograft  on  an  outpatient  basis  at  the  Liberty  
Campus  of  CCHMC.    Prior  to  the  start  of  enrollment,  a  novel  data  collection  tool  was  
developed  and  piloted  in  an  effort  to  reduce  error  during  the  measurement  process.    
Five  volunteers  undergoing  ACL  reconstruction  with  a  hamstring  autograft  at  the  Liberty  
Campus  of  CCHMC  were  sought  out  to  trial  the  data  collection  tool,  with  the  ensuing  
refinement  of  the  data  collection  tool  focused  on  reliability  and  validity.          
Once  initiated,  the  data  collection  phase  lasted  approximately  nine  months.    A  
total  of  50  subjects  were  screened  for  recruitment.    Inability  to  recruit  all  potential  study  
patients  was  attributed  to  failure  to  meet  inclusion  criteria  (n  =  4),  the  use  of  a  patellar  
graft  rather  than  a  hamstring  autograft  (n  =  3),  subject  refusal  (n  =  3),  and  lack  of  clinical  
staff  to  support  study  enrollment  (n  =  3).    Subsequent  to  enrollment,  data  was  gathered  
preoperatively,  during  the  intraoperative  phase,  and  postoperatively.    Data  was  
gathered  72  hours  postoperatively  via  the  data  collection  tool  and  entered  into  
REDCapTM  by  the  research  coordinator.    
Following  enrollment,  five  subjects  were  excluded  from  the  study  due  to  the  
inability  to  contact  the  family  postoperatively  (n  =  4)  and  the  occurrence  of  transient  
global  amnesia  postoperatively  in  an  adolescent  with  a  recent  history  of  concussion  (n  =  
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1).    While  unrelated  to  the  study,  it  was  thought  the  patient’s  transient  inability  to  recall  
or  create  new  memories  deemed  them  an  unreliable  data  source.    Exclusion  following  
enrollment  lead  to  the  utilization  of  a  sample  size  slightly  larger  than  projected  to  ensure  
equal  groups  were  available  for  analysis.    Ultimately,  data  from  32  subjects  was  
available  for  analyses  (Figure  8).    Data  collected  on  all  measures  were  manually  
entered  into  REDCapTM  by  the  research  coordinator.    Data  was  then  exported  directly  to  
SASTM  (Cary,  NC)  v9.3  for  analysis.  
Data  preparation  and  cleaning.    All  data  were  inspected  for  accuracy  and  
variable  names  and  labels  were  amended  as  needed.    Table  6  defines  the  relevant  
variable  abbreviations  used  throughout  the  analyses.  
Age  in  years  on  the  day  of  surgery  was  entered  for  the  AGE  variable.    Value  
labels  were  assigned  to  GENDER  (1  =  male,  2  =  female)  and  ASA  physical  status  (1  =  
ASA  I,  2  =  ASA  II).    Calculated  BMI,  based  on  the  patient’s  height  and  weight  the  day  of  
surgery,  was  entered  was  entered  for  the  BMI  variable.    It  was  noted  whether  or  not  the  
patient  had  a  history  of  previous  surgery  of  any  type  (0  =  no,  1  =  yes).    Self-­reported  
tolerance  of  pain  scores  were  entered  for  the  PAIN_TOLERANCE  variable  (1  =  low  
tolerance  of  pain,  2  =  moderate  tolerance  of  pain,  3  =  high  tolerance  of  pain).    Self-­
reported  level  of  activity  since  the  time  of  ACL  injury  was  entered  for  the  
ACTIVITY_SINCE_ACL_IJNURY  variable  (1  =  not  active  at  all,  2  =  not  active,  3  =  
partially  active,  4  =  active,  5  =  highly  active).      
Data  regarding  which  of  the  two  orthopedic  surgeons  performed  the  ACL  
reconstruction  with  the  ORTHOPEDIC_SURGEON  variable  (1  =  Wall,  2  =  Parikh).    All  
intravenous  opioids  administered  during  the  intraoperative  phase  were  converted  to  
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Figure  8.  CONSORT  Flow  Diagram  Displaying  Progress  of  All  Participants  Through  the  
Study.  
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Table  6    
Relevant  Variables  Abbreviations  in  Analyses  
AGE   Age  in  years  on  day  of  surgery  
GENDER   Gender  (1=Male,  2=Female)  
ASA   ASA  physical  status  (1=ASA  I,  2=ASA  II)    
BMI   Calculated  BMI  based  on  height  and  weight  day  of  surgery    
PREVIOUS_SURGERY   History  of  previous  surgery  (0=No,  1=Yes)  
PAIN_TOLERANCE   Reported  tolerance  of  pain  (1=low,  2=moderate,  3=high)  
ACTIVITY_SINCE_ACL_INJURY  
Reported  level  of  activity  since  the  time  of  ACL  injury  (1=not  
active  at  all,  2=not  active,  3=partially  active,  4=active,  5=highly  
active)  
ORTHOPEDIC_SURGEON   Surgeon  performing  procedure  (1=Wall,  2=Parikh)  
INTRAOP_MSO4   Total  intraoperative  morphine  equivalents  in  mg  administered  
SURG_LENGTH   Surgery  length  in  minutes  
TOUR_INFLA_TIME   Tourniquet  inflation  time  in  minutes  
TOUR_GREATER_120   Tourniquet  inflation  time  greater  than  120  minutes  (1=Yes,  2=No)  
RANDOMIZATION_GROUP   Study  group  randomized  to  (1=Single-­injection  sciatic  PNB,  2=Continuous  sciatic  PNB)  
PV   Morphine  equivalents  administered  postoperatively  
KNEE_MOVEMENT   Reported  ability  to  bend  leg  at  the  knee  (1=Able  to  bend  with  no  pain,  2=Able  to  bend  but  with  pain,  3=Too  much  pain  to  bend)  
FRONT   Reported  pain  score:  Anterior  aspect  of  knee      (0=  No  pain,  10=Worst  pain)  
BACK   Reported  pain  score:  Posterior  aspect  of  knee    (0=  No  pain,  10=Worst  pain)  
SATISFACTION  
Reported  satisfaction  with  pain  management  (1=Not  satisfied  at  
all,  2=Not  satisfied,  3=Partially  satisfied,  4=Satisfied,  5=Highly  
Satisfied)  
  
morphine  equivalents  in  milligrams  (mg).    Following  conversion  to  morphine  
equivalents,  weight-­based  dosing  was  calculated  using  milligrams  per  kilograms  (kg).    
The  weight-­based  dose  administered  was  then  entered  for  the  INTRAOP_MSO4  
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variable.    Surgery  length  in  minutes  was  entered  for  the  SURG_LENGTH  variable.    
Tourniquet  inflation  time  in  minutes  was  entered  for  the  TOUR_INFLA_TIME  variable.      
The  RANDOMIZATION_GROUP  variable  denotes  which  study  group  the  patient  
was  randomized  to  for  the  study  (1  =  single-­injection  sciatic  PNB,  2  =  continuous  sciatic  
PNB).    The  reported  ability  to  flex  the  operative  leg  at  the  knee  following  surgery  was  
entered  for  the  KNEE_MOVEMENT  variable  (1  =  able  to  bend  with  no  pain,  2  =  able  to  
bend  but  with  pain,  3  =  too  much  pain  to  bend).    Data  for  the  KNEE_MOVEMENT  
variable  was  captured  once  every  twelve  hours  through  the  72  hour  postoperative  
period.    Pain  scores  were  collected  postoperatively  for  72  hours.    Scores  were  collected  
for  the  anterior  aspect  of  the  knee,  as  well  as  the  posterior  aspect  of  the  knee,  to  better  
discern  if  the  reported  pain  score  correlated  with  sciatic  nerve  distribution.    Reported  
pain  scores  for  the  anterior  aspect  of  the  knee  were  entered  for  the  FRONT  variable  (0  
=  no  pain,  10  =  worst  pain)  and  reported  pain  scores  for  the  posterior  aspect  of  the  knee  
were  entered  for  the  BACK  variable  (0  =  no  pain,  10  =  worst  pain).    Data  regarding  
FRONT  and  BACK  scores  were  captured  once  every  six  hours  through  the  72  hour  
postoperative  period.    In  addition,  reported  scores  for  pain  in  both  the  anterior  and  
posterior  aspect  of  the  knee  were  averaged  per  each  of  the  three  24  hour  time  periods  
throughout  the  72  hour  data  collection  period  and  entered  under  the  appropriate  
supplemental  variable.    It  was  thought  that  the  ability  to  compare  pain  in  24  hour  
intervals  may  provide  a  broader  perspective  of  the  impact  of  each  sciatic  PNB  
technique.    Scores  regarding  satisfaction  with  overall  pain  management  were  collected  
postoperatively  for  72  hours  and  entered  for  the  SATISFACTION  variable  (1  =  not  
satisfied  at  all,  2  =  not  satisfied,  3  =  partially  satisfied,  4  =  satisfied,  5  =  highly  satisfied).    
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Data  for  the  SATISFACTION  variable  were  captured  once  every  twelve  hours  through  
the  72  hour  postoperative  period.      
Following  inspection  of  the  data  set  several  data  points  and  variables  were  
addressed  prior  to  analysis.    It  was  discovered  that  several  of  the  time  points  pertaining  
to  the  timing  of  medication  administration  postoperatively  were  entered  incorrectly.    
Subsequently,  eight  data  points  were  corrected  to  military  time  to  reflect  proper  timing  of  
occurrence.    On  the  data  collection  tool,  data  was  gathered  pertaining  to  the  “date  and  
time  the  leg  was  no  longer  numb  behind  the  knee”,  which  was  intended  to  refer  to  the  
time  the  posterior  aspect  of  the  leg  was  no  longer  numb.    It  was  thought  that  this  metric  
would  provide  insight  as  to  the  occurrence  of  rebound  pain  once  the  posterior  aspect  of  
the  leg  was  no  longer  insensate.    Upon  initial  inspection  of  the  data  set,  it  was  found  
that  despite  the  training  given  to  the  patients  and  their  parents  prior  to  surgery,  this  data  
point  on  the  data  collection  tool  was  either  omitted  (n  =  7)  or  recorded  incorrectly  (n  =  
9).    With  over  half  of  the  data  for  this  variable  unavailable,  this  variable  was  excluded  
from  analyses.      
BMI  calculations  were  converted  to  z-­scores  and  added  to  the  data  set  under  the  
supplemental  variable  BMIZ.    BMIZ  reflects  the  measures  of  weight-­for-­height  adjusted  
for  patient  age  and  sex  relative  to  a  national  standard.    This  conversion  was  done  via  a  
program  in  SAS  TM  that  can  be  used  to  calculate  z-­scores  and  percentiles  for  patients  up  
to  20  years  of  age  based  on  Center  for  Disease  Control  and  Prevention  (CDC)  growth  
charts.    The  conversion  was  not  exact,  however,  as  the  CDC  charts  are  based  on  age  in  
months  rather  than  age  in  years.    In  adults  BMI  cut  points  exist  that  define  obesity  and  
overweight  that  are  not  linked  to  age  and  do  not  differ  based  on  gender  (Must  &  
  116  
Anderson,  2006).    In  growing  children,  BMI  varies  with  age  and  gender.    Therefore,  for  
BMI  calculations  to  be  meaningful  it  must  be  compared  to  a  reference  standard  that  
accounts  for  both  age  and  gender  (Must  &  Anderson,  2006).      
To  simplify  analysis,  data  gathered  for  “number  of  pills”  administered  
postoperatively  were  converted  to  morphine  equivalents  to  align  with  intraoperative  
opioid  measurement.    A  conversion  factor  of  5  mg  of  oral  Percocet®  (Endo  
Pharmaceuticals,  Malvern,  PA)  being  equivalent  to  2.5  mg  of  intravenous  morphine  and  
5  mg  of  oral  Vicodin®  (Mallinckrodt,  St.  Louis,  MO)  being  equivalent  to  2.0  mg  of  
intravenous  morphine  was  employed.    Following  conversion  to  morphine  equivalents,  
the  data  was  entered  under  the  supplemental  label  “PV”,  which  captured  the  morphine  
equivalents  of  all  opioids  administered  during  the  72  hour  postoperative  period.        
As  one  of  the  primary  focuses  of  the  study  was  to  examine  the  impact  duration  of  
sciatic  PNB  had  on  postoperative  opioid  consumption,  data  collected  regarding  the  use  
of  Tylenol®  (Johnson  &  Johnson,  New  Brunswick,  NJ)  postoperatively  was  not  included  
in  the  analyses  as  oral  Tylenol®  offers  10%  or  less  opioid  sparing  effects  for  immediate  
postoperative  pain.    Likewise,  data  collected  regarding  the  use  of  Valium®  (Genentech,  
San  Francisco,  CA)  or  Robaxin®  (Endo  Pharmaceuticals,  Malvern,  PA)  was  omitted  
from  analyses  as  PNB  does  not  impede  the  occurrence  of  postoperative  muscle  spasm  
for  which  the  medications  were  prescribed.      
Two  additional  variables  regarding  tourniquet-­related  data  were  added  to  simplify  
analyses.    Tourniquet  times  were  change  to  a  dichotomous  measure,  >120  minutes  and  
<  120  minutes,  and  entered  under  the  newly  created  variable  TOUR_GREATER_120.    
Tourniquet  times  greater  than  120  minutes  have  been  reported  as  being  associated  with  
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an  increased  risk  of  clinically  significant  compression  resulting  in  nerve  palsy  (Horlocker  
et  al.,  2006).    Tourniquet  pressure  was  also  transformed  into  a  supplemental  
dichotomous  variable,  TOUR_INFL_GREATER_THAN_100,  with  data  indicating  if  the  
tourniquet  pressure  was  greater  than  100  mmHg  when  compared  to  SBP  at  time  of  
inflation  (1  =  yes,  2  =  no).    Tourniquet  inflation  pressures  greater  than  100  mmHg  higher  
than  systolic  blood  pressure  have  been  associated  with  an  increased  risk  of  clinically  
significant  compression  resulting  in  nerve  palsy  (Horlocker  et  al.,  2006).      
Following  initial  inspection  of  the  data  set,  multiple  supplemental  variables  were  
created  to  allow  further  analysis  of  the  outcomes  of  interest.    More  specifically,  variables  
were  established  to  explore  the  outcomes  of  interest  in  24  hour  intervals  and  over  the  
entire  72  hour  postoperative  period.    The  list  of  created  variables  includes:    the  total  
number  of  opioids  required  per  24  hour  interval,  the  average  morphine  equivalents  per  
24  hour  interval  postoperatively,  the  average  morphine  equivalents  during  the  72  hour  
postoperative  period,  the  average  pain  score  at  the  front  of  the  knee  per  24  hour  
interval,  the  average  pain  score  at  the  front  of  the  knee  during  the  72  hour  postoperative  
period,  the  average  pain  score  at  the  back  of  the  knee  per  24  hour  interval,  the  average  
pain  score  at  the  back  of  the  knee  during  the  72  hour  postoperative  period,  the  average  
satisfaction  score  per  24  hour  interval,  and  the  average  satisfaction  score  during  the  72  
hour  postoperative  period.      
Data  Analysis  
Descriptive  statistics.    The  distribution  of  the  demographic  variables  was  
assessed  via  descriptive  statistics,  with  histograms  used  to  depict  continuous  
distributions  and  bar  charts  used  to  compare  statistical  summaries  of  the  distributions  of  
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the  same  continuous  variable  across  the  categories  of  categorical  variables  (Gray  &  
Kinnear,  2012).    Normality  of  variables  was  assessed  by  either  statistical  or  graphical  
methods.    Tests  of  normality  employed  empirical  distribution  function  (EDF)  statistics  to  
assess  for  goodness  of  fit.    EDF  statistics  are  based  on  a  comparison  of  the  
hypothesized  distribution  function  F(x)  with  the  empirical  distribution  function  Fn(x)  
(Davis  &  Stephens,  1989).    When  F(x)  is  continuous  and  completely  satisfied,  EDF  
statistics  give  a  more  powerful  tests  of  H0  than  the  classical  chi-­square  test  (Davis  &  
Stephens,  1989).    Findings  pertinent  to  outcomes  of  interest  in  this  study  are  discussed  
in  this  section.  
Descriptive  statistics  for  the  four  demographic  variables  were  generated  in  
SASTM  and  are  summarized  in  Table  7.    AGE  represents  the  continuous  variable  age  in  
years.    Once  enrolled,  patients  were  categorized  into  one  of  two  age  groups,  10  to  14  
years  of  age  inclusive  and  15  to  18  years  of  age  inclusive,  in  an  attempt  to  negate  the  
impact  of  age  on  outcomes  with  age  being  used  as  a  surrogate  for  maturity.    Patients  
enrolled  in  this  study  age  10  to  14  years  accounted  for  37.5%  (n  =  12)  of  the  study  
sample,  with  patients  age  15  to  18  years  accounting  for  62.5%  (n  =  20)  of  the  study  
sample  (Figure  9).    Overall,  the  mean  age  of  patients  enrolled  in  the  study  was  14.63  
years  with  a  standard  deviation  of  1.84.    Using  the  NPAR1WAY  Procedure  in  SASTM  to  
perform  a  Wilcoxon-­Mann-­Whitney  test  revealed  that  the  age  of  patients  who  received  
single-­injection  sciatic  PNB  (Mdn  =  15)  did  not  significantly  differ  from  those  who  
received  continuous  sciatic  PNB  (Mdn  =  15),  Ws  =  257.0000,  z  =  -­0.2501,  p  =  0.8025.  
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Table  7    
Observed  Frequencies  and  Percentages  of  Demographic  Variables  
Variable   Number  missing   Category   Frequency   Percent  
AGE   0   10  years   1   3.13  
     
11  years   1   3.13  
     
12  years   3   9.38  
     
13  years   3   9.38  
     
14  years   4   12.50  
     
15  years   8   25.00  
     
16  years   9   28.13  
     
17  years   2   6.25  
     
18  years   1   3.13  
GENDER   0   Male   14   43.75  
     
Female   18   56.25  
ASA   0   ASA  I   21   65.63  
     
ASA  II   11   34.38  
BMI   0   BMI  >  30   3   9.68  
     
BMI  <  30   28   90.32  
  
  
Figure  9.  Age  in  Years  of  Patients  in  the  Study.  
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The  percentages  of  males  and  females  enrolled  in  the  study  were  similar,  with  
males  comprising  43.75%  of  the  study  population  and  females  comprising  56.25%  of  
the  study  population  (Figure  10).        
  
Figure  10.  Gender  of  Patients  in  the  Study  (1  =  male,  2  =  female).  
  
  
Not  surprisingly,  the  frequency  distribution  for  ASA  physical  status  demonstrated  
that  more  patients  classified  as  ASA  physical  class  I  (n  =  21)  underwent  ACL  
reconstruction  than  those  classified  as  ASA  physical  class  II  (n  =  11)  (Figure  11).    Given  
that  the  population  of  adolescents  undergoing  ACL  are  largely  athletes  who  sustained  
their  injury  while  playing  sports,  it  is  of  no  surprise  that  the  vast  majority  of  patients  
enrolled  in  the  study  are  healthy  patients  without  preexisting  comorbidities.    As  
anticipated,  the  use  of  a  computer  generated  randomized  scheme  yielded  study  groups  
that  did  not  significantly  differ  in  regard  to  ASA  physical  classification  (x2  =  0.1385,  df  =  
1,  p  =  0.7097).      
Few  patients  enrolled  in  this  study  had  a  BMI  greater  than  30  (n  =  3)  (Figure  12).    
BMI  z-­scores  were  calculated  based  on  CDC  growth  charts.    In  children  and    
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Figure  12.  Calculated  BMI  of  Patients  in  the  Study.  
  
  
adolescents,  BMI  z-­scores  are  typically  used  in  research  rather  than  actual  BMI  as  they  
are  particularly  useful  to  monitor  changes  in  patients  with  a  BMI  above  the  99th  
percentile  or  below  the  1st  percentile.    Tests  of  normality  indicated  a  normal  distribution  
of  BMI  z-­scores  between  groups  existed  with  no  significant  differences  noted  (W  =  
0.9532,  p  =  0.1785),  allowing  for  parametric  testing.    No  significant  difference  was  found  
in  BMI  z-­scores  between  study  groups,  with  patients  randomized  to  the  single-­injection  
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sciatic  PNB  group  (M  =  0.8856,  SE  =  0.2286)  having  similar  BMI  z-­scores  to  those  
randomized  to  the  continuous  sciatic  PNB  group  (M  =  0.9253,  SE  =  0.2286),  t(30)  =  -­
0.12,  p  =  0.9030.    
A  Spearman’s  rank-­order  correlation  was  run  that  determined  there  was  a  
relationship  between  BMI  z-­scores  and  reported  pain  at  the  posterior  aspect  of  the  knee  
42,  48,  and  54  hours  postoperatively.    In  addition,  there  was  a  relationship  between  BMI  
z-­scores  and  satisfaction  scores  for  the  final  12  hour  interval  of  the  72  postoperative  
phase.    BMI  z-­score  was  significantly  related  to  posterior  knee  pain  reported  42  hours  
postoperatively,  rs  =  0.4480,  p  =  0.0101.    Likewise,  BMI  z-­score  was  significantly  related  
to  posterior  knee  pain  reported  48  hours  postoperatively,  rs  =  0.4764,  p  =  0.0058.    BMI  
z-­score  was  also  significantly  related  to  posterior  knee  pain  reported  54  hours  
postoperatively,  rs  =  0.3986,  p  =  0.0238.    BMI  z-­score  was  significantly  related  to  
satisfaction  scores  for  the  final  12  hour  interval  of  the  72  postoperative  phase,  rs  =                    
-­0.4083,  p  =  0.0203.      
Prior  to  initiation  of  this  study,  several  confounding  variables  were  identified.    
Data  was  collected  regarding  these  variables  and  analyzed  to  assess  their  potential  
impact  on  the  outcomes  of  interest.    Data  regarding  history  of  previous  surgery  of  any  
type  was  captured  during  the  preoperative  phase.    Eighteen  (56.25%)  of  the  thirty-­two  
patients  enrolled  in  this  study  had  previously  undergone  surgery,  which  was  distributed  
equally  among  study  group  with  nine  patients  in  each  group  having  undergone  surgery  
previously.    In  three  of  the  eighteen  cases,  it  was  noted  that  the  patient  previously  
underwent  ACL  reconstruction.    History  of  previous  surgery  proved  significant  at  several  
points  during  analyses  (Table  8).    More  specifically,  at  several  data  collection  time    
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Table  8    
Results  of  Wilcoxon-­Mann-­Whitney  Analysis  Based  on  History  of  Previous  Surgery      
Variable   Description   Previous  Surgery   N  
Mean  
Score   Statistic   Z   p  
BACK_12  
Pain  at  back  of  
knee  12  hours  
postop.  
1   18   19.6111   175   -­2.1717   0.0299  
0   14   12.5           
BACK_18  
Pain  at  back  of  
knee  18  hours  
postop.  
1   18   19.75   172.5   -­2.2407   0.025  
0   14   12.3214           
BACK_30  
Pain  at  back  of  
knee  30  hours  
postop.  
1   18   19.6388   174.5   -­2.1508   0.0315  
0   14   12.4643           
BACK_36  
Pain  at  back  of  
knee  36  hours  
postop.  
1   18   19.6667   174   -­2.1636   0.0305  
0   14   12.4286           
BACK_024  
Average  pain  
score  at  back  of  
knee  first  24  hour  
interval  postop.  
1   18   19.6111   175   -­2.1164   0.0343  
0   14   12.5           
BACK_2448  
Average  pain  
score  at  back  of  
knee  second  24  
hour  interval  
postop.  
1   18   19.4167   178.5   -­1.9789   0.0478  
0   14   12.75           
BACK  
Average  pain  
score  at  back  of  
knee  over  72  
hours  postop.  
1   18   19.5278   176.5   -­2.0515   0.402  




second  24  hour  
interval  postop.  
1   18   13.2222   290   2.2949   0.0217  




third  24  hour  
interval  postop.  
1   18   11.9722   312.5   3.1637   0.0016  




over  72  hours  
postop.  
1   18   13.3056   288.5   2.199   0.0279  
0   14   20.6071           
  
intervals  patients  who  previously  underwent  surgery  reported  significantly  higher  pain  
scores  at  the  posterior  aspect  of  their  knee.    Patients  who  previously  underwent  surgery  
also  reported  significantly  lower  satisfaction  scores  at  several  data  collection  intervals.  
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Data  regarding  self-­reported  pain  tolerance  was  gathered  in  the  preoperative  phase,  
with  patients  rating  their  pain  tolerance  as  low  (1),  moderate  (2),  or  high  (3).    Most  
patients  reported  having  a  moderate  (n  =  15)  or  high  (n  =  13)  pain  tolerance  (Table  9).    
Composition  of  study  groups  (Table  10)  was  not  significantly  different  in  regards  to  
representation  of  self-­reported  pain  tolerance  (x2  =  0.4451,  df  =  2,  p  =  0.8005).    
Table  9    
Frequencies  of  Self-­Reported  Pain  Tolerance        
pain_tolerance   Frequency   Percent   Cumulative  Frequency  
Cumulative  
Percent  
1   3   9.68   3   9.68  
2   15   48.39   18   58.06  
3   13   41.94   31   100.00  
  
Table  10    
Distribution  of  Self-­Reported  Pain  Tolerance  Among  Study  Groups    
Table  of  randomization_group  by  pain_tolerance  




Col  Pct   1   2   3   Total  








































Frequency  Missing  =  1  
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Activity  since  ACL  injury  was  gathered  as  potential  indicator  of  severity  of  ACL  
injury  and  possible  presence  of  collateral  damage  and  inclination  for  active  knee  flexion  
in  the  face  of  pain.    Patients  ranked  their  activity  level  as  1  =  not  active  at  all,  2  =  not  
active,  3  =  partially  active,  4  =  active,  5  =  highly  active.    Most  patients  (54.84%)  reported  
that  at  the  time  of  surgery  they  remained  partially  active  (Table  11).    Composition  of  
study  groups  (Table  12)  was  not  significantly  different  in  regards  to  representation  of  
self-­reported  level  of  activity  since  injury  (x2  =  3.5008,  df  =  4,  p  =  0.4778).  
Table  11    
Frequencies  of  Self-­Reported  Activity  Level  Among  Study  Groups    
activity_since_acl_injury   Frequency   Percent   Cumulative  Frequency  
Cumulative  
Percent  
1   2   6.45   2   6.45  
2   2   6.45   4   12.90  
3   17   54.84   21   67.74  
4   6   19.35   27   87.10  
5   4   12.90   31   100.00  
  
  
Two  orthopedic  surgeons  performed  all  of  the  ACL  reconstructions  in  this  study.    
Although  Orthopedic  Surgeon  1  performed  the  majority  (87.10%)  of  the  surgeries,  
composition  of  study  groups  in  regard  to  surgeon  was  not  significantly  different  (x2  =  
0.0048,  df  =  1,  p  =  0.9449).    When  compared  between  study  groups,  average  
postoperative  morphine  equivalent  administration  over  the  72  hour  postoperative  phase  
did  not  significantly  differ  for  patients  who  received  single-­injection  sciatic  PNB  (Mdn  =    
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Table  12    
Distribution  of  Self-­Reported  Activity  Level  Among  Study  Groups    
Table  of  randomization_group  by  activity_since_acl_injury  
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Frequency  Missing  =  1  
    
  
30.00)  when  compared  to  those  who  received  continuous  sciatic  PNB  (Mdn  =  45.00),  
Ws  =  91.5000,  z  =  1.5944,  p  =  0.1109    
The  anesthetic  delivered  during  the  intraoperative  phase,  including  intravenous  
opioid  administration,  was  left  to  the  discretion  of  the  team  providing  direct  care.    
Suggested  dosing  guidelines,  however,  were  made  available  to  each  team  in  an  effort  
to  minimize  variability  in  opioid  dosing.    Despite  the  available  dosing  guidelines,  there  
was  a  wide  variety  of  opioid  dosing  ranging  from  0.03  mg/kg  of  morphine  equivalents  to  
0.19  mg/kg  of  morphine  equivalents.    The  variation  in  opioid  dosing  resulted  in  a  non-­
normal  distribution  among  the  study  population  (W  =  0.7783,  p  <  0.0001).    When  
  127  
compared  between  study  groups,  however,  intraoperative  morphine  equivalents  
administered  those  randomized  to  receive  single-­injection  sciatic  PNB  (Mdn  =  
0.07mg/kg)  did  not  significantly  differ  from  those  who  received  continuous  sciatic  PNB  
(Mdn  =  0.07mg/kg),  Ws  =  233.0000,  z  =  -­1.1913,  p  =  0.2335.  
Surgery  length  in  this  study  ranged  from  75  minutes  to  240  minutes  and  was  
found  not  to  have  a  normal  distribution  among  the  study  population  (W  =  0.8455,  p  =  
0.003).    Surgery  length  for  patients  randomized  to  the  single-­injection  sciatic  PNB  group  
(Mdn  =  97.00)  did  not  significantly  differ  from  those  who  received  continuous  sciatic  
PNB  (Mdn  =  121.50),  Ws  =  297.5000,  z  =  1.2445,  p  =  0.2133.    A  Spearman’s  rank-­order  
correlation  was  run  that  determined  there  was  a  relationship  between  surgery  length  
and  reported  pain  at  the  anterior  aspect  of  the  knee  60  hours  postoperatively  and  72  
hours  postoperatively.    Surgery  length  was  significantly  related  to  anterior  knee  pain  
reported  60  hours  postoperatively,  rs  =  -­0.4184,  p  =  0.0192.    Likewise,  surgery  length  
was  significantly  related  to  anterior  knee  pain  reported  72  hours  postoperatively,  rs  =            
-­0.4571,  p  =  0.0097.  
Tourniquet  inflation  time  ranged  from  72  minutes  to  173  minutes,  with  tourniquet  
inflation  greater  than  120  minutes  occurring  in  34.48%  of  the  cases  (n  =  11).    Tourniquet  
times  were  change  to  a  dichotomous  measure,  with  data  indicating  whether  the  
tourniquet  inflation  time  was  >  120  minutes  or  <  120  minutes.    Date  regarding  
distribution  of  tourniquet  inflation  times  in  relation  to  the  120  minute  benchmark  came  
from  a  normally  distributed  population  (W  =  0.9401,  p  =  0.0752).    On  average,  study  
participants  randomized  to  the  single-­injection  sciatic  PNB  group  experienced  similar  
tourniquet  times  (M  =  104.6,  SE  =  6.4478)  to  those  randomized  to  the  continuous  sciatic  
  128  
PNB  group  (M  =  112.2,  SE  =  5.4515),  t(30)  =  -­0.90,  p  =  0.3737.    Tourniquet  inflation  
times  for  patients  having  surgery  with  Orthopedic  Surgeon  1  (M  =  109.7,  SE  =  4.6002)  
were  not  significantly  different  than  those  having  surgery  with  Orthopedic  Surgeon  2  (M  
=  107.3,  SE  =  11.8418),  t(29)  =  0.19,  p  =  0.8493.      
A  Spearman’s  rank-­order  correlation  was  run  that  determined  there  was  a  
relationship  between  tourniquet  inflation  time  and  reported  pain  at  the  anterior  aspect  of  
the  knee  60  hours  postoperatively  and  72  hours  postoperatively.    Tourniquet  inflation  
time  was  significantly  related  to  anterior  knee  pain  reported  60  hours  postoperatively,  rs  
=  -­0.4736,  p  =  0.0071.    Likewise,  tourniquet  inflation  time  was  significantly  related  to  
anterior  knee  pain  reported  72  hours  postoperatively,  rs  =  -­0.5010,  p  =  0.0041.    
Accordingly,  tourniquet  inflation  time  was  significantly  related  to  the  average  anterior  
knee  pain  reported  during  the  final  24  hours  of  the  72  hours  postoperative  period,  rs  =          
-­0.3937,  p  =  0.0258.    This  mirrors  of  the  correlation  found  between  surgery  length  and  
reported  anterior  knee  pain  60  and  72  hours  postoperatively.  
Tourniquet  inflation  pressure  was  transformed  into  a  dichotomous  variable  with  
data  indicating  if  the  tourniquet  pressure  was  greater  than  100  mmHg  when  compared  
to  SBP  at  time  of  inflation.    Tourniquet  inflation  ranged  between  200  mmHg  and  250  
mmHg,  with  the  predominate  setting  being  225  mmHg  (Table  13).    All  but  one  of  the  
patients  enrolled  in  this  study  experienced  tourniquet  inflation  pressures  greater  than  
100  mmHg  higher  than  their  systolic  blood  pressure  at  the  time  of  inflation.    
Composition  of  study  groups  in  regard  to  tourniquet  inflation  pressure  was  not  
significantly  different  (x2  =  2.0400,  df  =  3,  p  =  0.5641)  (Table  14).      
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Table  13    
Frequencies  of  Tourniquet  Inflation  Pressures  (in  mmHg)    
tour_set_press   Frequency   Percent   Cumulative  Frequency  
Cumulative  
Percent  
200   4   12.50   4   12.50  
210   1   3.13   5   15.63  
225   25   78.13   30   93.75  
250   2   6.25   32   100.00  
  
Table  14    
Distribution  of  Tourniquet  Inflation  Pressures  (in  mmHg)  Among  Groups  
Table  of  randomization_group  by  tour_set_press  




Col  Pct   200   210   225   250   Total  




















































Table  15  provides  a  summary  of  key  variables  in  the  analyses  per  each  
treatment  group  in  the  study.  
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Table  15    
Summary  of  Variables  by  Study  Group    
Randomization  
Group   Variable   N   #  Missing   Mean   Std  Dev  
   AGE   16   0   14.81   1.38  
   BMI   16   0   23.77   3.58  
   PREOPERATIVE_PAIN_SCORE   15   1   0.53   1.46  
   INTRAOP_MSO4   16   0   0.09   0.03  
   SURG_LENGTH   16   0   109.63   40.45  
   TOUR_INFLA_TIME   16   0   104.56   25.79  
   PV_POD1   16   0   12.05   5.22  
   PV_POD2   16   0   14.83   8.09  
   PV_POD3   16   0   9.63   5.59  
   PV   16   0   36.5   16.74  
1   FRONT_024   16   0   3.45   3.43  
   FRONT_2448   16   0   3.48   2.91  
   FRONT_4872   16   0   4.38   2.52  
   FRONT   16   0   3.77   2.74  
   BACK_024   16   0   4.43   2.72  
   BACK_2448   16   0   4.24   2.63  
   BACK_4872   16   0   3.69   2.67  
   BACK   16   0   4.12   2.49  
   SATISFACTION_024   16   0   3.84   1.01  
   SATISFACTION_2448   16   0   3.81   0.83  
   SATISFACTION_4872   16   0   3.94   0.83  
   SATISFACTION   16   0   3.86   0.77  
   AGE   16   0   14.44   2.25  
   BMI   16   0   23.63   4.29  
   PREOPERATIVE_PAIN_SCORE   16   0   1.25   1.81  
   INTRAOP_MSO4   16   0   0.07   0.02  
   SURG_LENGTH   16   0   115.75   25.93  
   TOUR_INFLA_TIME   16   0   112.19   21.81  
2   PV_POD1   16   0   10.61   5.22  
   PV_POD2   16   0   14.02   6.38  
   PV_POD3   16   0   8.77   5.83  
   PV   16   0   33.39   13.76  
   FRONT_024   16   0   2.81   2.55  
   FRONT_2448   16   0   3.38   2.41  
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Table  15  continued  
  
        
Randomization  
Group   Variable   N   #  Missing   Mean   Std  Dev  
   FRONT_4872   16   0   2.71   1.97  
   FRONT   16   0   2.81   1.79  
   BACK_024   16   0   2.48   2.73  
   BACK_2448   16   0   2.38   1.77  
2   BACK_4872   16   0   1.65   1.51  
   BACK   16   0   2.17   1.51  
   SATISFACTION_024   16   0   3.88   1.06  
   SATISFACTION_2448   16   0   4.16   0.91  
   SATISFACTION_4872   16   0   4.41   0.58  
   SATISFACTION   16   0   4.15   0.76  
  
Hypothesis  Testing  
Prior  to  hypothesis  testing,  all  variables  included  in  the  analyses  were  examined  
through  various  SAS  TM  programs  for  accuracy  of  data  entry,  missing  values,  and  fit  
between  their  distributions  and  the  assumptions  of  multivariate  analysis.    The  variables  
were  examined  separately  for  each  of  the  treatment  groups,  single-­injection  sciatic  PNB  
and  continuous  sciatic  PNB,  and  then  compared  between  groups.    
Assignment  into  one  of  two  treatment  groups  was  determined  via  a  computer  
generated  randomization  model,  based  on  age,  gender,  and  ASA  physical  status.    Two  
groups  for  age  were  established:  10  to  14  years  of  age  (inclusive)  and  15  to  18  years  of  
age  (inclusive).    To  satisfy  inclusion  criteria,  only  patients  classified  as  ASA  physical  
status  I  or  II  were  enrolled.    While  considered  a  confounding  variable,  BMI  was  not  
considered  in  the  randomization  scheme  as  most  adolescents  undergoing  ACL  
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reconstruction  with  the  available  sample  population  were  not  obese.    As  planned,  the  
demographic  data  of  each  study  group  was  reasonably  balanced.  
Once  the  descriptive  data  analyses  were  reviewed  and  it  was  confirmed  that  
confounding  variables  did  not  significantly  impact  the  outcomes  of  interest,  the  Specific  
Aims  and  associated  research  hypotheses  were  then  tested.    
Specific  Aim  1.    Sciatic  PNB  significantly  reduces  pain  following  hamstring  
autograft  harvest  when  compared  to  intravenous  opioids.    It  remains  unknown,  
however,  if  any  benefit  is  gained  during  the  initial  72  hour  postoperative  period  from  
extending  analgesia  for  the  hamstring  donor  site  via  continuous  sciatic  PNB.    Specific  
Aim  One  posited  that  the  extended  duration  of  analgesia  offered  by  continuous  sciatic  
PNB  improves  pain  control  during  the  72  hour  postoperative  period  following  hamstring  
autograft  harvest  when  compared  to  single-­injection  sciatic  PNB.    Pain  control  is  a  
multifaceted  phenomenon,  therefore,  three  hypotheses  were  developed  to  more  
completely  explore  the  question:  Does  continuous  sciatic  PNB  improve  pain  control  
following  hamstring  autograft  harvest  when  compared  to  single-­injection  sciatic  PNB?  
H1.1.    Pain  scores  during  the  initial  72  hours  following  hamstring  autograft  harvest  
will  be  lower  in  patients  receiving  continuous  sciatic  PNB  when  compared  to  those  
receiving  single-­injection  sciatic  PNB.    
H1.2.    The  use  of  oral  pain  medication  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  lower  in  patients  receiving  continuous  sciatic  PNB  
when  compared  to  those  receiving  single-­injection  sciatic  PNB.  
H1.3.    The  incidence  of  unplanned  admission  to  the  hospital  due  to  poor  pain  
control  during  the  initial  72  hours  following  hamstring  autograft  harvest  will  be  lower  in  
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patients  receiving  continuous  sciatic  PNB  when  compared  to  those  receiving  single-­
injection  sciatic  PNB.      
Hypothesis  H1.1  focused  on  reported  pain  scores  as  a  metric  for  determining  pain  
control.    Hypothesis  H1.1  was  tested  via  non-­parametric  statistical  testing  as  the  
distribution  across  the  study  population  was  not  normal.    Pain  scores  were  collected  
from  each  patient  enrolled  in  the  study  once  every  six  hours  for  72  hours  following  the  
completion  of  surgery.    Scores  for  both  the  anterior  and  posterior  portion  of  the  knee  
were  collected  in  an  effort  to  better  discern  if  the  reported  pain  was  attributable  to  the  
sciatic  nerve  distribution,  which  is  the  particular  area  of  interest  in  this  study.    After  initial  
analysis,  scores  correlating  to  the  anterior  and  posterior  aspects  of  the  knee  were  
averaged  per  each  of  the  three  24  hour  intervals  observed  during  the  postoperative  
phase.    In  addition,  scores  for  anterior  and  posterior  knee  pain  over  the  entire  72  hour  
postoperative  phase  were  average  for  each  patient.        
Several  time  points  during  the  72  hour  postoperative  phase  were  found  to  have  
significantly  different  posterior  knee  pain  scores  between  each  of  the  treatment  groups.    
Using  the  NPAR1WAY  Procedure  in  SASTM  to  perform  a  Wilcoxon-­Mann-­Whitney  test  
revealed  that  the  posterior  knee  pain  scores  reported  24  hours  postoperatively  by  
patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  3.75)  significantly  differed  
from  those  who  received  continuous  sciatic  PNB  (Mdn  =  0.00),  Ws  =  213.5000,  z  =                  
-­1.9719,  p  =  0.0486.    Posterior  knee  pain  scores  reported  48  hours  postoperatively  by  
patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  4.50)  also  significantly  
differed  from  those  who  received  continuous  sciatic  PNB  (Mdn  =  1.50),  Ws  =  212.0000,  
z  =  -­1.9740,  p  =  0.0484.    In  addition,  posterior  knee  pain  scores  reported  54  hours  
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postoperatively  by  patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  5.00)  
significantly  differed  from  those  who  received  continuous  sciatic  PNB  (Mdn  =  1.00),  Ws  
=  208.5000,  z  =  -­2.1058,  p  =  0.0352.      
In  addition  to  the  individual  time  points,  averages  of  posterior  knee  pain  scores  
over  each  24  hour  interval,  as  well  as  the  entire  72  hour  postoperative  phase,  
significantly  differed.    During  the  initial  24  hour  interval  of  the  postoperative  phase,  the  
average  posterior  knee  pain  score  reported  by  patients  who  received  single-­injection  
sciatic  PNB  (Mdn  =  4.13)  significantly  differed  from  those  who  received  continuous  
sciatic  PNB  (Mdn  =  1.75),  Ws  =  210.0000,  z  =  -­2.0242,  p  =  0.0430.    During  the  second  
24  hour  interval  of  the  postoperative  phase,  the  average  posterior  knee  pain  score  
reported  by  patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  4.63)  significantly  
differed  from  those  who  received  continuous  sciatic  PNB  (Mdn  =  2.00),  Ws  =  205.0000,  
z  =  -­2.2089,  p  =  0.0272.    During  the  final  24  hour  interval  of  postoperative  phase,  the  
average  posterior  knee  pain  score  reported  by  patients  who  received  single-­injection  
sciatic  PNB  (Mdn  =  2.68)  significantly  differed  from  those  who  received  continuous  
sciatic  PNB  (Mdn  =  1.25),  Ws  =  202.5000,  z  =  -­2.3049,  p  =  0.0212.    The  average  
posterior  knee  pain  score  over  the  72  hour  postoperative  phase  significantly  differed  as  
well,  with  patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  3.46)  reporting  
higher  pain  scores  than  those  who  received  continuous  sciatic  PNB  (Mdn  =  1.93),  Ws  =  
203.0000,  z  =  -­2.2804,  p  =  0.0226.      
Hypothesis  H1.2  focused  on  oral  pain  medication  use  as  a  metric  for  determining  
pain  control.    Hypothesis  H1.2  was  tested  via  non-­parametric  statistical  testing  as  the  
distribution  across  the  study  population  was  not  normal.    Pain  medication  use  was  
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recorded  at  the  time  of  administration  rather  than  at  set  intervals  as  with  pain  scores.    
To  better  discern  the  amount  of  pain  medication  administered,  morphine  equivalents  
administered  for  each  patient  were  averaged  per  each  of  the  three  24  hour  intervals  
observed  during  the  postoperative  phase.    In  addition,  the  total  morphine  equivalents  
administered  over  the  entire  72  hour  postoperative  phase  were  average  for  each  
patient.    Total  oral  pain  medication  use  was  gathered,  converted  into  morphine  
equivalents,  and  analyzed.      
The  intended  analysis  was  via  t-­test,  however,  it  was  discovered  that  distribution  
across  the  population  was  inconsistent  depending  on  time  point  and  interval  (Table  16).    
Since  this  violated  the  assumption  of  normal  distribution  among  groups,  testing  was  via  
Wilcoxon-­Mann-­Whitney  testing.    Interestingly,  no  significant  differences  were  noted  
between  the  treatment  groups.    During  the  initial  24  hour  interval  of  the  postoperative  
phase,  the  average  dose  of  morphine  equivalent  administered  to  patients  who  received  
single-­injection  sciatic  PNB  (Mdn  =  10.00)  did  not  significantly  differ  from  those  who  
received  continuous  sciatic  PNB  (Mdn  =  9.38),  Ws  =  241.5000,  z  =  -­0.8375,  p  =  0.4023.      
During  the  second  24  hour  interval  of  the  postoperative  phase,  the  average  dose  of  
morphine  equivalent  administered  to  patients  who  received  single-­injection  sciatic  PNB  
(Mdn  =  13.75)  did  not  significantly  differ  from  those  who  received  continuous  sciatic  
PNB  (Mdn  =  12.50),  Ws  =  259.5000,  z  =  -­0.1518,  p  =  0.8804.    During  the  final  24  hour  
interval  of  the  postoperative  phase,  the  average  dose  of  morphine  equivalent  
administered  to  patients  who  received  single-­injection  sciatic  PNB  (Mdn  =  10.00)  did  not  
significantly  differ  from  those  who  received  continuous  sciatic  PNB  (Mdn  =  8.25),  Ws  =  
251.5000,  z  =  -­0.4561,  p  =  0.6483.    The  average  dose  of  morphine  equivalent  
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Table  16    
Test  of  Normality  for  Postoperative  Pain  Medication  Use  (24  hour  intervals  and  overall  
average)    
  
Variable:    pv_pod1  
 
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.922777   Pr  <  W   0.0247  
Kolmogorov-­Smirnov   D   0.164254   Pr  >  D   0.0262  
Cramer-­von  Mises   W-­Sq   0.15803   Pr  >  W-­Sq   0.0188  
Anderson-­Darling   A-­Sq   0.962826   Pr  >  A-­Sq   0.0144  
  
  
Variable:    pv_pod2  
 
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.962576   Pr  <  W   0.3226  
Kolmogorov-­Smirnov   D   0.136796   Pr  >  D   0.1295  
Cramer-­von  Mises   W-­Sq   0.066119   Pr  >  W-­Sq   >0.2500  
Anderson-­Darling   A-­Sq   0.405752   Pr  >  A-­Sq   >0.2500  
  
  
Variable:    pv_pod3  
 
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.95084   Pr  <  W   0.1523  
Kolmogorov-­Smirnov   D   0.130698   Pr  >  D   >0.1500  
Cramer-­von  Mises   W-­Sq   0.074644   Pr  >  W-­Sq   0.2394  
Anderson-­Darling   A-­Sq   0.500474   Pr  >  A-­Sq   0.2024  
  
  137  
  
Table  16  continued  
  
Variable:    pv  
 
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.95116   Pr  <  W   0.1555  
Kolmogorov-­Smirnov   D   0.159133   Pr  >  D   0.0385  
Cramer-­von  Mises   W-­Sq   0.092895   Pr  >  W-­Sq   0.1371  
Anderson-­Darling   A-­Sq   0.523813   Pr  >  A-­Sq   0.1761  
  
administered  over  the  72  hour  postoperative  phase  did  not  significantly  differ  either,  with  
the  average  dose  of  morphine  equivalent  administered  to  patients  who  received  single-­
injection  sciatic  PNB  (Mdn  =  35.00)  being  similar  to  those  who  received  continuous  
sciatic  PNB  (Mdn  =  29.38),  Ws  =  248.0000,  z  =  -­0.5855,  p  =  0.5582.          
Hypothesis  H1.3  focused  on  unplanned  admission  due  to  poor  pain  control  as  a  
metric  for  determining  pain  control.    No  patients  in  this  study  were  admitted  to  the  
hospital  due  to  poor  pain  control  during  the  postoperative  period,  therefore  no  statistical  
testing  was  performed  for  Hypothesis  H1.3.  
Specific  Aim  Two.  Questions  remain  as  to  the  impact  of  of  sciatic  PNB  on  
active  knee  flexion  postoperatively.    Specific  Aim  Two  posited  that  the  extended  
duration  of  action  offered  by  continuous  sciatic  PNB  does  not  delay  active  knee  
flexion  during  the  72  hour  postoperative  period  following  hamstring  autograft  harvest  
when  compared  to  single-­injection  sciatic  PNB.         
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H2.1.    Active  knee  flexion  during  the  initial  72  hours  following  hamstring  autograft  
harvest  will  not  be  delayed  in  patients  receiving  continuous  sciatic  PNB  when  compared  
to  those  receiving  single-­injection  sciatic  PNB.  
Hypothesis  H2.1  focused  on  reported  knee  movement  scores  as  a  metric  for  
determining  the  impact  of  continuous  sciatic  PNB  on  active  knee  flexion.    Knee  
movement  scores  were  collected  from  each  patient  enrolled  in  the  study  once  every  
twelve  hours  for  72  hours  following  the  completion  of  surgery.    Chi-­square  testing  was  
employed  to  analyze  Hypothesis  H2.1  as  the  DV  was  ordinal  in  nature.    No  significant  
differences  were  found  between  treatment  groups  in  relation  to  active  knee  flexion  
(Table  17).    Distribution  of  responses  followed  a  similar  pattern  for  each  treatment  group  
at  each  time  interval  (Table  18).    For  each  treatment  group,  the  majority  of  answers  
regarding  the  ability  to  actively  flex  the  knee  improved  from  “too  much  pain  to  bend”  to  
“able  to  bend,  but  with  pain”  at  the  36  hour  time  interval.    
Table  17    
Summary  of  Chi-­Square  Analyses  for  Active  Knee  Flexion  by  Treatment  Group  
Time  Interval   x2   df   p  
12   5.9429   2   0.0512  
24   1.4   2   0.4966  
36   0.1497   2   0.9279  
48   0.4762   2   0.7881  
60   0.3768   2   0.8283  
72   0.1107   2   0.9461  
Specific  Aim  Three.    Pain  control  is  often  closely  associated  with  patient  
satisfaction.    Specific  Aim  Three  posited  that  the  extended  duration  of  analgesia  offered  
by  continuous  sciatic  PNB  will  improve  patient  satisfaction  during  the  72  hour 
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Table  18    
Summary  of  Distribution  of  Active  Knee  Flexion  Responses  by  Treatment  Group  for  
Each  Time  Interval  
Time  Interval   Randomization  Group  
Able  to  bend  
with  no  pain  (n)  
Able  to  bend,  but  
with  pain  (n)  
Too  much  pain  
to  bend  (n)  
12  
1   0   4   12  
2   5   3   8  
24  
1   1   6   9  
2   3   4   9  
36  
1   2   8   6  
2   2   9   5  
48  
1   1   11   4  
2   2   11   3  
60  
1   2   11   3  
2   1   12   3  
72  
1   3   10   2  
2   4   10   2  
postoperative  period  following  hamstring  autograft  harvest  when  compared  to  single-­
injection  sciatic  PNB.      
H3.1.    Patient  satisfaction  with  pain  control  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  improved  in  patients  receiving  continuous  sciatic  
PNB  when  compared  to  those  receiving  single-­injection  sciatic  PNB.  
Hypothesis  H3.1  focused  on  reported  satisfaction  scores  as  a  metric  for  
determining  the  impact  of  continuous  sciatic  PNB  on  patient  satisfaction.    Satisfaction  
scores  were  collected  from  each  patient  enrolled  in  the  study  once  every  twelve  hours  
for  72  hours  following  the  completion  of  surgery.    In  addition,  satisfaction  scores  for  
each  patient  were  averaged  per  each  of  the  three  24  hour  intervals  observed  during  the  
postoperative  phase.    Satisfaction  scores  over  the  entire  72  hour  postoperative  phase  
were  averaged  for  each  patient  as  well.    The  distribution  of  satisfaction  scores  across  
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the  population  was  not  normal  (Table  19),  indicating  that  non-­parametric  testing  would  
be  appropriate.    As  such,  the  Wilcoxon-­Mann-­Whitney  test  was  employed  to  analyze  
satisfaction  scores.     
Table  19    
Test  of  Normality  for  Satisfaction  Scores      
  
Variable:    satisfaction_12  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.842626   Pr  <  W   0.0003  
Kolmogorov-­Smirnov   D   0.236293   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.303116   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   1.915763   Pr  >  A-­Sq   <0.0050  
  
  
Variable:    satisfaction_24  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.847882   Pr  <  W   0.0004  
Kolmogorov-­Smirnov   D   0.213176   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.266317   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   1.733284   Pr  >  A-­Sq   <0.0050  
  
  
Variable:    satisfaction_36  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.830486   Pr  <  W   0.0002  
Kolmogorov-­Smirnov   D   0.200717   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.296049   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   1.927452   Pr  >  A-­Sq   <0.0050  
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Table  19  continued  
  
Variable:    satisfaction_48  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.849884   Pr  <  W   0.0004  
Kolmogorov-­Smirnov   D   0.21875   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.332025   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   2.027425   Pr  >  A-­Sq   <0.0050  
  
  
Variable:    satisfaction_60  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.808472   Pr  <  W   <0.0001  
Kolmogorov-­Smirnov   D   0.204723   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.362817   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   2.41014   Pr  >  A-­Sq   <0.0050  
  
  
Variable:    satisfaction_72  
  
Tests  for  Normality  
Test   Statistic   p  Value  
Shapiro-­Wilk   W   0.750444   Pr  <  W   <0.0001  
Kolmogorov-­Smirnov   D   0.320219   Pr  >  D   <0.0100  
Cramer-­von  Mises   W-­Sq   0.513726   Pr  >  W-­Sq   <0.0050  
Anderson-­Darling   A-­Sq   3.230695   Pr  >  A-­Sq   <0.0050  
     
As  a  whole,  satisfaction  scores  between  groups  proved  to  be  similar.    The  sole  
exception,  however,  was  at  the  72  hour  interval.    When  compared  between  study  
groups,  satisfaction  scores  72  hours  postoperatively  of  those  randomized  to  receive  
single-­injection  sciatic  PNB  (Mdn  =  4.00)  significantly  differed  from  those  who  received  
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continuous  sciatic  PNB  (Mdn  =  4.50),  Ws  =  290.0000,  z  =  2.1456,  p  =  0.0319.    Despite  
this  finding,  satisfaction  scores  per  24  hour  interval  and  overall  failed  to  be  significantly  
different  (Table  20).  
Table  20    
Summary  of  Wilcoxon-­Mann-­Whitney  Analyses  of  Satisfaction  Scores    
Time  Interval   Single-­injection  PNB  median  
Continuous  
PNB  median   Ws   z   p  
Initial  24  hour  interval   3.75   4   267   0.0976   0.9222  
Second  24  hour  interval   3.5   4   305   1.763   0.115  
Final  24  hour  interval   4   4.5   306   1.6082   0.1078  
Average  over  entire    
72  hours   3.67   4   294.5   1.1483   0.2509  
  
Chapter  Summary  
   This  chapter  presented  the  statistical  analyses  and  results  of  this  study  which  
aimed  to  answer  the  following  research  question:  does  single-­injection  sciatic  PNB  or  
continuous  sciatic  PNB  provide  more  effective  postoperative  pain  control  following  ACL  
reconstruction  with  a  hamstring  autograft  in  the  adolescent  population?      Effective  care  
is  multifaceted.    Accordingly,  this  study  utilized  a  variety  of  measures  of  pain  scores  to  
best  capture  the  impact  duration  of  sciatic  PNB  may  have  on  outcomes  related  to  
effective  care.    A  variety  of  parametric  and  non-­parametric  statistical  testing  methods  
were  employed  to  most  appropriately  analyze  the  data.    The  measures  analyzed  
included  postoperative  medication  requirements,  rate  of  unplanned  admission  due  to  
poor  pain  control,  active  knee  flexion  throughout  the  72  hour  postoperative  phase,  and  
satisfaction  scores.    Of  these,  postoperative  pain  scores  were  most  impacted  by  
duration  of  sciatic  PNB.    Chapter  Five  will  discuss  theoretical  and  practical  implications  
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of  the  results,  limitations  of  the  study,  and  will  offer  recommendations  for  future  
research.    
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Chapter  Five:  Discussion  
  
Chapter  Introduction  
This  chapter  reviews  the  findings  of  this  study  which  explored  a  question  
clinicians  providing  care  for  adolescents  undergoing  ACL  utilizing  a  hamstring  autograft  
routinely  encounter:  What  duration  of  sciatic  PNB  provides  the  most  effective  
postoperative  pain  control?    A  brief  synopsis  of  the  clinical  relevance,  as  well  as  the  
study  design,  methodology,  ensuing  analyses  and  findings,  are  discussed.    This  
includes  a  discourse  on  the  theoretical  and  practical  implications  of  the  findings,  in  
addition  to  consideration  of  study-­related  limitations.    Finally,  recommendations  for  
future  research  are  offered.  
Summary  and  Overview  of  the  Problem  
ACL  reconstruction  among  the  adolescent  population  has  increased  by  over  400  
percent  in  the  last  decade.    With  an  ever  increasing  number  of  adolescents  now  
routinely  undergoing  ACL  reconstruction,  the  mean  age  of  all  patients  scheduled  for  this  
surgery  has  decreased  to  18  years  of  age  (Silvers  &  Mandelbaum,  2007).    Several  
surgical  techniques  for  ACL  reconstruction  are  commonly  accepted,  however,  use  of  a  
hamstring  autograft  has  emerged  as  the  technique  of  choice  for  adolescents  due  to  the  
decreased  morbidity  and  proven  long-­term  stability  when  compared  to  the  other  
ligament  replacement  options  (Mehta,  Mandala,  Foster,  &  Petsche,  2010;;  Pallis,  
Svoboda,  Cameron,  &  Owens,  2012).    The  advantages  of  using  a  hamstring  autograft  
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over  other  techniques  include  the  decreased  incidence  of  graft  failure,  lower  infection  
rate,  decreased  risk  of  disease  transmission,  a  potential  faster  return  to  full  activities,  
and  a  significant  reduction  in  postoperative  pain  scores  (Ryu  &  Provencher,  2011;;  
Feller,  Webster,  &  Gavin,  2001).      Still,  the  pain  attributed  to  hamstring  autograft  harvest  
is  considered  to  be  significant  during  the  immediate  postoperative  phase  and  must  be  
addressed  accordingly.  
  While  it  is  accepted  that  sciatic  PNB  best  palliates  hamstring  donor  site  pain,  
controversy  remains  as  to  the  appropriate  duration  of  sciatic  PNB.    It  has  been  reported  
that  hamstring  donor  site  pain  may  persist  up  to  48  hours  postoperatively,  but  definitive  
studies  regarding  the  duration  of  hamstring  donor  site  pain  are  lacking  (Frost,  et  al.,  
2000).    This  void  in  the  literature  yields  a  lack  of  evidence-­based  practice,  forcing  
clinicians  to  rely  upon  anecdotal  experiences  to  guide  their  decision  making  when  
choosing  between  single-­injection  and  continuous  sciatic  PNB.    As  a  result,  there  
remains  no  consensus  as  to  the  duration  of  sciatic  PNB  required  to  effectively  control  
donor  site  pain  throughout  the  postoperative  period  (Tran,  Ganley,  Wells,  Ganesh,  
Minger,  &  Cucchiaro,  2005;;  Bushnell,  Sakryd,  &  Noonan,  2010).          
Both  single-­injection  and  continuous  sciatic  PNB  elicit  concerns  making  it  
challenging  for  clinicians  to  discern  best  practice.    Advocates  of  single-­injection  sciatic  
PNB,  which  can  last  up  to  24  hours  or  longer,  note  that  in  adult  studies  sciatic  PNB  
offered  significant  advantages  in  postoperative  pain  control  only  during  the  initial  24  
hours  following  knee  surgery  (Wegener  et  al.,  2011).    Furthermore,  concerns  regarding  
increased  risk  of  falls,  decreased  active  knee  movement  and  the  masking  of  
compartment  syndrome  often  preclude  the  routine  use  of  continuous  sciatic  PNB  (Liu  &  
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Wu,  2007).    Proponents  of  continuous  sciatic  PNB  assert  that  the  extended  duration  of  
analgesia  afforded  by  this  technique  improves  overall  pain  control  postoperatively  and  
decreases  the  need  for  supplemental  pain  medications  (Ganesh  &  Cucchiaro,  2007).    In  
addition,  it  has  been  reported  that  the  duration  of  action  of  single-­injection  sciatic  PNB  
may  fail  to  outlast  that  of  hamstring  donor  site  pain  (Ganesh  &  Cucchiaro,  2007).  
The  choice  between  single-­injection  and  continuous  sciatic  PNB  is  important,  as  
patient  outcomes  may  be  greatly  affected  based  on  the  technique  chosen  to  employ.    
Should  postoperative  pain  be  mismanaged,  negative  physiological,  psychological,  and  
economic  consequences  often  result  (Agin  &  Glass,  2005).    Failure  to  address  pain  may  
lead  to  future  impairment  in  functioning  as  well  as  heighten  anxiety  and  fear,  which  in  
turn  may  further  increase  the  perception  of  pain  (Matthews,  2011).    Suffering  secondary  
to  protracted  pain  can  lead  to  detrimental  derangements  in  lifestyle  and  personality  
(Beales,  Holt,  Keen  &  Mellor,  1983).    Furthermore,  poorly  managed  pain  may  impede  
recovery,  resulting  in  increased  healthcare-­related  costs  and  time  away  from  school  and  
work  (Twycross,  2002).    Ultimately,  the  profound  impact  duration  of  sciatic  PNB  may  
have  on  patient  outcomes  merits  investigation  as  there  remains  a  lack  of  comparative  
effectiveness  studies  exists  in  the  literature  regarding  the  ideal  duration  of  sciatic  PNB  
following  hamstring  autograft  harvest  to  guide  clinical  practice.      
Purpose  of  the  Study  
Despite  the  exponential  increase  in  adolescents  undergoing  ACL  reconstruction  
with  a  hamstring  autograft,  there  is  not  an  accepted  standard  of  care  addressing  
postoperative  pain  control  stemming  from  hamstring  autograft  harvest.    The  purpose  of  
this  research  was  to  compare  the  effect  of  single-­injection  sciatic  PNB  to  continuous  
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sciatic  PNB  on  1)  postoperative  pain  control  as  measured  by  self-­reported  pain  scores,  
pain  medication  use,  and  unplanned  hospital  admission  due  to  poor  pain  control,  2)  
active  knee  flexion,  and  3)  patient  satisfaction  with  pain  control  following  ACL  
reconstruction  with  a  hamstring  autograft.    The  results  of  this  research  have  the  
potential  to  impact  clinical  decision  making  regarding  pain  control  management  when  
caring  for  adolescents  undergoing  ACL  reconstruction  with  a  hamstring  autograft.    
Review  of  Theory  and  Research  Question  
Melzack  and  Wall  (1965)  introduced  the  most  renowned  theory  of  pain  control  
several  decades  ago.    While  much  regarding  the  human  neuromatrix  has  been  
uncovered  since  that  time,  the  tenets  of  the  gate  control  theory  continue  to  guide  pain-­
related  research  around  the  globe.    The  gate  control  theory  of  pain  proposed  that  small  
neuronal  C  fibers  activate  excitatory  systems  that  subsequently  excite  output  cells  
which  enhances  pain.    Conversely,  it  was  suggested  that  large  neuronal  A  fibers  
mediate  inhibitory  processes  and  descending  control  systems  from  the  central  nervous  
system,  thereby  mitigating  further  enhancement  of  pain  by  excited  output  cells  
(Dickenson,  2002).    Melzack  and  Wall  (1965)  suggested  that  pain  could  be  modulated  
or  “gated”  not  only  in  the  dorsal  horn,  but  also  at  a  number  of  points  in  the  pain  pathway.    
The  ability  to  inhibit  excitatory  influences  and  enhance  inhibitory  influences  within  the  
pain  pathway  provides  the  theoretical  foundation  for  alleviating  pain  via  sciatic  PNB.      
Successful  modulation  of  the  pain  pathway  following  a  painful  insult,  such  as  a  ACL  
reconstruction  with  a  hamstring  autograft,  should  theoretically  lead  to  reductions  in  the  
perception  of  pain  and  subsequently  the  need  for  supplement  opioids.    If  true,  it  follows    
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that  overall  patient  satisfaction  levels  should  rise  as  many  of  the  deleterious  opioid-­
related  side  effects  that  often  derail  recovery  from  surgery  could  be  averted.  
The  gap  in  knowledge  regarding  management  of  hamstring  autograft  donor  site  
pain  in  adolescents  is  demonstrated  by  a  lack  of  literature  of  the  same.    While  
improvements  in  pain  control  for  adolescents  have  given  rise  to  improved  patient  
outcomes  postoperatively,  many  questions  remain  as  to  appropriate  resource  
management  and  utilization,  as  both  the  cost  and  duration  of  action  vary  greatly  
between  single-­injection  and  continuous  PNB  techniques.    This  study  was  designed  to  
answer  the  research  question:  Does  single-­injection  sciatic  PNB  or  continuous  sciatic  
PNB  provide  more  effective  postoperative  pain  control  following  ACL  reconstruction  with  
a  hamstring  autograft  in  the  adolescent  population?      
Methodology  
   An  experimental  posttest-­only  design  with  repeated  follow-­up  was  employed  for  
this  study.    Following  receipt  of  IRB  approval  from  both  CCHMC  and  VCU,  patients  from  
a  convenience  sample  were  enrolled  into  the  study  and  allocated  to  one  of  two  
treatment  groups  in  a  prospective,  randomized  manner.      Once  data  was  collected  from  
the  predetermined  number  of  patients  necessary  for  interim  analysis,  study  enrollment  
ceased  to  allow  for  data  analysis.    Descriptive  statistics  were  used  to  assess  whether  or  
not  the  data  set  would  be  adequate  to  address  the  hypotheses.    Following  initial  review  
of  the  data,  it  was  determined  that  the  data  set  was  appropriate  to  address  the  
proposed  hypotheses.    Subsequently,  analysis  commenced  with  Pearson  correlation,  
the  Wilcoxon-­Mann-­Whitney  test,  the  independent  samples  t-­test,  and  the  chi-­square  
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test  serving  as  the  predominate  analytic  tests  used  to  address  the  hypotheses  of  this  
study.  
Study  Findings  
Hypotheses.  Following  analysis,  it  was  discovered  that  only  two  of  the  five  
proposed  hypotheses  were  supported.  
H1.1.    Pain  scores  during  the  initial  72  hours  following  hamstring  autograft  harvest  
will  be  lower  in  patients  receiving  continuous  sciatic  PNB  when  compared  to  those  
receiving  single-­injection  sciatic  PNB.    Analysis  of  multiple  data  points  confirmed  that  
pain  scores  throughout  the  72  hour  postoperative  phase  were  significantly  lower  for  
patients  who  received  continuous  sciatic  PNB  when  compared  to  those  who  received  
single-­injection  sciatic  PNB.    This  included  significant  differences  being  reported  24,  48,  
and  54  hours  postoperatively,  with  those  who  received  continuous  sciatic  PNB  reporting  
much  lower  pain  scores  in  reference  to  the  posterior  aspect  of  their  knee.    Additionally,  
when  posterior  knee  scores  were  averaged,  patients  receiving  continuous  sciatic  PNB  
reported  significantly  lower  pain  scores  for  each  of  the  three  24  hour  postoperative  
intervals  for  which  data  was  gathered.    Over  the  course  of  the  72  hour  postoperative  
phase  the  overall  average  posterior  knee  pain  score  was  found  to  be  significantly  lower  
for  those  who  received  continuous  sciatic  PNB.    
H1.2.    The  use  of  oral  pain  medication  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  lower  in  patients  receiving  continuous  sciatic  PNB  
when  compared  to  those  receiving  single-­injection  sciatic  PNB.    Over  the  course  of  the  
72  hour  postoperative  phase,  at  no  point  was  a  significant  difference  in  pain  medication  
use  noted  on  analysis.    Wilcoxon-­Mann-­Whitney  testing  determined  that  patients  who  
  150  
received  single-­injection  sciatic  PNB  required  similar  doses  of  oral  pain  medication  
during  the  initial  72  hours  following  hamstring  autograft  harvest  to  those  who  received  
continuous  sciatic  PNB.  
H1.3.    The  incidence  of  unplanned  admission  to  the  hospital  due  to  poor  pain  
control  during  the  initial  72  hours  following  hamstring  autograft  harvest  will  be  lower  in  
patients  receiving  continuous  sciatic  PNB  when  compared  to  those  receiving  single-­
injection  sciatic  PNB.    This  hypothesis  was  not  supported  as  the  rate  of  unplanned  
admission  due  to  poor  pain  control  for  patients  enrolled  in  this  study  was  the  same  for  
each  treatment  group.    No  patients  in  this  study  were  admitted  due  to  poor  pain  control,  
therefore  no  statistical  testing  was  performed  in  regards  to  Hypothesis  H1.3.  
H2.1.    Active  knee  flexion  during  the  initial  72  hours  following  hamstring  autograft  
harvest  will  not  be  delayed  in  patients  receiving  continuous  sciatic  PNB  when  compared  
to  those  receiving  single-­injection  sciatic  PNB.    The  results  of  the  analyses  supported  
this  hypothesis.    Chi-­square  testing  was  employed  to  analyze  whether  significant  
differences  existed  between  treatment  groups  in  relation  to  active  knee  flexion  during  
the  72  hour  postoperative  phase.    No  statistically  significant  differences  were  found.    In  
fact,  the  distribution  of  responses  in  each  treatment  group  followed  a  similar  pattern  
throughout  the  72  hour  postoperative  phase,  with  the  majority  of  patients  reporting  that  
their  ability  to  actively  flex  the  knee  improved  from  “too  much  pain  to  bend”  to  “able  to  
bend,  but  with  pain”  at  the  36  hour  time  postoperative  interval.  
H3.1.    Patient  satisfaction  with  pain  control  during  the  initial  72  hours  following  
hamstring  autograft  harvest  will  be  improved  in  patients  receiving  continuous  sciatic  
PNB  when  compared  to  those  receiving  single-­injection  sciatic  PNB.    Analysis  via  the  
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Wilcoxon-­Mann-­Whitney  test  failed  to  support  this  hypothesis  as  satisfaction  scores  
between  groups  were  found  to  be  similar.    The  sole  exception,  however,  was  
satisfaction  scores  reported  at  the  72  hour  postoperative  interval.    When  compared  
between  study  groups,  satisfaction  scores  72  hours  postoperatively  of  those  
randomized  to  receive  continuous  sciatic  PNB  were  significantly  lower  than  those  who  
received  single-­injection  sciatic  PNB.    Despite  this  finding,  however,  satisfaction  scores  
per  24  hour  interval  and  overall  failed  to  be  significantly  different  implying  that  the  
singular  finding  of  significance  may  have  been  a  spurious  result  of  analysis  given  the  
small  sample  sized  being  analyzed.   
Application  to  the  Literature  
Despite  the  frequency  of  ACL  reconstruction  with  a  hamstring  autograft  in  the  
adolescent,  there  is  a  dearth  of  information  pertaining  to  how  to  most  effectively  
manage  pain  at  the  hamstring  donor  site  postoperatively.    Furthermore,  few  studies  
have  been  reported  in  the  literature  comparing  the  impact  of  single-­injection  sciatic  PNB  
with  continuous  sciatic  PNB  following  knee  surgery.      
Jansen,  Miller,  Arretche,  and  Pellegrini  (2009)  investigated  whether  the  addition  
of  sciatic  PNB  following  ACL  reconstruction  would  improve  postoperative  pain  control.      
This  study  failed  to  address  duration  of  sciatic  PNB,  however,  as  the  study  compared  
the  outcomes  of  patients  who  received  single-­injection  sciatic  PNB  with  those  who  did  
not  receive  sciatic  PNB.    It  should  also  be  noted  that  the  study  failed  to  specifically  
address  hamstring  donor  site  pain  as  the  grafts  included  in  the  study  varied,  ranging  
from  patellar  tendon  grafts,  to  semitendinosus  grafts,  to  allograft.    Nonetheless,  
following  analysis  it  was  reported  that  the  addition  of  sciatic  PNB  improved  
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postoperative  analgesia.    It  was  offered  that  sciatic  PNB  should  be  include  as  part  of  
anesthetic  care  plans  going  forward  to  facilitate  improved  patient-­reported  outcomes  
(Jansen  et  al.,  2009).    This  study  builds  upon  the  study  presented  by  Jansen  et  al.  as  it  
explores  the  impact  of  sciatic  PNB  following  ACL  reconstruction  in  greater  depth.      In  
addition  to  comparing  the  impact  secondary  to  the  varying  durations  single-­injection  and  
continuous  sciatic  PNB  offer,  outcome  measures  relating  to  effective  care  were  more  
clearly  defined.    This  included  measures  beyond  pain  scores  such  as  opioid  
requirements,  admission  rates  due  to  poor  pain  control,  the  impact  duration  of  sciatic  
PNB  has  on  active  knee  flexion,  and  patient  satisfaction  scores.  
Wegener  et  al.  (2011)  previously  investigated  the  impact  of  single-­injection  and  
continuous  sciatic  PNB  following  total  knee  arthroplasty.    Although  Wegener  et  al.  
attacked  a  significant  problem,  the  aims  of  the  study  were  poorly  delineated.    It  was  
difficult  to  discern  what  the  true  primary  aim  of  the  study  was:  to  investigate  the  impact  
duration  of  sciatic  PNB  had  on  pain  control,  the  impact  duration  of  sciatic  PNB  had  on  
rehabilitation,  the  ability  of  continuous  sciatic  PNB  to  decrease  time-­to-­discharge  
readiness  or  the  ability  of  continuous  sciatic  PNB  to  decrease  overall  length  of  
admission  postoperatively.    As  a  result,  the  study  failed  to  offer  solid  guidance  in  
regards  to  determining  the  ideal  duration  of  sciatic  PNB  following  knee  surgery.    
Readdressing  many  of  the  same  questions  in  a  clearly  delineated  manner,  this  study  
furthers  the  work  of  Wegener  et  al.  by  thoroughly  investigating  the  impact  duration  of  
sciatic  PNB  has  on  postoperative  outcomes.    The  findings  of  this  research  contribute  to  
the  understanding  clinicians  have  in  regards  to  the  impact  duration  of  sciatic  PNB  has  
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on  pain  control,  movement,  and  satisfaction  following  ACL  reconstruction  with  hamstring  
autograft  harvest.      
Implications  
Theoretical  implications.  The  gate  control  theory  suggest  that  pain  signals  can  
be  modulated  modulated  or  “gated”  not  only  in  the  dorsal  horn,  but  also  at  a  number  of  
points  in  the  pain  pathway.    The  ability  to  inhibit  excitatory  influences  and  enhance  
inhibitory  influences  within  the  pain  pathway  provides  the  theoretical  foundation  for  
alleviating  pain  via  sciatic  PNB.      The  results  of  this  study  only  partially  support  Melzack  
and  Wall’s  theory.    While  reported  pain  scores  were  significantly  lower  for  those  
randomized  to  receive  continuous  sciatic  PNB,  opioid  requirements  did  not  significantly  
differ  between  treatment  groups.    The  results  of  this  study  suggest  that  the  ability  of  
sciatic  PNB  to  inhibit  excitatory  influences  in  this  study  was  not  absolute.    While  a  lower  
concentration  of  local  anesthetic  was  used  in  this  study  achieve  sensory  blockade,  
rather  than  motor  blockade,  complete  inhibition  of  excitatory  influences  should  have  
been  present.    This  suggests  additional  influences  following  ACL  reconstruction  with  a  
hamstring  autograft  contribute  to  the  experience  of  pain.    Additionally,  the  results  of  this  
study  dispel  the  contention  that  lower  pain  scores  result  in  a  decrease  in  opioid  
requirements.        
Practical  implications.  From  a  practical  standpoint,  the  use  of  continuous  
sciatic  PNB  seemingly  benefits  patients  and  improves  reported  outcomes  without  
detriment  to  patients’  postoperative  course.    While  only  two  of  the  five  hypotheses  were  
supported  by  the  results  of  the  analyses,  this  limited  study  suggests  that  the  use  of  
continuous  sciatic  PNB  improves  reported  pain  scores  without  impeding  recovery  
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following  ACL  reconstruction  with  a  hamstring  autograft.    To  the  contrary,  the  use  of  
continuous  sciatic  PNB  did  not  preclude  active  knee  flexion  among  the  patients  enrolled  
in  this  study.  
It  can  be  hypothesized  that  the  use  of  continuous  sciatic  PNB  may  lead  to  
improved  postoperative  metrics  among  the  adult  population.    Physical  therapy  and  
rehabilitation  for  many  knee  surgeries  typically  commences  either  the  day  of  surgery  or  
the  morning  of  postoperative  day  one.    The  literature  supporting  early  initiation  of  
rehabilitation  following  joint  surgery  is  robust  and  well  founded.    One  of  the  primary  
limiting  factors  during  the  initiation  of  physical  therapy,  however,  is  the  pain  associated  
with  movement  of  the  newly  reconstructed  joint.    Given  the  significantly  lower  pain  
scores  and  retained  ability  to  actively  flex  the  knee,  it  is  feasible  that  the  utilization  of  
continuous  PNB  may  facilitate  early  initiation  of  rehabilitation.      
It  is  of  no  surprise  that  the  extended  analgesia  offered  by  continuous  sciatic  PNB  
significantly  improved  postoperative  pain  scores  during  the  72  hour  postoperative  phase  
of  this  study.    The  lower  pain  scores,  however,  did  not  translate  to  a  decrease  in  opioid  
administration  or  improved  satisfaction  scores.    As  there  were  not  significant  wide  
spread  improvements  in  most  of  the  metrics  analyzed,  some  clinicians  may  continue  to  
find  the  increased  costs  associated  with  continuous  sciatic  PNB  prohibitive.    Further  
analysis  of  a  larger  sample  is  required  to  determine  if  the  additional  costs  associated  
with  continuous  sciatic  PNB  are  justified.    Should  further  significant  improvements  in  
outcomes  be  identified,  it  may  be  easier  to  persuade  clinicians  to  utilize  continuous  
sciatic  PNB  to  facilitate  pain  control  following  ACL  reconstruction  with  a  hamstring  
autograft.    Significant  improvements  in  satisfaction  scores  would  be  especially  
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persuading,  as  reimbursement  for  health  care  will  be  largely  based  on  patient  
satisfaction  scores  in  the  near  future.        
Limitations  
Threats  to  internal  validity.    Several  threats  to  internal  validity  of  this  study  
were  recognized  during  the  design  of  this  study.    At  that  time  all  levels  of  measurement  
were  reassessed  to  confirm  that  the  tool  aligns  with  the  constructs  within  the  design  of  
the  study.    Nonetheless,  it  is  recognized  that  this  study  continues  to  have  several  
limitations.      
Criterion-­related  validity  remains  supported,  as  the  utilization  of  sciatic  PNB  for  
pain  control  following  hamstring  autograft  is  grounded  in  the  literature.    The  study  was  
designed  to  offer  predictive  validity,  as  the  study  was  designed  to  differentiate  between  
the  efficacy  of  single-­injection  sciatic  PNB  and  continuous  sciatic  PNB  following  
hamstring  autograft  harvest.    Adherence  to  study  protocols  by  the  clinicians  involved  
was  essential  to  safeguarding  intervention  fidelity.    Were  study  protocols  not  followed,  
variability  due  to  the  intervention  may  have  been  suppressed  and  variability  due  to  other  
factors  may  have  been  inflated,  possibly  leading  to  erroneous  conclusions.    While  
suggested  guidelines  regarding  PNB  and  opioid  administration  were  offered  to  all  
clinicians  providing  direct  patients  care,  adherence  to  these  guidelines  was  not  
monitored  or  enforced.    
Patients  enrolled  in  this  study  were  randomized  to  treatment  group  via  a  
computer-­generated  randomization  scheme  taking  into  consideration  three  key  
demographic  variables;;  age,  gender,  and  ASA  physical  status.    While  randomization  
allows  for  control  of  individual  characteristics  and  removes  selection  bias,  in  addition  to  
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decreasing  the  chance  for  homogeneity,  it  fails  to  completely  control  for  all  inherent  
traits  of  the  study  population  that  may  be  detrimental  to  the  results  of  this  study  (Polit  &  
Beck,  2012).      One  such  example  is  design  contamination  leading  to  compensatory  
rivalry.    Upon  awaking  from  surgery,  it  was  apparent  to  the  patient  and  their  guardian  
which  treatment  group  they  were  randomized  to  as  patients  were  not  blinded  to  the  
treatment  group.    It  is  possible  that  those  randomized  to  the  single-­injection  sciatic  PNB  
group  unknowingly  altered  their  responses  as  part  of  a  compensatory  mechanism.    Pain  
is  a  unique  experience  that  is  dealt  with  in  a  multitude  of  ways,  one  of  which  is  
rationalization.    By  convincing  one’s  self  that  they  received  the  “ideal”  intervention,  
patients  may  have  unknowingly  skewed  outcome  data.  
The  potential  threat  of  history  was  not  assessed  during  the  preoperative  phase.    
Many  patients  have  a  family  member,  friend,  or  classmate  who  have  previously  
undergone  ACL  reconstruction  or  received  PNB.    Conversations  with  those  with  prior  
experience  may  have  had  undue  influence  on  the  results  reported  by  those  enrolled  in  
this  study.    However,  while  the  threat  of  history  exists,  it  is  acknowledged  that  it  likely  
affected  both  treatment  groups  in  the  study  and  had  minimal  to  no  effect  on  outcomes.    
Temporal  ambiguity  was  not  a  concern,  as  the  focus  of  the  study  is  the  efficacy  
of  single-­injection  sciatic  PNB  in  controlling  pain  at  the  hamstring  autograft  donor  site,  
mandating  that  the  cause  of  pain  (hamstring  autograft  harvest)  preceded  any  perceived  
effect  (postoperative  pain  control  secondary  to  sciatic  PNB).    However,  in  assessing  
postoperative  pain,  we  failed  to  adequately  assess  the  origins  of  pain.    Not  all  ACL  
injuries  are  equal  and  the  degree  of  collateral  damage  secondary  to  the  injury  can  be  
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quite  variable.    It  is  within  reason  then  to  anticipate  increased  pain  for  more  extensive  
repairs  when  compared  to  ACL  reconstructions  with  less  extensive  damage.      
   Maturation,  not  in  relation  to  age  but  in  relation  to  time,  may  have  impacted  the  
scoring  of  the  self-­reported  measures.    Just  as  one’s  performance  decreases  with  
fatigue,  patients  enrolled  in  this  study  may  have  grown  weary  of  recording  data  points  
once  every  six  hours  for  a  72  hour  period.    A  lack  of  interest  or  effort  on  the  part  of  the  
patients  enrolled  in  the  study  may  have  ultimately  resulted  in  erroneous  results  and  
conclusions.  
Pain  following  ACL  reconstruction  with  a  hamstring  autograft  is  associated  with  
cutaneous  distributions  of  the  femoral,  sciatic,  obturator,  and  lateral  femoral  cutaneous  
nerves.    For  this  study,  we  chose  to  decrease  the  level  of  complexity  and  focused  on  
the  two  primary  nerve  distributions  associated  with  ACL  reconstruction;;  the  femoral  and  
sciatic  nerve  distributions.    The  contribution  of  the  lateral  femoral  cutaneous  nerve  to  
postoperative  pain  following  ACL  reconstruction  is  minimal  at  best.    However,  pain  over  
the  lateral  femoral  cutaneous  nerve  distribution  increases  as  tourniquet  times  and  
tourniquet  pressures  rise.    The  same  holds  true  for  the  cutaneous  innervation  of  the  
obturator  nerve,  although  the  cutaneous  distribution  of  the  obturator  nerve  is  far  more  
variable.    Because  of  the  inherent  variability,  it  is  often  not  considered  in  regards  to  
tourniquet  pain.    The  obturator  nerve  plays  a  role  in  hamstring  autograft  donor  site  pain,  
however,  as  it  provides  partial  sensory  innervation  to  the  gracilis  muscle  which  is  
sometimes  harvested  as  part  of  the  hamstring  autograft.    The  influence  of  pain  derived  
from  the  sensory  distribution  of  the  lateral  cutaneous  femoral  and  obturator  nerves  was  
not  controlled  for  in  this  study.  
  158  
Finally,  while  attrition  during  the  postoperative  phase  was  anticipated,  the  actual  
attrition  rate  was  higher  than  expected  (13.5%).    During  analysis  it  was  found  that  
patient  attrition  was  largely  due  to  the  inability  to  contact  patients  and  families  
postoperatively.    Prior  to  enrollment,  point  of  contact  information  was  gathered  from  
patients  and/or  their  parents,  however,  it  was  not  verified  if  the  provided  contact  
information  was  valid  and/or  operating.        
Threats  to  external  validity.   Several  threats  to  the  external  validity  of  this  study  
have  been  recognized.    First,  this  study  was  performed  as  a  single-­center  trial,  with  all  
of  the  patients  recruited  from  a  convenience  sample.    Choosing  this  sampling  method  
has  significant  inherent  limitations  in  terms  of  external  validity.    Convenience  sampling  
ultimately  may  not  produce  a  sample  typical  of  the  population  with  regard  to  critical  
variables.    It  was  anticipated,  however,  that  the  study  sample  would  be  diverse  and  
representative  of  patients  who  comprise  the  target  population.      
While  the  sample  population  in  this  study  was  representative  of  the  target  
population  in  many  aspects,  several  key  factors  were  not  accounted  for  such  as  home  
environment  following  surgery.    After  some  reflection,  it  was  recognized  that  this  study  
assumes  that  adolescents  undergoing  ACL  reconstruction  on  an  outpatient  basis  will  
have  the  appropriate  support,  means,  and  faculties  to  achieve  optimal  outcomes.    This  
does  not  hold  true  for  all  adolescents  nationally.    Perhaps  to  say  that  the  results  of  this  
study  are  generalizable  to  suburban  youth  would  be  more  appropriate.      
Additional  patient-­related  factors,  such  as  the  genetic  variability  relating  to  
morphine  metabolism,  should  be  considered.    Over  the  last  decade  much  has  been  
discovered  regarding  the  genetic  variability  that  guides  opioid  transport  and  metabolism.    
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It  is  now  accepted  that  genetics  play  a  significant  role  in  postoperative  opioid  
requirements.    These  are  but  a  few  examples  of  patient-­related  variables  that  were  not  
accounted  for  that  may  impact  the  outcomes  of  interest  in  this  study.      
It  is  acknowledged  that  the  techniques  and  protocols  employed  clinicians  at  
CCHMC  are  not  universal.    Regional  influence  and  individual  training  background  both  
guide  clinical  practice.    In  regards  to  this  study,  it  should  be  recognized  that  regional  
influence  impacts  both  anesthetic  and  orthopedic  practice.      While  PNB  is  routinely  part  
of  the  anesthetic  plan  at  CCHMC,  not  all  facilities  are  comfortable  with  performing  PNB  
on  patients  under  general  anesthesia,  thereby  limiting  its  utility  in  the  pediatric  and  
adolescent  population.    Likewise,  not  all  orthopedic  surgeons  performing  ACL  
reconstruction  for  the  adolescent  population  prefer  to  use  a  hamstring  autograft,  which  
potentially  limits  the  significance  of  the  results  of  the  study.    Moreover,  it  would  be  ill-­
advised  to  report  the  results  of  this  study  as  generalizable  given  the  results  were  from  
the  interim  analysis  of  a  much  larger  study.  
Conclusions  and  Recommendations  for  Future  Research  
The  addition  of  continuous  sciatic  PNB  may  improve  patent-­reported  outcome  
measures  after  ACL  reconstruction  with  a  hamstring  autograft  in  the  adolescent  
population,  but  the  benefits  of  this  approach  remain  uncertain.    Wegener  et  al.  (2011)  
reported  that  continuous  sciatic  PNB  lead  to  the  reduction  of  pain  scores  during  the  
initial  24  hours  following  total  knee  arthroplasty,  but  failed  to  demonstrate  a  significant  
impact  beyond  that  time.    Though  drawn  from  a  limited  sample,  the  results  of  the  study  
demonstrate  that  continuous  sciatic  PNB  significantly  reduces  postoperative  pain  scores  
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for  72  hours  postoperatively  when  compared  to  those  of  patients  who  received  single-­
injection  sciatic  PNB  without  further  impeding  active  knee  flexion.      
Although  the  choice  to  perform  continuous  sciatic  PNB  should  be  based  on  the  
individual  case  and  each  institution’s  policy,  continuous  sciatic  PNB  appears  to  be  
worthwhile  in  the  adolescent  population  undergoing  ACL  reconstruction  with  a  
hamstring  autograft.    Further  studies  with  a  larger  sample  are  warranted  to  better  
discern  the  impact  duration  of  sciatic  PNB  has  following  hamstring  autograft  harvest.    In  
addition,  studies  are  needed  to  understand  the  relationship  between  pain  scores,  opioid  
requirements  following  surgery,  and  patient  satisfaction  scores  as  the  relationship  
between  the  three  variables  does  not  seem  to  be  linear.  
In  summary,  pain  is  an  individual  experience.    While  every  patient  has  a  unique  
perception  of  pain,  it  is  a  reasonable  expectation  that  evidence-­based  protocols  exist  to  
guide  pain  control  following  surgery.    Given  the  frequency  ACL  reconstruction  is  
performed  in  the  adolescent  population,  it  is  imperative  further  studies  are  done  to  
determine  the  most  effective  duration  of  sciatic  PNB  to  effectively  manage  pain  
following  hamstring  autograft  harvest.    This  study  has  answered  several  questions,  but  
has  given  rise  to  many  more.    There  remains  much  to  be  learned  about  optimizing  pain  
control  so  that  negative  physiological,  psychological,  and  economic  consequences  are  
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several  other  funded  studies.    His  work  has  been  published  in  Pediatrics,  Journal  of  
  193  
Opioid  Management,  Current  Opinions  in  Anesthesiology,  Anesthesiology,  Anesthesia  
and  Analgesia,  and  the  Journal  of  Clinical  Anesthesia.    Dr.  Sadhasivam  will  aid  in  study  
design  and  preliminary  exam  of  the  data.  
  
Susan  Glynn,  CCRP  (Research  Coordinator:  18.0  calendar  months,  15%  effort)  
has  worked  on  a  variety  of  investigator-­initiated  studies  at  Cincinnati  Children’s  Hospital  
Medical  Center,  ranging  from  retrospective  chart  reviews  to  prospective,  randomized,  to  
blinded  studies.    Currently,  she  serves  as  lead  CRC  for  several  studies,  including  a  
multi-­center  foundation-­funded  prospective,  observational  study  evaluating  the  
association  between  specific  genotypes  and  phenotypes,  as  defined  by  pain  and  
analgesic  response,  in  children  following  adenotonsillectomy.    Mrs.  Glynn  also  
coordinates  several  studies  evaluating  the  effectiveness  of  pain  management  
techniques.    Mrs.  Glynn  will  aid  in  screening  the  operating  room  schedule  for  potential  
study  candidates,  consenting  patients  and/or  their  guardian(s),  collecting  data  pertinent  
to  the  study  and  completing  all  postoperative  data  collection  via  telephone  
conversations  with  study  participants  and  the  designated  scoring  guardian(s).    Mrs.  
Glynn  will  be  supervised  by  the  PI  throughout  the  course  of  the  study.  
     





Sample  Post-­Discharge  Data  Collection  Instrument  
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PAIN  CONTROL:  
  
Keep  track  of  your  pain  score  and  location  of  pain:    
  
Pain  score:  0  =  no  pain,  10  =  worst  pain  
Pain  location:  F  =  front  of  knee,  B  =  back  of  knee,  X  =  both  front  &  back    
6  hours      42  hours     
12  hours      48  hours     
18  hours      54  hours     
24  hours      60  hours     
30  hours      66  hours     
36  hours      72  hours     
  




Pain  medicine  prescribed  (circle  one):              Vicodin              Percocet              Other:____________  
  
  
Write  down  every  time  pain  medication  is  taken:  
  
Time/date   Type  of  medicine   Number  of  pills  
        
        
        
        
        
        
        
        
        
        
        
        
        
        
  
ACTIVE  KNEE  MOVEMENT:  
  
Rate  the  ability  to  bend  the  knee  that  was  operated  on:  
  
  











0  =  Able  to  bend  with  no  pain    
  
1  =  Able  to  bend,  but  with  pain    
  
2  =  Too  much  pain  to  bend    
                 




Rate  your  overall  satisfaction  score  with  pain  management:  
  











0  =  Not  satisfied  at  all  
  
1  =  Not  satisfied  
  
2  =  Partially  satisfied  
  
3  =  Satisfied  
  
4  =  Highly  satisfied  
                 
  
  
























Aims,  Variables,  Analyses  Table  
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Aim  1:  Explore  the  impact  of  sciatic  PNB  technique  on  hamstring  donor  site  pain  control  
postoperatively.      
  
Objective(s)   Hypothesis   Variable(s)   Analyses  
1.  Assess  pain  control  
following  hamstring  
autograft  harvest,  
comparing  the  efficacy  
of  single-­injection  and  
continuous  sciatic  
PNB.    
1.1  Pain  scores  during  
the  initial  72  hours  
following  hamstring  
autograft  harvest  will  
be  lower  in  patients  
receiving  continuous  
sciatic  PNB  when  
compared  to  those  
receiving  single-­
injection  sciatic  PNB.  
Self-­reported  pain  
scores  (DV),  sciatic  




1.2  The  use  of  oral  
pain  medication  during  
the  initial  72  hours  
following  hamstring  
autograft  harvest  will  
be  lower  in  patients  
receiving  continuous  
sciatic  PNB  when  
compared  to  those  
receiving  single-­
injection  sciatic  PNB.  
Self-­reported  oral  pain  
medication  use  (DV),  
sciatic  PNB  technique  
(IV)  
Independent  
samples  t-­test    
1.3  The  incidence  of  
unplanned  admission  
to  the  hospital  due  to  
poor  pain  control  
during  the  initial  72  
hours  following  
hamstring  autograft  
harvest  will  be  lower  in  
patients  receiving  
continuous  sciatic  PNB  
when  compared  to  
those  receiving  single-­
injection  sciatic  PNB.      
Unplanned  admission  
due  to  poor  pain  
control  (DV),  sciatic  
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Aim  2:  Explore  the  impact  of  sciatic  PNB  technique  on  active  knee  flexion  
postoperatively.  
  
Objective(s)   Hypothesis   Variable(s)   Analyses  
2.  Assess  impact  of  
sciatic  PNB  
technique  on  active  
knee  flexion.    
2.1  Active  knee  flexion  
during  the  initial  72  hours  
following  hamstring  
autograft  harvest  will  not  
be  delayed  in  patients  
receiving  continuous  
sciatic  PNB  when  




Active  knee  flexion  





Aim  3:  Explore  the  impact  of  sciatic  PNB  technique  on  patient  satisfaction  with  
postoperative  pain  control.      
  
Objective(s)   Hypothesis   Variable(s)   Analyses  
3.  Assess  the  impact  
of  sciatic  PNB  





with  a  hamstring  
autograft.    
3.1  Patient  
satisfaction  with  pain  
control  during  the  
initial  72  hours  
following  hamstring  
autograft  harvest  will  
be  improved  in  
patients  receiving  
continuous  sciatic  
PNB  when  compared  
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